*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 5 1ci8_c00 CARBOXYLESTERASE user 1 5 # 1 A 75 SER A 35 SER~? 7.73 O1 EDO A 103 A 78 LYS A 37 LYS~? 12.10 O1 EDO A 103 A 181 TYR A 58 TYR^? 4.97 C1 EDO A 103 A 348 TRP A 34 TRP~? -4.23 O1 EDO A 103s A 351 VAL B 99 VAL^? 12.11 O1 EDO A 103 coo 7.44 68.66 155.69 7.55 68.90 153.28 10.05 35.64 25.48 8.77 33.72 26.17 coo 4.47 64.28 156.50 5.73 67.40 151.90 12.12 40.22 23.70 13.00 44.76 21.03 coo 9.00 66.23 147.40 8.68 66.91 150.09 3.55 34.19 28.36 5.98 35.22 27.53 coo 10.47 64.90 153.97 12.37 63.89 150.67 6.13 38.14 24.92 3.44 40.11 22.82 coo 11.81 73.97 154.31 10.30 74.04 152.71 13.02 30.83 28.56 12.89 31.69 26.52 ULMN 5 1ci8_c00 CARBOXYLESTERASE user 2 5 # 2 A 75 SER B 35 SER~? 8.71 CL CL B 101 A 78 LYS B 37 LYS~? 12.27 CL CL B 101 A 181 TYR B 58 TYR^? 6.57 CL CL B 101 A 348 TRP B 34 TRP~? -4.42 CL CL B 101s A 351 VAL A 99 VAL^? 12.36 CL CL B 101 coo 7.44 68.66 155.69 7.55 68.90 153.28 3.17 24.62 50.92 3.13 26.96 50.21 coo 4.47 64.28 156.50 5.73 67.40 151.90 2.75 19.57 52.71 1.11 15.06 54.82 coo 9.00 66.23 147.40 8.68 66.91 150.09 -0.68 28.61 46.28 0.81 26.77 47.73 coo 10.47 64.90 153.97 12.37 63.89 150.67 -0.74 23.47 48.78 -4.45 24.02 47.66 coo 11.81 73.97 154.31 10.30 74.04 152.71 8.71 28.11 49.56 7.46 27.42 51.26 1ci8_c00 source 1ci8 CARBOXYLESTERASE : 2 hits 1ci8_c00 naa= 5 ULMN 5 1ci8_c01 CARBOXYLESTERASE user 1 5 # 1 B 75 SER A 35 SER~? 7.73 O1 EDO A 103 B 78 LYS A 37 LYS~? 12.10 O1 EDO A 103 B 181 TYR A 58 TYR^? 4.97 C1 EDO A 103 B 348 TRP A 34 TRP~? -4.23 O1 EDO A 103s B 351 VAL B 99 VAL^? 12.11 O1 EDO A 103 coo 7.78 77.14 199.76 7.73 77.03 202.11 10.05 35.64 25.48 8.77 33.72 26.17 coo 5.04 81.39 198.42 5.53 78.70 203.26 12.12 40.22 23.70 13.00 44.76 21.03 coo 8.25 79.97 207.93 8.15 79.14 205.25 3.55 34.19 28.36 5.98 35.22 27.53 coo 10.64 80.87 201.79 11.97 82.17 205.26 6.13 38.14 24.92 3.44 40.11 22.82 coo 11.94 71.99 202.02 10.19 71.99 203.33 13.02 30.83 28.56 12.89 31.69 26.52 ULMN 5 1ci8_c01 CARBOXYLESTERASE user 2 5 # 2 B 75 SER B 35 SER~? 8.71 CL CL B 101 B 78 LYS B 37 LYS~? 12.27 CL CL B 101 B 181 TYR B 58 TYR^? 6.57 CL CL B 101 B 348 TRP B 34 TRP~? -4.42 CL CL B 101s B 351 VAL A 99 VAL^? 12.36 CL CL B 101 coo 7.78 77.14 199.76 7.73 77.03 202.11 3.17 24.62 50.92 3.13 26.96 50.21 coo 5.04 81.39 198.42 5.53 78.70 203.26 2.75 19.57 52.71 1.11 15.06 54.82 coo 8.25 79.97 207.93 8.15 79.14 205.25 -0.68 28.61 46.28 0.81 26.77 47.73 coo 10.64 80.87 201.79 11.97 82.17 205.26 -0.74 23.47 48.78 -4.45 24.02 47.66 coo 11.94 71.99 202.02 10.19 71.99 203.33 8.71 28.11 49.56 7.46 27.42 51.26 1ci8_c01 source 1ci8 CARBOXYLESTERASE : 2 hits 1ci8_c01 naa= 5 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 1 4 # 1 A 92 TYR B 29 TYR~? 11.81 CL CL B 101 A 112 PHE B 48 PHE^? 12.98 CL CL B 101 A 178 PHE B 23 PHE~? 14.97 CL CL B 102 A 333 TRP B 34 TRP~? -4.42 CL CL B 101s coo 36.26 31.30 22.39 35.67 33.02 24.49 -4.54 27.31 54.97 -5.26 24.64 54.93 coo 45.52 35.08 26.96 42.72 35.07 26.70 -0.09 33.91 47.42 -2.69 34.81 47.10 coo 43.67 42.67 22.02 43.98 41.21 24.38 -6.14 38.29 50.40 -3.96 38.36 48.76 coo 37.80 27.73 29.78 38.27 31.62 30.15 -0.74 23.47 48.78 -4.45 24.02 47.66 1di1_c00 source 1di1 ARISTOLOCHENE SYNTHASE : 1 hits 1di1_c00 naa= 4 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 1 4 # 1 B 92 TYR B 29 TYR~? 11.81 CL CL B 101 B 112 PHE B 48 PHE^? 12.98 CL CL B 101 B 178 PHE B 23 PHE~? 14.97 CL CL B 102 B 333 TRP B 34 TRP~? -4.42 CL CL B 101s coo 99.56 54.98 23.15 101.17 54.32 25.32 -4.54 27.31 54.97 -5.26 24.64 54.93 coo 95.53 46.26 28.54 97.54 48.18 28.09 -0.09 33.91 47.42 -2.69 34.81 47.10 coo 102.10 41.65 23.98 100.86 42.71 26.26 -6.14 38.29 50.40 -3.96 38.36 48.76 coo 96.01 57.16 30.39 98.35 54.06 31.01 -0.74 23.47 48.78 -4.45 24.02 47.66 1di1_c01 source 1di1 ARISTOLOCHENE SYNTHASE : 1 hits 1di1_c01 naa= 4 ULMN 4 1eyp_c00 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 A 48 THR A 28 THR~? 16.04 C1 EDO A 103 A 106 TYR A 29 TYR~? 10.97 C1 EDO A 103 A 113 ASN A 86 ASN~? 11.47 C1 EDO A 103 A 190 THR A 16 THR^? 12.60 CL CL A 102 coo 22.06 26.20 31.80 23.25 24.42 31.55 6.04 28.84 19.10 6.33 27.60 17.37 coo 25.78 19.82 28.38 24.53 18.95 30.74 5.07 34.81 17.81 5.67 37.48 17.25 coo 31.98 16.71 37.61 32.38 18.76 37.14 -5.68 35.74 21.70 -4.36 34.88 20.32 coo 28.27 16.17 41.32 28.66 15.49 39.31 -7.11 31.50 24.64 -8.86 30.85 25.63 1eyp_c00 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 1 hits 1eyp_c00 naa= 4 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 B 48 THR A 28 THR~? 16.04 C1 EDO A 103 B 106 TYR A 29 TYR~? 10.97 C1 EDO A 103 B 113 ASN A 86 ASN~? 11.47 C1 EDO A 103 B 190 THR A 16 THR^? 12.60 CL CL A 102 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 6.04 28.84 19.10 6.33 27.60 17.37 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 5.07 34.81 17.81 5.67 37.48 17.25 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 -5.68 35.74 21.70 -4.36 34.88 20.32 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 -7.11 31.50 24.64 -8.86 30.85 25.63 1eyp_c01 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 1 hits 1eyp_c01 naa= 4 ULMN 4 1pya_c00 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 1 4 # 1 A 62 TYR B 62 TYR^? -4.93 CL CL B 101s E 81 SER B 45 SER^? 10.95 CL CL B 101 F 195 PHE A 97 PHE^? 12.39 CL CL B 101 F 197 GLU B 47 GLU^? 13.68 CL CL B 101 coo 21.01 117.52 52.05 23.52 118.14 53.02 3.66 19.37 41.31 2.04 19.67 43.57 coo 26.04 111.43 51.39 26.10 113.09 53.23 8.38 25.14 44.78 8.69 26.36 42.73 coo 24.21 105.21 44.37 26.00 103.45 43.24 4.50 32.64 50.54 2.47 30.85 50.01 coo 21.61 104.53 49.23 23.55 104.37 50.08 5.37 31.65 43.25 6.96 32.44 42.04 1pya_c00 source 1pya PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE : 1 hits 1pya_c00 naa= 4 ULMN 4 1pya_c01 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 1 4 # 1 A 81 SER B 45 SER^? 10.95 CL CL B 101 B 195 PHE A 97 PHE^? 12.39 CL CL B 101 B 197 GLU B 47 GLU^? 13.68 CL CL B 101 C 62 TYR B 62 TYR^? -4.93 CL CL B 101s coo 33.85 117.83 62.00 33.48 115.65 62.93 8.38 25.14 44.78 8.69 26.36 42.73 coo 34.74 126.89 58.64 35.76 127.46 56.11 4.50 32.64 50.54 2.47 30.85 50.01 coo 29.77 125.13 60.32 30.09 123.64 58.88 5.37 31.65 43.25 6.96 32.44 42.04 coo 34.01 116.98 69.72 34.94 114.70 68.46 3.66 19.37 41.31 2.04 19.67 43.57 1pya_c01 source 1pya PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE : 1 hits 1pya_c01 naa= 4 ULMN 4 1pya_c02 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 1 4 # 1 C 81 SER B 45 SER^? 10.95 CL CL B 101 D 195 PHE A 97 PHE^? 12.39 CL CL B 101 D 197 GLU B 47 GLU^? 13.68 CL CL B 101 E 62 TYR B 62 TYR^? -4.93 CL CL B 101s coo 33.24 103.14 61.07 31.36 104.32 60.00 8.38 25.14 44.78 8.69 26.36 42.73 coo 40.56 100.60 66.46 43.12 101.64 66.41 4.50 32.64 50.54 2.47 30.85 50.01 coo 36.24 102.96 69.12 36.80 104.56 67.83 5.37 31.65 43.25 6.96 32.44 42.04 coo 27.20 98.12 60.65 27.40 99.75 58.44 3.66 19.37 41.31 2.04 19.67 43.57 1pya_c02 source 1pya PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE : 1 hits 1pya_c02 naa= 4 ULMN 4 3csm_c00 CHORISMATE MUTASE user 1 4 # 1 A 16 ARG B 11 ARG^? -4.26 CL CL B 101s A 157 ARG B 83 ARG~? 10.85 CL CL B 102 A 168 LYS B 37 LYS~? 12.27 CL CL B 101 A 246 GLU B 78 GLU~? 9.53 CL CL B 101 coo 37.85 22.13 39.07 35.08 21.72 40.26 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 42.53 17.43 30.59 39.80 18.74 31.20 -13.74 24.05 46.82 -12.84 23.81 43.90 coo 36.10 13.35 45.30 34.36 14.97 39.48 2.75 19.57 52.71 1.11 15.06 54.82 coo 36.95 11.32 36.89 36.00 13.20 36.97 -4.08 21.32 52.83 -3.90 19.30 53.45 3csm_c00 source 3csm CHORISMATE MUTASE : 1 hits 3csm_c00 naa= 4 ULMN 4 3csm_c01 CHORISMATE MUTASE user 1 4 # 1 B 16 ARG B 11 ARG^? -4.26 CL CL B 101s B 157 ARG B 83 ARG~? 10.85 CL CL B 102 B 168 LYS B 37 LYS~? 12.27 CL CL B 101 B 246 GLU B 78 GLU~? 9.53 CL CL B 101 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 -13.74 24.05 46.82 -12.84 23.81 43.90 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 2.75 19.57 52.71 1.11 15.06 54.82 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 -4.08 21.32 52.83 -3.90 19.30 53.45 3csm_c01 source 3csm CHORISMATE MUTASE : 1 hits 3csm_c01 naa= 4 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 98 ARG^? 14.79 CL CL B 101 265 HIS A 61 HIS^? 11.02 CL CL A 101 274 TYR B 9 TYR^? 9.45 CL CL B 101 coo -15.18 55.46 8.55 -14.82 52.98 10.38 10.54 31.08 44.97 12.01 28.63 43.83 coo -14.48 45.59 11.18 -14.02 47.49 10.42 8.98 34.66 37.52 7.84 33.05 38.23 coo 0.94 52.26 9.16 1.95 54.78 9.91 1.66 19.18 35.77 -1.08 19.00 35.58 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG B 98 ARG^? 15.14 CL CL A 101 265 HIS A 61 HIS^? 11.02 CL CL A 101 274 TYR B 62 TYR^? -4.93 CL CL B 101s coo -15.18 55.46 8.55 -14.82 52.98 10.38 12.36 28.08 33.40 14.26 29.94 34.96 coo -14.48 45.59 11.18 -14.02 47.49 10.42 8.98 34.66 37.52 7.84 33.05 38.23 coo 0.94 52.26 9.16 1.95 54.78 9.91 3.66 19.37 41.31 2.04 19.67 43.57 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG B 98 ARG^? 15.14 CL CL A 101 265 HIS B 61 HIS^? 11.05 CL CL B 101 274 TYR A 9 TYR^? 9.51 CL CL A 101 coo -15.18 55.46 8.55 -14.82 52.98 10.38 12.36 28.08 33.40 14.26 29.94 34.96 coo -14.48 45.59 11.18 -14.02 47.49 10.42 6.99 25.63 39.23 6.79 27.36 38.08 coo 0.94 52.26 9.16 1.95 54.78 9.91 5.74 42.78 39.87 3.37 44.03 39.19 1a41_c01 source 1a41 TOPOISOMERASE I : 3 hits 1a41_c01 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 61 HIS^? 11.02 CL CL A 101 B 40 LYS A 94 LYS^? 17.13 CL CL A 101 B 114 HIS B 61 HIS^? 11.05 CL CL B 101 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 8.98 34.66 37.52 7.84 33.05 38.23 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 3.98 41.23 44.04 4.99 47.03 46.41 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 6.99 25.63 39.23 6.79 27.36 38.08 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS B 61 HIS^? 11.05 CL CL B 101 B 40 LYS B 94 LYS^? 17.24 CL CL B 101 B 114 HIS A 61 HIS^? 11.02 CL CL A 101 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 6.99 25.63 39.23 6.79 27.36 38.08 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 2.42 20.83 31.52 1.85 15.08 28.99 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 8.98 34.66 37.52 7.84 33.05 38.23 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 2 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 61 HIS^? 11.02 CL CL A 101 E 40 LYS A 94 LYS^? 17.13 CL CL A 101 E 114 HIS B 61 HIS^? 11.05 CL CL B 101 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 8.98 34.66 37.52 7.84 33.05 38.23 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 3.98 41.23 44.04 4.99 47.03 46.41 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 6.99 25.63 39.23 6.79 27.36 38.08 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS B 61 HIS^? 11.05 CL CL B 101 E 40 LYS B 94 LYS^? 17.24 CL CL B 101 E 114 HIS A 61 HIS^? 11.02 CL CL A 101 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 6.99 25.63 39.23 6.79 27.36 38.08 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 2.42 20.83 31.52 1.85 15.08 28.99 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 8.98 34.66 37.52 7.84 33.05 38.23 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 2 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 92 GLU^? 7.22 O2 EDO A 103 A 60 ASP A 73 ASP~? 10.71 CL CL A 101 A 175 TYR A 9 TYR^? 9.51 CL CL A 101 coo 46.10 28.27 19.27 45.48 26.99 20.84 0.05 42.98 37.01 0.92 44.18 35.56 coo 56.42 28.06 12.93 55.01 27.92 14.50 5.34 51.24 29.08 4.06 51.85 30.69 coo 45.02 22.04 15.38 46.16 24.00 13.76 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 92 GLU^? 7.22 O2 EDO A 103 A 60 ASP A 73 ASP~? 10.71 CL CL A 101 A 175 TYR A 62 TYR^? -4.89 CL CL A 101s coo 46.10 28.27 19.27 45.48 26.99 20.84 0.05 42.98 37.01 0.92 44.18 35.56 coo 56.42 28.06 12.93 55.01 27.92 14.50 5.34 51.24 29.08 4.06 51.85 30.69 coo 45.02 22.04 15.38 46.16 24.00 13.76 8.83 41.55 35.27 8.22 41.73 32.60 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 92 GLU^? 7.39 CL CL B 101 A 60 ASP B 73 ASP~? 12.11 CL CL B 101 A 175 TYR B 9 TYR^? 9.45 CL CL B 101 coo 46.10 28.27 19.27 45.48 26.99 20.84 -4.23 21.44 36.57 -4.25 20.15 38.22 coo 56.42 28.06 12.93 55.01 27.92 14.50 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 45.02 22.04 15.38 46.16 24.00 13.76 1.66 19.18 35.77 -1.08 19.00 35.58 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 3 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 62 TYR^? -4.89 CL CL A 101s A 125 HIS A 61 HIS^? 11.02 CL CL A 101 A 156 LYS A 94 LYS^? 17.13 CL CL A 101 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 8.83 41.55 35.27 8.22 41.73 32.60 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 8.98 34.66 37.52 7.84 33.05 38.23 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR B 62 TYR^? -4.93 CL CL B 101s A 125 HIS B 61 HIS^? 11.05 CL CL B 101 A 156 LYS B 94 LYS^? 17.24 CL CL B 101 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 3.66 19.37 41.31 2.04 19.67 43.57 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 6.99 25.63 39.23 6.79 27.36 38.08 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 2.42 20.83 31.52 1.85 15.08 28.99 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 62 TYR^? -4.89 CL CL A 101s B 125 HIS A 61 HIS^? 11.02 CL CL A 101 B 156 LYS A 94 LYS^? 17.13 CL CL A 101 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 8.83 41.55 35.27 8.22 41.73 32.60 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 8.98 34.66 37.52 7.84 33.05 38.23 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR B 62 TYR^? -4.93 CL CL B 101s B 125 HIS B 61 HIS^? 11.05 CL CL B 101 B 156 LYS B 94 LYS^? 17.24 CL CL B 101 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 3.66 19.37 41.31 2.04 19.67 43.57 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 6.99 25.63 39.23 6.79 27.36 38.08 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 2.42 20.83 31.52 1.85 15.08 28.99 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 62 TYR^? -4.89 CL CL A 101s C 125 HIS A 61 HIS^? 11.02 CL CL A 101 C 156 LYS A 94 LYS^? 17.13 CL CL A 101 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 8.83 41.55 35.27 8.22 41.73 32.60 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 8.98 34.66 37.52 7.84 33.05 38.23 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR B 62 TYR^? -4.93 CL CL B 101s C 125 HIS B 61 HIS^? 11.05 CL CL B 101 C 156 LYS B 94 LYS^? 17.24 CL CL B 101 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 3.66 19.37 41.31 2.04 19.67 43.57 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 6.99 25.63 39.23 6.79 27.36 38.08 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 2.42 20.83 31.52 1.85 15.08 28.99 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 62 TYR^? -4.89 CL CL A 101s D 125 HIS A 61 HIS^? 11.02 CL CL A 101 D 156 LYS A 94 LYS^? 17.13 CL CL A 101 coo 54.10 1.42 85.16 54.14 4.17 85.62 8.83 41.55 35.27 8.22 41.73 32.60 coo 61.27 5.43 85.32 62.73 6.38 86.49 8.98 34.66 37.52 7.84 33.05 38.23 coo 60.28 4.62 76.00 58.35 6.41 80.65 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR B 62 TYR^? -4.93 CL CL B 101s D 125 HIS B 61 HIS^? 11.05 CL CL B 101 D 156 LYS B 94 LYS^? 17.24 CL CL B 101 coo 54.10 1.42 85.16 54.14 4.17 85.62 3.66 19.37 41.31 2.04 19.67 43.57 coo 61.27 5.43 85.32 62.73 6.38 86.49 6.99 25.63 39.23 6.79 27.36 38.08 coo 60.28 4.62 76.00 58.35 6.41 80.65 2.42 20.83 31.52 1.85 15.08 28.99 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c03 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 98 ARG^? 14.79 CL CL B 101 78 HIS B 61 HIS^? 11.05 CL CL B 101 122 TYR A 29 TYR~? 10.97 C1 EDO A 103 coo 48.32 72.26 30.89 48.69 69.28 31.53 10.54 31.08 44.97 12.01 28.63 43.83 coo 53.63 68.24 34.99 53.08 69.10 33.16 6.99 25.63 39.23 6.79 27.36 38.08 coo 75.01 61.87 32.93 75.34 59.26 31.96 5.07 34.81 17.81 5.67 37.48 17.25 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG B 98 ARG^? 15.14 CL CL A 101 78 HIS A 61 HIS^? 11.02 CL CL A 101 122 TYR B 29 TYR~? 11.81 CL CL B 101 coo 48.32 72.26 30.89 48.69 69.28 31.53 12.36 28.08 33.40 14.26 29.94 34.96 coo 53.63 68.24 34.99 53.08 69.10 33.16 8.98 34.66 37.52 7.84 33.05 38.23 coo 75.01 61.87 32.93 75.34 59.26 31.96 -4.54 27.31 54.97 -5.26 24.64 54.93 1ab4_c00 source 1ab4 GYRASE A : 2 hits 1ab4_c00 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 86 ASN~? 11.47 C1 EDO A 103 63 ARG A 87 ARG^? 9.16 CL CL A 102 255 ARG A 83 ARG~? -3.23 CL CL A 102s coo 42.10 13.02 11.14 41.85 11.12 10.23 -5.68 35.74 21.70 -4.36 34.88 20.32 coo 44.36 11.24 3.39 41.81 12.78 4.00 -11.91 35.66 26.57 -12.50 35.32 29.59 coo 38.40 3.83 10.26 40.02 6.30 9.25 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN B 86 ASN~? 10.05 CL CL B 102 63 ARG B 87 ARG^? -4.50 CL CL B 102s 255 ARG B 83 ARG~? 10.85 CL CL B 102 coo 42.10 13.02 11.14 41.85 11.12 10.23 -11.17 31.86 48.48 -9.81 32.48 50.00 coo 44.36 11.24 3.39 41.81 12.78 4.00 -15.08 34.06 42.30 -17.00 32.98 40.14 coo 38.40 3.83 10.26 40.02 6.30 9.25 -13.74 24.05 46.82 -12.84 23.81 43.90 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 2 hits 1aj0_c00 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 11 ARG^? 4.24 CL CL A 101s B 342 ASP A 73 ASP~? 10.71 CL CL A 101 B 531 ARG A 83 ARG~? -3.23 CL CL A 102s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 2.42 41.34 32.49 3.79 44.02 33.12 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 5.34 51.24 29.08 4.06 51.85 30.69 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 11 ARG^? -4.26 CL CL B 101s B 342 ASP B 73 ASP~? 12.11 CL CL B 101 B 531 ARG B 83 ARG~? 10.85 CL CL B 102 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -13.74 24.05 46.82 -12.84 23.81 43.90 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c00 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 2 PHE.? 22.39 CL CL A 101 A 223 ASP B 100 ASP.? 16.19 CL CL A 101 A 265 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 39.74 52.86 65.74 41.15 55.14 66.52 25.03 34.95 36.22 27.35 35.15 34.61 coo 30.70 47.50 67.53 29.83 49.47 67.39 15.54 31.73 32.19 17.10 30.29 31.96 coo 19.99 54.53 64.11 20.55 58.78 68.33 12.12 40.22 23.70 13.00 44.76 21.03 1ax4_c04 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 2 PHE.? 22.39 CL CL A 101 B 223 ASP B 100 ASP.? 16.19 CL CL A 101 B 265 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 7.48 54.94 99.62 7.67 52.27 100.42 25.03 34.95 36.22 27.35 35.15 34.61 coo 10.43 61.66 91.81 9.80 60.04 90.61 15.54 31.73 32.19 17.10 30.29 31.96 coo 5.43 58.06 80.08 8.57 53.00 79.37 12.12 40.22 23.70 13.00 44.76 21.03 1ax4_c05 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 2 PHE.? 22.39 CL CL A 101 C 223 ASP B 100 ASP.? 16.19 CL CL A 101 C 265 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo -6.55 73.45 23.60 -6.77 71.48 21.66 25.03 34.95 36.22 27.35 35.15 34.61 coo -9.52 75.74 33.62 -8.85 73.74 33.93 15.54 31.73 32.19 17.10 30.29 31.96 coo -4.44 67.20 42.32 -7.50 62.41 40.49 12.12 40.22 23.70 13.00 44.76 21.03 1ax4_c06 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 2 PHE.? 22.39 CL CL A 101 D 223 ASP B 100 ASP.? 16.19 CL CL A 101 D 265 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo -38.60 55.38 52.70 -40.06 57.72 53.04 25.03 34.95 36.22 27.35 35.15 34.61 coo -29.46 51.67 48.51 -28.63 53.31 49.56 15.54 31.73 32.19 17.10 30.29 31.96 coo -18.87 56.53 54.79 -19.47 62.22 53.03 12.12 40.22 23.70 13.00 44.76 21.03 1ax4_c07 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c07 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 61 HIS^? 11.02 CL CL A 101 A 91 ARG B 98 ARG^? 15.14 CL CL A 101 A 129 SER A 45 SER^? 10.94 CL CL A 101 coo 24.39 47.01 49.70 26.42 47.04 49.21 8.98 34.66 37.52 7.84 33.05 38.23 coo 25.98 44.20 42.23 28.53 42.98 43.43 12.36 28.08 33.40 14.26 29.94 34.96 coo 30.00 49.76 45.68 28.73 48.72 47.47 12.09 34.48 32.88 11.31 33.31 34.87 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS B 61 HIS^? 11.05 CL CL B 101 A 91 ARG A 98 ARG^? 14.79 CL CL B 101 A 129 SER B 45 SER^? 10.95 CL CL B 101 coo 24.39 47.01 49.70 26.42 47.04 49.21 6.99 25.63 39.23 6.79 27.36 38.08 coo 25.98 44.20 42.23 28.53 42.98 43.43 10.54 31.08 44.97 12.01 28.63 43.83 coo 30.00 49.76 45.68 28.73 48.72 47.47 8.38 25.14 44.78 8.69 26.36 42.73 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 2 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 61 HIS^? 11.02 CL CL A 101 B 91 ARG B 95 ARG^? 16.04 CL CL B 101 B 129 SER A 45 SER^? 10.94 CL CL A 101 coo 18.19 17.03 40.71 18.55 17.18 38.64 8.98 34.66 37.52 7.84 33.05 38.23 coo 25.60 21.10 38.54 23.57 20.93 36.25 7.82 25.35 32.62 10.50 24.66 33.91 coo 21.33 14.29 34.62 19.25 14.88 35.71 12.09 34.48 32.88 11.31 33.31 34.87 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 1 hits 1b6t_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 48 PHE^? 9.34 C1 EDO A 103 A 159 ASP A 24 ASP~? 18.92 C1 EDO A 103 A 188 LYS B 94 LYS^? 17.24 CL CL B 101 coo 13.91 34.58 14.67 12.95 36.00 12.47 3.02 29.67 26.88 0.81 30.82 25.66 coo 20.97 28.40 16.26 20.19 30.15 15.34 0.26 24.62 18.06 -0.77 23.04 19.07 coo 22.55 41.65 15.60 18.92 37.20 14.63 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE B 72 PHE~? 5.57 CL CL B 101 A 159 ASP B 80 ASP~? 13.43 CL CL B 101 A 188 LYS B 37 LYS~? 12.27 CL CL B 101 coo 13.91 34.58 14.67 12.95 36.00 12.47 -4.99 18.42 43.35 -6.92 20.39 43.58 coo 20.97 28.40 16.26 20.19 30.15 15.34 -12.29 21.04 51.71 -12.95 19.46 50.41 coo 22.55 41.65 15.60 18.92 37.20 14.63 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE B 97 PHE^? 11.11 C1 EDO A 103 A 159 ASP B 100 ASP.? 16.19 CL CL A 101 A 188 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 13.91 34.58 14.67 12.95 36.00 12.47 8.21 28.14 26.14 7.00 30.62 25.79 coo 20.97 28.40 16.26 20.19 30.15 15.34 15.54 31.73 32.19 17.10 30.29 31.96 coo 22.55 41.65 15.60 18.92 37.20 14.63 12.12 40.22 23.70 13.00 44.76 21.03 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 3 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 11 ARG^? 4.24 CL CL A 101s A 141 THR A 67 THR~? 9.89 CL CL A 101 A 235 ASP A 80 ASP~? 10.02 CL CL A 102 coo 6.21 93.81 36.58 4.58 96.33 37.17 2.42 41.34 32.49 3.79 44.02 33.12 coo 6.80 92.87 28.33 4.91 92.74 27.40 10.60 46.69 35.48 12.42 45.52 35.63 coo 12.98 90.36 47.57 11.26 89.62 46.62 -3.16 46.57 21.25 -3.22 47.75 23.02 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 83 ARG~? -3.23 CL CL A 102s A 141 THR A 84 THR~? 13.66 CL CL A 102 A 235 ASP A 73 ASP~? 10.71 CL CL A 101 coo 6.21 93.81 36.58 4.58 96.33 37.17 -6.07 43.34 24.57 -5.82 42.72 27.55 coo 6.80 92.87 28.33 4.91 92.74 27.40 -7.25 41.08 18.26 -5.92 42.25 17.01 coo 12.98 90.36 47.57 11.26 89.62 46.62 5.34 51.24 29.08 4.06 51.85 30.69 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG B 83 ARG~? 10.85 CL CL B 102 A 141 THR B 84 THR~? 12.39 CL CL B 102 A 235 ASP B 73 ASP~? 12.11 CL CL B 101 coo 6.21 93.81 36.58 4.58 96.33 37.17 -13.74 24.05 46.82 -12.84 23.81 43.90 coo 6.80 92.87 28.33 4.91 92.74 27.40 -14.62 27.87 52.41 -13.94 26.65 54.08 coo 12.98 90.36 47.57 11.26 89.62 46.62 -5.20 12.36 44.75 -6.92 11.08 44.83 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 11 ARG^? 4.24 CL CL A 101s D 141 THR A 67 THR~? 9.89 CL CL A 101 D 235 ASP A 80 ASP~? 10.02 CL CL A 102 coo -8.33 92.80 100.06 -7.71 95.33 98.44 2.42 41.34 32.49 3.79 44.02 33.12 coo -9.24 93.49 108.77 -7.37 94.21 109.61 10.60 46.69 35.48 12.42 45.52 35.63 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -3.16 46.57 21.25 -3.22 47.75 23.02 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 83 ARG~? -3.23 CL CL A 102s D 141 THR A 84 THR~? 13.66 CL CL A 102 D 235 ASP A 73 ASP~? 10.71 CL CL A 101 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -6.07 43.34 24.57 -5.82 42.72 27.55 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -7.25 41.08 18.26 -5.92 42.25 17.01 coo -14.64 87.74 89.51 -12.89 87.43 90.65 5.34 51.24 29.08 4.06 51.85 30.69 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG B 11 ARG^? -4.26 CL CL B 101s D 141 THR B 67 THR~? 10.38 CL CL B 101 D 235 ASP B 80 ASP~? 13.43 CL CL B 101 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -2.97 22.30 41.65 -2.03 19.36 41.23 coo -9.24 93.49 108.77 -7.37 94.21 109.61 3.55 13.82 40.95 5.56 14.17 41.67 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -12.29 21.04 51.71 -12.95 19.46 50.41 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 83 ARG~? 10.85 CL CL B 102 D 141 THR B 84 THR~? 12.39 CL CL B 102 D 235 ASP B 73 ASP~? 12.11 CL CL B 101 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -13.74 24.05 46.82 -12.84 23.81 43.90 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -14.62 27.87 52.41 -13.94 26.65 54.08 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -5.20 12.36 44.75 -6.92 11.08 44.83 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 11 ARG^? 4.24 CL CL A 101s C 141 THR A 67 THR~? 9.89 CL CL A 101 C 235 ASP A 80 ASP~? 10.02 CL CL A 102 coo -5.79 67.26 36.83 -4.57 64.58 37.74 2.42 41.34 32.49 3.79 44.02 33.12 coo -6.81 68.31 28.28 -4.82 68.47 27.57 10.60 46.69 35.48 12.42 45.52 35.63 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -3.16 46.57 21.25 -3.22 47.75 23.02 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 83 ARG~? -3.23 CL CL A 102s C 141 THR A 84 THR~? 13.66 CL CL A 102 C 235 ASP A 73 ASP~? 10.71 CL CL A 101 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -6.07 43.34 24.57 -5.82 42.72 27.55 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -7.25 41.08 18.26 -5.92 42.25 17.01 coo -13.01 70.96 47.58 -11.44 71.65 46.34 5.34 51.24 29.08 4.06 51.85 30.69 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG B 83 ARG~? 10.85 CL CL B 102 C 141 THR B 84 THR~? 12.39 CL CL B 102 C 235 ASP B 73 ASP~? 12.11 CL CL B 101 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -13.74 24.05 46.82 -12.84 23.81 43.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -14.62 27.87 52.41 -13.94 26.65 54.08 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -5.20 12.36 44.75 -6.92 11.08 44.83 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 11 ARG^? 4.24 CL CL A 101s B 141 THR A 67 THR~? 9.89 CL CL A 101 B 235 ASP A 80 ASP~? 10.02 CL CL A 102 coo 8.13 67.41 100.27 7.18 68.35 97.45 2.42 41.34 32.49 3.79 44.02 33.12 coo 8.28 67.78 108.81 6.22 67.65 109.43 10.60 46.69 35.48 12.42 45.52 35.63 coo 14.55 73.52 89.47 12.81 73.95 90.56 -3.16 46.57 21.25 -3.22 47.75 23.02 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 83 ARG~? -3.23 CL CL A 102s B 141 THR A 84 THR~? 13.66 CL CL A 102 B 235 ASP A 73 ASP~? 10.71 CL CL A 101 coo 8.13 67.41 100.27 7.18 68.35 97.45 -6.07 43.34 24.57 -5.82 42.72 27.55 coo 8.28 67.78 108.81 6.22 67.65 109.43 -7.25 41.08 18.26 -5.92 42.25 17.01 coo 14.55 73.52 89.47 12.81 73.95 90.56 5.34 51.24 29.08 4.06 51.85 30.69 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG B 83 ARG~? 10.85 CL CL B 102 B 141 THR B 84 THR~? 12.39 CL CL B 102 B 235 ASP B 73 ASP~? 12.11 CL CL B 101 coo 8.13 67.41 100.27 7.18 68.35 97.45 -13.74 24.05 46.82 -12.84 23.81 43.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 -14.62 27.87 52.41 -13.94 26.65 54.08 coo 14.55 73.52 89.47 12.81 73.95 90.56 -5.20 12.36 44.75 -6.92 11.08 44.83 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c03 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 81 GLU~? 14.16 C2 EDO A 103 B 504 TYR A 29 TYR~? 10.97 C1 EDO A 103 B 540 GLU A 78 GLU~? 10.37 C2 EDO A 103 coo 86.52 35.28 112.74 87.08 36.38 110.99 -1.07 42.33 16.34 -2.16 43.00 14.64 coo 84.93 40.21 105.31 85.72 41.45 107.72 5.07 34.81 17.81 5.67 37.48 17.25 coo 83.38 41.19 112.55 85.47 40.59 112.72 4.50 44.13 19.44 5.14 46.14 19.71 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 83 ARG~? -3.23 CL CL A 102s A 451 GLU A 78 GLU~? 10.37 C2 EDO A 103 A 540 GLU A 81 GLU~? 14.16 C2 EDO A 103 coo 79.04 80.20 80.81 79.58 81.40 83.63 -6.07 43.34 24.57 -5.82 42.72 27.55 coo 81.34 87.29 87.22 82.36 86.09 88.61 4.50 44.13 19.44 5.14 46.14 19.71 coo 79.94 80.46 88.84 81.11 81.36 87.27 -1.07 42.33 16.34 -2.16 43.00 14.64 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG B 83 ARG~? 10.85 CL CL B 102 A 451 GLU B 78 GLU~? 9.53 CL CL B 101 A 540 GLU B 81 GLU~? 14.80 CL CL B 101 coo 79.04 80.20 80.81 79.58 81.40 83.63 -13.74 24.05 46.82 -12.84 23.81 43.90 coo 81.34 87.29 87.22 82.36 86.09 88.61 -4.08 21.32 52.83 -3.90 19.30 53.45 coo 79.94 80.46 88.84 81.11 81.36 87.27 -9.05 25.50 55.61 -7.98 24.84 57.33 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c04 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 11 ARG^? 4.24 CL CL A 101s 183 LYS A 94 LYS^? 17.13 CL CL A 101 317 ARG B 11 ARG^? -4.26 CL CL B 101s coo 76.57 109.19 73.41 73.86 110.26 72.16 2.42 41.34 32.49 3.79 44.02 33.12 coo 82.09 117.51 66.37 80.60 114.32 71.44 3.98 41.23 44.04 4.99 47.03 46.41 coo 65.21 120.62 58.76 63.62 123.14 59.66 -2.97 22.30 41.65 -2.03 19.36 41.23 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 11 ARG^? 4.24 CL CL A 101s 183 LYS A 94 LYS^? 17.13 CL CL A 101 317 ARG B 87 ARG^? -4.50 CL CL B 102s coo 76.57 109.19 73.41 73.86 110.26 72.16 2.42 41.34 32.49 3.79 44.02 33.12 coo 82.09 117.51 66.37 80.60 114.32 71.44 3.98 41.23 44.04 4.99 47.03 46.41 coo 65.21 120.62 58.76 63.62 123.14 59.66 -15.08 34.06 42.30 -17.00 32.98 40.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG B 11 ARG^? -4.26 CL CL B 101s 183 LYS B 94 LYS^? 17.24 CL CL B 101 317 ARG A 11 ARG^? 4.24 CL CL A 101s coo 76.57 109.19 73.41 73.86 110.26 72.16 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 82.09 117.51 66.37 80.60 114.32 71.44 2.42 20.83 31.52 1.85 15.08 28.99 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.42 41.34 32.49 3.79 44.02 33.12 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 3 hits 1bib_c00 naa= 3 ULMN 3 1bol_c00 RIBONUCLEASE RH user 1 3 # 1 A 46 HIS A 61 HIS^? 11.02 CL CL A 101 A 105 GLU A 47 GLU^? 13.35 CL CL A 101 A 109 HIS B 61 HIS^? 11.05 CL CL B 101 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 8.98 34.66 37.52 7.84 33.05 38.23 coo 43.60 31.12 0.44 42.42 31.86 -1.18 6.76 29.94 33.50 7.56 29.03 35.26 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 6.99 25.63 39.23 6.79 27.36 38.08 ULMN 3 1bol_c00 RIBONUCLEASE RH user 2 3 # 2 A 46 HIS A 61 HIS^? 11.02 CL CL A 101 A 105 GLU B 47 GLU^? 13.68 CL CL B 101 A 109 HIS B 61 HIS^? 11.05 CL CL B 101 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 8.98 34.66 37.52 7.84 33.05 38.23 coo 43.60 31.12 0.44 42.42 31.86 -1.18 5.37 31.65 43.25 6.96 32.44 42.04 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 6.99 25.63 39.23 6.79 27.36 38.08 ULMN 3 1bol_c00 RIBONUCLEASE RH user 3 3 # 3 A 46 HIS B 61 HIS^? 11.05 CL CL B 101 A 105 GLU A 47 GLU^? 13.35 CL CL A 101 A 109 HIS A 61 HIS^? 11.02 CL CL A 101 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 6.99 25.63 39.23 6.79 27.36 38.08 coo 43.60 31.12 0.44 42.42 31.86 -1.18 6.76 29.94 33.50 7.56 29.03 35.26 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 8.98 34.66 37.52 7.84 33.05 38.23 ULMN 3 1bol_c00 RIBONUCLEASE RH user 4 3 # 4 A 46 HIS B 61 HIS^? 11.05 CL CL B 101 A 105 GLU B 47 GLU^? 13.68 CL CL B 101 A 109 HIS A 61 HIS^? 11.02 CL CL A 101 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 6.99 25.63 39.23 6.79 27.36 38.08 coo 43.60 31.12 0.44 42.42 31.86 -1.18 5.37 31.65 43.25 6.96 32.44 42.04 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 8.98 34.66 37.52 7.84 33.05 38.23 1bol_c00 source 1bol RIBONUCLEASE RH : 4 hits 1bol_c00 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 30 PHE~? 6.00 C1 EDO A 103 A 205 ASP A 80 ASP~? 10.02 CL CL A 102 A 236 LYS A 74 LYS~? 11.85 CL CL A 101 coo 4.14 2.10 36.34 6.69 3.08 36.92 3.91 34.16 23.42 2.15 36.32 23.43 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -3.16 46.57 21.25 -3.22 47.75 23.02 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 7.23 49.23 25.52 13.07 49.77 27.70 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 48 PHE^? 9.34 C1 EDO A 103 A 205 ASP B 100 ASP.? 16.19 CL CL A 101 A 236 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 4.14 2.10 36.34 6.69 3.08 36.92 3.02 29.67 26.88 0.81 30.82 25.66 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 15.54 31.73 32.19 17.10 30.29 31.96 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE B 30 PHE~? 8.93 CL CL B 101 A 205 ASP B 80 ASP~? 13.43 CL CL B 101 A 236 LYS B 74 LYS~? 11.95 CL CL B 101 coo 4.14 2.10 36.34 6.69 3.08 36.92 -2.29 29.30 49.67 -4.50 29.02 48.02 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -12.29 21.04 51.71 -12.95 19.46 50.41 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -3.92 13.74 48.91 -1.31 9.83 46.45 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE B 48 PHE^? 12.98 CL CL B 101 A 205 ASP A 100 ASP.? 15.68 CL CL B 101 A 236 LYS B 37 LYS~? 12.27 CL CL B 101 coo 4.14 2.10 36.34 6.69 3.08 36.92 -0.09 33.91 47.42 -2.69 34.81 47.10 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 11.90 26.11 47.01 13.15 27.58 47.89 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 2.75 19.57 52.71 1.11 15.06 54.82 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 4 hits 1bs0_c01 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 80 ASP~? 10.02 CL CL A 102 B 354 GLU A 78 GLU~? 10.37 C2 EDO A 103 B 421 ASP A 73 ASP~? 10.71 CL CL A 101 coo 25.90 8.19 53.87 25.36 6.97 52.29 -3.16 46.57 21.25 -3.22 47.75 23.02 coo 27.87 10.66 47.95 27.82 8.60 48.27 4.50 44.13 19.44 5.14 46.14 19.71 coo 26.02 1.87 43.38 25.90 1.97 45.49 5.34 51.24 29.08 4.06 51.85 30.69 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 1 hits 1bvz_c09 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 95 ARG^? -17.49 CL CL A 101s 127 ARG A 98 ARG^? 14.79 CL CL B 101 270 GLU A 47 GLU^? 13.35 CL CL A 101 coo -0.83 25.63 1.57 0.97 28.05 0.90 8.08 35.24 44.69 10.92 34.84 45.57 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 10.54 31.08 44.97 12.01 28.63 43.83 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 95 ARG^? -17.49 CL CL A 101s 127 ARG A 98 ARG^? 14.79 CL CL B 101 270 GLU B 31 GLU~? 16.05 CL CL B 101 coo -0.83 25.63 1.57 0.97 28.05 0.90 8.08 35.24 44.69 10.92 34.84 45.57 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 10.54 31.08 44.97 12.01 28.63 43.83 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 4.21 30.96 54.15 4.85 32.92 54.48 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 98 ARG^? 14.79 CL CL B 101 127 ARG A 95 ARG^? -17.49 CL CL A 101s 270 GLU A 47 GLU^? 13.35 CL CL A 101 coo -0.83 25.63 1.57 0.97 28.05 0.90 10.54 31.08 44.97 12.01 28.63 43.83 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 8.08 35.24 44.69 10.92 34.84 45.57 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG A 98 ARG^? 14.79 CL CL B 101 127 ARG A 95 ARG^? -17.49 CL CL A 101s 270 GLU B 31 GLU~? 16.05 CL CL B 101 coo -0.83 25.63 1.57 0.97 28.05 0.90 10.54 31.08 44.97 12.01 28.63 43.83 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 8.08 35.24 44.69 10.92 34.84 45.57 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 4.21 30.96 54.15 4.85 32.92 54.48 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG B 95 ARG^? 16.04 CL CL B 101 127 ARG B 98 ARG^? 15.14 CL CL A 101 270 GLU B 47 GLU^? 13.68 CL CL B 101 coo -0.83 25.63 1.57 0.97 28.05 0.90 7.82 25.35 32.62 10.50 24.66 33.91 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.36 28.08 33.40 14.26 29.94 34.96 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 5.37 31.65 43.25 6.96 32.44 42.04 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG B 98 ARG^? 15.14 CL CL A 101 127 ARG B 95 ARG^? 16.04 CL CL B 101 270 GLU B 47 GLU^? 13.68 CL CL B 101 coo -0.83 25.63 1.57 0.97 28.05 0.90 12.36 28.08 33.40 14.26 29.94 34.96 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 7.82 25.35 32.62 10.50 24.66 33.91 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 5.37 31.65 43.25 6.96 32.44 42.04 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 6 hits 1cbx_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 31 GLU~? 15.39 O1 EDO A 103 A 89 GLU A 47 GLU^? 13.35 CL CL A 101 A 120 SER A 45 SER^? 10.94 CL CL A 101 coo -24.35 9.53 67.64 -25.07 11.29 68.60 10.31 28.74 22.96 10.37 26.64 22.82 coo -31.18 6.91 75.60 -32.39 8.51 74.91 6.76 29.94 33.50 7.56 29.03 35.26 coo -34.73 8.57 68.21 -33.63 9.08 70.28 12.09 34.48 32.88 11.31 33.31 34.87 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 47 GLU^? 13.35 CL CL A 101 A 89 GLU A 31 GLU~? 15.39 O1 EDO A 103 A 120 SER A 35 SER~? 7.73 O1 EDO A 103 coo -24.35 9.53 67.64 -25.07 11.29 68.60 6.76 29.94 33.50 7.56 29.03 35.26 coo -31.18 6.91 75.60 -32.39 8.51 74.91 10.31 28.74 22.96 10.37 26.64 22.82 coo -34.73 8.57 68.21 -33.63 9.08 70.28 10.05 35.64 25.48 8.77 33.72 26.17 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 47 GLU^? 13.35 CL CL A 101 A 89 GLU B 47 GLU^? 13.68 CL CL B 101 A 120 SER B 45 SER^? 10.95 CL CL B 101 coo -24.35 9.53 67.64 -25.07 11.29 68.60 6.76 29.94 33.50 7.56 29.03 35.26 coo -31.18 6.91 75.60 -32.39 8.51 74.91 5.37 31.65 43.25 6.96 32.44 42.04 coo -34.73 8.57 68.21 -33.63 9.08 70.28 8.38 25.14 44.78 8.69 26.36 42.73 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU B 31 GLU~? 16.05 CL CL B 101 A 89 GLU B 47 GLU^? 13.68 CL CL B 101 A 120 SER B 45 SER^? 10.95 CL CL B 101 coo -24.35 9.53 67.64 -25.07 11.29 68.60 4.21 30.96 54.15 4.85 32.92 54.48 coo -31.18 6.91 75.60 -32.39 8.51 74.91 5.37 31.65 43.25 6.96 32.44 42.04 coo -34.73 8.57 68.21 -33.63 9.08 70.28 8.38 25.14 44.78 8.69 26.36 42.73 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 47 GLU^? 13.68 CL CL B 101 A 89 GLU B 31 GLU~? 16.05 CL CL B 101 A 120 SER B 35 SER~? 8.71 CL CL B 101 coo -24.35 9.53 67.64 -25.07 11.29 68.60 5.37 31.65 43.25 6.96 32.44 42.04 coo -31.18 6.91 75.60 -32.39 8.51 74.91 4.21 30.96 54.15 4.85 32.92 54.48 coo -34.73 8.57 68.21 -33.63 9.08 70.28 3.17 24.62 50.92 3.13 26.96 50.21 1cns_c00 source 1cns CHITINASE : 5 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 31 GLU~? 15.39 O1 EDO A 103 B 89 GLU A 47 GLU^? 13.35 CL CL A 101 B 120 SER A 45 SER^? 10.94 CL CL A 101 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 10.31 28.74 22.96 10.37 26.64 22.82 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.76 29.94 33.50 7.56 29.03 35.26 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 12.09 34.48 32.88 11.31 33.31 34.87 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 47 GLU^? 13.35 CL CL A 101 B 89 GLU A 31 GLU~? 15.39 O1 EDO A 103 B 120 SER A 35 SER~? 7.73 O1 EDO A 103 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.76 29.94 33.50 7.56 29.03 35.26 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 10.31 28.74 22.96 10.37 26.64 22.82 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 10.05 35.64 25.48 8.77 33.72 26.17 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 47 GLU^? 13.35 CL CL A 101 B 89 GLU B 47 GLU^? 13.68 CL CL B 101 B 120 SER B 45 SER^? 10.95 CL CL B 101 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 6.76 29.94 33.50 7.56 29.03 35.26 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 5.37 31.65 43.25 6.96 32.44 42.04 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 8.38 25.14 44.78 8.69 26.36 42.73 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 31 GLU~? 16.05 CL CL B 101 B 89 GLU B 47 GLU^? 13.68 CL CL B 101 B 120 SER B 45 SER^? 10.95 CL CL B 101 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 4.21 30.96 54.15 4.85 32.92 54.48 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 5.37 31.65 43.25 6.96 32.44 42.04 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 8.38 25.14 44.78 8.69 26.36 42.73 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 47 GLU^? 13.68 CL CL B 101 B 89 GLU A 47 GLU^? 13.35 CL CL A 101 B 120 SER A 45 SER^? 10.94 CL CL A 101 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.37 31.65 43.25 6.96 32.44 42.04 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 6.76 29.94 33.50 7.56 29.03 35.26 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 12.09 34.48 32.88 11.31 33.31 34.87 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU B 47 GLU^? 13.68 CL CL B 101 B 89 GLU B 31 GLU~? 16.05 CL CL B 101 B 120 SER B 35 SER~? 8.71 CL CL B 101 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 5.37 31.65 43.25 6.96 32.44 42.04 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 4.21 30.96 54.15 4.85 32.92 54.48 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 3.17 24.62 50.92 3.13 26.96 50.21 1cns_c01 source 1cns CHITINASE : 6 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 9 TYR^? 9.51 CL CL A 101 A 173 ASP A 64 ASP~? 12.85 CL CL A 101 C 48 ARG A 11 ARG^? 4.24 CL CL A 101s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 5.74 42.78 39.87 3.37 44.03 39.19 coo 24.35 4.55 25.11 25.94 3.23 25.53 10.93 45.62 41.10 12.24 46.52 39.71 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 2.42 41.34 32.49 3.79 44.02 33.12 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 9 TYR^? 9.45 CL CL B 101 A 173 ASP B 64 ASP~? 13.25 CL CL B 101 C 48 ARG B 11 ARG^? -4.26 CL CL B 101s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 1.66 19.18 35.77 -1.08 19.00 35.58 coo 24.35 4.55 25.11 25.94 3.23 25.53 6.48 14.60 36.08 6.70 13.36 37.77 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -2.97 22.30 41.65 -2.03 19.36 41.23 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 11 ARG^? 4.24 CL CL A 101s C 101 TYR A 9 TYR^? 9.51 CL CL A 101 C 173 ASP A 64 ASP~? 12.85 CL CL A 101 coo 32.27 5.62 48.15 31.93 6.48 51.06 2.42 41.34 32.49 3.79 44.02 33.12 coo 29.64 3.64 57.39 31.22 5.14 55.65 5.74 42.78 39.87 3.37 44.03 39.19 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 10.93 45.62 41.10 12.24 46.52 39.71 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 11 ARG^? -4.26 CL CL B 101s C 101 TYR B 9 TYR^? 9.45 CL CL B 101 C 173 ASP B 64 ASP~? 13.25 CL CL B 101 coo 32.27 5.62 48.15 31.93 6.48 51.06 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 29.64 3.64 57.39 31.22 5.14 55.65 1.66 19.18 35.77 -1.08 19.00 35.58 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 6.48 14.60 36.08 6.70 13.36 37.77 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 11 ARG^? 4.24 CL CL A 101s D 101 TYR A 9 TYR^? 9.51 CL CL A 101 D 173 ASP A 64 ASP~? 12.85 CL CL A 101 coo 69.08 8.58 32.60 69.70 10.81 30.58 2.42 41.34 32.49 3.79 44.02 33.12 coo 71.77 11.86 24.26 70.23 12.22 26.56 5.74 42.78 39.87 3.37 44.03 39.19 coo 71.60 6.14 19.25 70.26 6.87 20.69 10.93 45.62 41.10 12.24 46.52 39.71 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 11 ARG^? -4.26 CL CL B 101s D 101 TYR B 9 TYR^? 9.45 CL CL B 101 D 173 ASP B 64 ASP~? 13.25 CL CL B 101 coo 69.08 8.58 32.60 69.70 10.81 30.58 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 71.77 11.86 24.26 70.23 12.22 26.56 1.66 19.18 35.77 -1.08 19.00 35.58 coo 71.60 6.14 19.25 70.26 6.87 20.69 6.48 14.60 36.08 6.70 13.36 37.77 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 9 TYR^? 9.51 CL CL A 101 B 173 ASP A 64 ASP~? 12.85 CL CL A 101 D 48 ARG A 11 ARG^? 4.24 CL CL A 101s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 5.74 42.78 39.87 3.37 44.03 39.19 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 10.93 45.62 41.10 12.24 46.52 39.71 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 2.42 41.34 32.49 3.79 44.02 33.12 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 9 TYR^? 9.45 CL CL B 101 B 173 ASP B 64 ASP~? 13.25 CL CL B 101 D 48 ARG B 11 ARG^? -4.26 CL CL B 101s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 1.66 19.18 35.77 -1.08 19.00 35.58 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 6.48 14.60 36.08 6.70 13.36 37.77 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -2.97 22.30 41.65 -2.03 19.36 41.23 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 100 ASP.? 15.68 CL CL B 101 A 56 ILE B 60 ILE^? -3.94 CL CL B 101s A 82 TYR B 62 TYR^? -4.93 CL CL B 101s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 11.90 26.11 47.01 13.15 27.58 47.89 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 2.13 24.27 43.24 1.36 24.18 43.83 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.66 19.37 41.31 2.04 19.67 43.57 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 100 ASP.? 16.19 CL CL A 101 A 56 ILE A 60 ILE^? 4.09 CL CL A 101 A 82 TYR A 62 TYR^? -4.89 CL CL A 101s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 15.54 31.73 32.19 17.10 30.29 31.96 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 6.55 37.49 32.39 6.15 37.82 31.64 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 8.83 41.55 35.27 8.22 41.73 32.60 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 100 ASP.? 15.68 CL CL B 101 B 56 ILE B 60 ILE^? -3.94 CL CL B 101s B 82 TYR B 62 TYR^? -4.93 CL CL B 101s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 11.90 26.11 47.01 13.15 27.58 47.89 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 2.13 24.27 43.24 1.36 24.18 43.83 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.66 19.37 41.31 2.04 19.67 43.57 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 100 ASP.? 16.19 CL CL A 101 B 56 ILE A 60 ILE^? 4.09 CL CL A 101 B 82 TYR A 62 TYR^? -4.89 CL CL A 101s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 15.54 31.73 32.19 17.10 30.29 31.96 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 6.55 37.49 32.39 6.15 37.82 31.64 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 8.83 41.55 35.27 8.22 41.73 32.60 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 58 TYR^? 4.97 C1 EDO A 103 A 243 ASP A 100 ASP.? 15.68 CL CL B 101 A 272 LYS B 37 LYS~? 12.27 CL CL B 101 coo 2.03 68.31 21.46 0.66 68.36 23.90 3.55 34.19 28.36 5.98 35.22 27.53 coo 16.93 55.67 9.65 17.16 54.23 11.19 11.90 26.11 47.01 13.15 27.58 47.89 coo 14.13 45.79 13.40 14.25 49.41 18.30 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR B 58 TYR^? 6.57 CL CL B 101 A 243 ASP B 100 ASP.? 16.19 CL CL A 101 A 272 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 2.03 68.31 21.46 0.66 68.36 23.90 -0.68 28.61 46.28 0.81 26.77 47.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 15.54 31.73 32.19 17.10 30.29 31.96 coo 14.13 45.79 13.40 14.25 49.41 18.30 12.12 40.22 23.70 13.00 44.76 21.03 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 2 hits 1d7r_c02 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 9 TYR^? 9.51 CL CL A 101 A 138 ARG A 11 ARG^? 4.24 CL CL A 101s A 161 LYS A 94 LYS^? 17.13 CL CL A 101 coo 29.03 88.95 86.80 28.09 90.57 84.75 5.74 42.78 39.87 3.37 44.03 39.19 coo 23.31 93.18 82.88 23.00 93.71 79.86 2.42 41.34 32.49 3.79 44.02 33.12 coo 33.83 91.15 88.62 31.07 91.06 83.02 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR A 9 TYR^? 9.51 CL CL A 101 A 138 ARG A 95 ARG^? -17.49 CL CL A 101s A 161 LYS A 65 LYS~? 13.92 CL CL A 101 coo 29.03 88.95 86.80 28.09 90.57 84.75 5.74 42.78 39.87 3.37 44.03 39.19 coo 23.31 93.18 82.88 23.00 93.71 79.86 8.08 35.24 44.69 10.92 34.84 45.57 coo 33.83 91.15 88.62 31.07 91.06 83.02 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 133 TYR B 9 TYR^? 9.45 CL CL B 101 A 138 ARG B 11 ARG^? -4.26 CL CL B 101s A 161 LYS B 65 LYS~? 14.42 CL CL B 101 coo 29.03 88.95 86.80 28.09 90.57 84.75 1.66 19.18 35.77 -1.08 19.00 35.58 coo 23.31 93.18 82.88 23.00 93.71 79.86 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 33.83 91.15 88.62 31.07 91.06 83.02 2.20 15.51 35.93 -2.75 14.71 32.15 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 133 TYR B 9 TYR^? 9.45 CL CL B 101 A 138 ARG B 11 ARG^? -4.26 CL CL B 101s A 161 LYS B 94 LYS^? 17.24 CL CL B 101 coo 29.03 88.95 86.80 28.09 90.57 84.75 1.66 19.18 35.77 -1.08 19.00 35.58 coo 23.31 93.18 82.88 23.00 93.71 79.86 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 33.83 91.15 88.62 31.07 91.06 83.02 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 133 TYR B 9 TYR^? 9.45 CL CL B 101 A 138 ARG B 95 ARG^? 16.04 CL CL B 101 A 161 LYS B 65 LYS~? 14.42 CL CL B 101 coo 29.03 88.95 86.80 28.09 90.57 84.75 1.66 19.18 35.77 -1.08 19.00 35.58 coo 23.31 93.18 82.88 23.00 93.71 79.86 7.82 25.35 32.62 10.50 24.66 33.91 coo 33.83 91.15 88.62 31.07 91.06 83.02 2.20 15.51 35.93 -2.75 14.71 32.15 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 133 TYR B 62 TYR^? -4.93 CL CL B 101s A 138 ARG B 11 ARG^? -4.26 CL CL B 101s A 161 LYS B 65 LYS~? 14.42 CL CL B 101 coo 29.03 88.95 86.80 28.09 90.57 84.75 3.66 19.37 41.31 2.04 19.67 43.57 coo 23.31 93.18 82.88 23.00 93.71 79.86 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 33.83 91.15 88.62 31.07 91.06 83.02 2.20 15.51 35.93 -2.75 14.71 32.15 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 6 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 9 TYR^? 9.51 CL CL A 101 B 138 ARG A 11 ARG^? 4.24 CL CL A 101s B 161 LYS A 94 LYS^? 17.13 CL CL A 101 coo 4.62 122.69 99.88 5.46 122.82 97.24 5.74 42.78 39.87 3.37 44.03 39.19 coo 10.44 122.27 94.08 11.02 123.87 91.53 2.42 41.34 32.49 3.79 44.02 33.12 coo -0.17 119.75 99.65 2.51 123.83 95.70 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR A 9 TYR^? 9.51 CL CL A 101 B 138 ARG A 95 ARG^? -17.49 CL CL A 101s B 161 LYS A 65 LYS~? 13.92 CL CL A 101 coo 4.62 122.69 99.88 5.46 122.82 97.24 5.74 42.78 39.87 3.37 44.03 39.19 coo 10.44 122.27 94.08 11.02 123.87 91.53 8.08 35.24 44.69 10.92 34.84 45.57 coo -0.17 119.75 99.65 2.51 123.83 95.70 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 133 TYR B 9 TYR^? 9.45 CL CL B 101 B 138 ARG B 11 ARG^? -4.26 CL CL B 101s B 161 LYS B 65 LYS~? 14.42 CL CL B 101 coo 4.62 122.69 99.88 5.46 122.82 97.24 1.66 19.18 35.77 -1.08 19.00 35.58 coo 10.44 122.27 94.08 11.02 123.87 91.53 -2.97 22.30 41.65 -2.03 19.36 41.23 coo -0.17 119.75 99.65 2.51 123.83 95.70 2.20 15.51 35.93 -2.75 14.71 32.15 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 133 TYR B 9 TYR^? 9.45 CL CL B 101 B 138 ARG B 11 ARG^? -4.26 CL CL B 101s B 161 LYS B 94 LYS^? 17.24 CL CL B 101 coo 4.62 122.69 99.88 5.46 122.82 97.24 1.66 19.18 35.77 -1.08 19.00 35.58 coo 10.44 122.27 94.08 11.02 123.87 91.53 -2.97 22.30 41.65 -2.03 19.36 41.23 coo -0.17 119.75 99.65 2.51 123.83 95.70 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 133 TYR B 9 TYR^? 9.45 CL CL B 101 B 138 ARG B 95 ARG^? 16.04 CL CL B 101 B 161 LYS B 65 LYS~? 14.42 CL CL B 101 coo 4.62 122.69 99.88 5.46 122.82 97.24 1.66 19.18 35.77 -1.08 19.00 35.58 coo 10.44 122.27 94.08 11.02 123.87 91.53 7.82 25.35 32.62 10.50 24.66 33.91 coo -0.17 119.75 99.65 2.51 123.83 95.70 2.20 15.51 35.93 -2.75 14.71 32.15 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 133 TYR B 62 TYR^? -4.93 CL CL B 101s B 138 ARG B 11 ARG^? -4.26 CL CL B 101s B 161 LYS B 65 LYS~? 14.42 CL CL B 101 coo 4.62 122.69 99.88 5.46 122.82 97.24 3.66 19.37 41.31 2.04 19.67 43.57 coo 10.44 122.27 94.08 11.02 123.87 91.53 -2.97 22.30 41.65 -2.03 19.36 41.23 coo -0.17 119.75 99.65 2.51 123.83 95.70 2.20 15.51 35.93 -2.75 14.71 32.15 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 6 hits 1dhp_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 28 THR~? 16.04 C1 EDO A 103 A 45 THR A 26 THR~? 11.13 C1 EDO A 103 A 161 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 26.16 88.25 79.16 25.22 89.47 80.71 6.04 28.84 19.10 6.33 27.60 17.37 coo 27.73 89.90 76.08 29.24 91.46 75.95 1.24 31.22 19.26 -0.47 32.28 19.98 coo 33.83 91.15 88.62 31.07 91.06 83.02 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR B 28 THR~? 17.43 CL CL B 101 A 45 THR B 26 THR~? 13.23 CL CL B 102 A 161 LYS B 37 LYS~? 12.27 CL CL B 101 coo 26.16 88.25 79.16 25.22 89.47 80.71 -0.99 32.38 55.69 -1.02 33.32 57.62 coo 27.73 89.90 76.08 29.24 91.46 75.95 -5.66 32.28 53.16 -7.14 31.96 51.67 coo 33.83 91.15 88.62 31.07 91.06 83.02 2.75 19.57 52.71 1.11 15.06 54.82 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 28 THR~? 16.04 C1 EDO A 103 B 45 THR A 26 THR~? 11.13 C1 EDO A 103 B 161 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 7.39 128.28 94.56 8.34 126.36 94.79 6.04 28.84 19.10 6.33 27.60 17.37 coo 5.75 129.25 91.25 4.29 128.16 90.07 1.24 31.22 19.26 -0.47 32.28 19.98 coo -0.17 119.75 99.65 2.51 123.83 95.70 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR B 28 THR~? 17.43 CL CL B 101 B 45 THR B 26 THR~? 13.23 CL CL B 102 B 161 LYS B 37 LYS~? 12.27 CL CL B 101 coo 7.39 128.28 94.56 8.34 126.36 94.79 -0.99 32.38 55.69 -1.02 33.32 57.62 coo 5.75 129.25 91.25 4.29 128.16 90.07 -5.66 32.28 53.16 -7.14 31.96 51.67 coo -0.17 119.75 99.65 2.51 123.83 95.70 2.75 19.57 52.71 1.11 15.06 54.82 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c03 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 65 LYS~? 13.92 CL CL A 101 A 215 LYS A 74 LYS~? 11.85 CL CL A 101 A 277 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 0.50 24.09 51.68 1.51 29.34 52.35 6.91 46.21 39.54 1.48 48.90 41.27 coo 13.06 30.79 51.73 11.40 35.76 53.48 7.23 49.23 25.52 13.07 49.77 27.70 coo 13.04 31.88 60.72 10.57 35.34 57.49 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS B 65 LYS~? 14.42 CL CL B 101 A 215 LYS B 74 LYS~? 11.95 CL CL B 101 A 277 LYS B 37 LYS~? 12.27 CL CL B 101 coo 0.50 24.09 51.68 1.51 29.34 52.35 2.20 15.51 35.93 -2.75 14.71 32.15 coo 13.06 30.79 51.73 11.40 35.76 53.48 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 13.04 31.88 60.72 10.57 35.34 57.49 2.75 19.57 52.71 1.11 15.06 54.82 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 65 LYS~? 13.92 CL CL A 101 B 215 LYS A 74 LYS~? 11.85 CL CL A 101 B 277 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 6.78 45.91 16.15 7.82 40.81 15.84 6.91 46.21 39.54 1.48 48.90 41.27 coo 17.88 38.77 19.81 16.38 34.23 17.24 7.23 49.23 25.52 13.07 49.77 27.70 coo 20.33 37.78 11.20 16.77 34.53 13.47 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS B 65 LYS~? 14.42 CL CL B 101 B 215 LYS B 74 LYS~? 11.95 CL CL B 101 B 277 LYS B 37 LYS~? 12.27 CL CL B 101 coo 6.78 45.91 16.15 7.82 40.81 15.84 2.20 15.51 35.93 -2.75 14.71 32.15 coo 17.88 38.77 19.81 16.38 34.23 17.24 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 20.33 37.78 11.20 16.77 34.53 13.47 2.75 19.57 52.71 1.11 15.06 54.82 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c01 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 76 LYS~? 8.49 CL CL A 102 C 207 LYS A 74 LYS~? 11.85 CL CL A 101 C 366 ASP A 80 ASP~? 10.02 CL CL A 102 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 1.66 47.49 24.58 -2.99 49.01 27.08 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 7.23 49.23 25.52 13.07 49.77 27.70 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -3.16 46.57 21.25 -3.22 47.75 23.02 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c06 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA B 43 ALA.? 6.51 CL CL B 101 A 257 ALA B 68 ALA~? 6.91 CL CL B 101 A 328 ASP B 64 ASP~? 13.25 CL CL B 101 coo 39.84 24.12 8.44 38.50 24.23 9.11 6.49 19.72 44.71 5.42 20.69 45.24 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.21 16.83 40.58 1.14 17.74 39.39 coo 38.17 34.10 6.67 37.72 32.06 6.84 6.48 14.60 36.08 6.70 13.36 37.77 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 1 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 70 SER~? 10.35 CL CL A 101 A 140 TYR A 62 TYR^? -4.89 CL CL A 101s A 144 LYS A 65 LYS~? 13.92 CL CL A 101 coo 34.67 35.79 48.83 33.57 37.88 49.47 8.69 49.45 31.83 11.01 49.78 31.31 coo 29.60 38.99 53.89 30.10 37.88 51.36 8.83 41.55 35.27 8.22 41.73 32.60 coo 32.73 32.94 54.42 29.29 32.83 50.35 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER B 70 SER~? 11.08 CL CL B 101 A 140 TYR B 62 TYR^? -4.93 CL CL B 101s A 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo 34.67 35.79 48.83 33.57 37.88 49.47 -0.88 12.28 43.05 0.57 10.68 44.17 coo 29.60 38.99 53.89 30.10 37.88 51.36 3.66 19.37 41.31 2.04 19.67 43.57 coo 32.73 32.94 54.42 29.29 32.83 50.35 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER B 70 SER~? 11.08 CL CL B 101 B 140 TYR B 62 TYR^? -4.93 CL CL B 101s B 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo 30.90 35.65 89.60 29.85 37.72 88.83 -0.88 12.28 43.05 0.57 10.68 44.17 coo 24.43 38.83 86.53 27.07 38.03 86.12 3.66 19.37 41.31 2.04 19.67 43.57 coo 25.13 32.62 89.49 27.74 32.61 84.91 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 70 SER~? 10.35 CL CL A 101 C 140 TYR A 62 TYR^? -4.89 CL CL A 101s C 144 LYS A 65 LYS~? 13.92 CL CL A 101 coo -8.96 33.70 98.81 -8.96 35.77 97.56 8.69 49.45 31.83 11.01 49.78 31.31 coo -8.28 37.01 91.79 -6.99 36.16 94.13 8.83 41.55 35.27 8.22 41.73 32.60 coo -10.48 30.66 93.19 -5.27 31.07 94.32 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER B 70 SER~? 11.08 CL CL B 101 C 140 TYR B 62 TYR^? -4.93 CL CL B 101s C 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -0.88 12.28 43.05 0.57 10.68 44.17 coo -8.28 37.01 91.79 -6.99 36.16 94.13 3.66 19.37 41.31 2.04 19.67 43.57 coo -10.48 30.66 93.19 -5.27 31.07 94.32 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER B 70 SER~? 11.08 CL CL B 101 D 140 TYR B 62 TYR^? -4.93 CL CL B 101s D 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -0.88 12.28 43.05 0.57 10.68 44.17 coo -23.30 35.33 62.20 -25.10 34.24 64.06 3.66 19.37 41.31 2.04 19.67 43.57 coo -24.76 28.82 60.31 -24.27 29.01 65.58 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER B 70 SER~? 11.08 CL CL B 101 E 140 TYR B 62 TYR^? -4.93 CL CL B 101s E 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -0.88 12.28 43.05 0.57 10.68 44.17 coo 0.04 36.70 38.68 -2.21 35.46 37.50 3.66 19.37 41.31 2.04 19.67 43.57 coo 1.93 30.52 36.31 -2.84 30.18 38.54 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 70 SER~? 10.35 CL CL A 101 F 140 TYR A 62 TYR^? -4.89 CL CL A 101s F 144 LYS A 65 LYS~? 13.92 CL CL A 101 coo 55.30 92.46 56.72 55.15 90.39 55.38 8.69 49.45 31.83 11.01 49.78 31.31 coo 54.49 89.31 49.65 53.35 90.16 52.06 8.83 41.55 35.27 8.22 41.73 32.60 coo 56.78 95.62 51.15 51.59 95.31 52.37 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER B 70 SER~? 11.08 CL CL B 101 F 140 TYR B 62 TYR^? -4.93 CL CL B 101s F 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo 55.30 92.46 56.72 55.15 90.39 55.38 -0.88 12.28 43.05 0.57 10.68 44.17 coo 54.49 89.31 49.65 53.35 90.16 52.06 3.66 19.37 41.31 2.04 19.67 43.57 coo 56.78 95.62 51.15 51.59 95.31 52.37 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER B 70 SER~? 11.08 CL CL B 101 G 140 TYR B 62 TYR^? -4.93 CL CL B 101s G 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo 76.25 95.63 21.56 75.29 93.40 21.36 -0.88 12.28 43.05 0.57 10.68 44.17 coo 69.78 91.62 20.06 71.51 92.68 22.02 3.66 19.37 41.31 2.04 19.67 43.57 coo 71.19 98.21 18.32 70.69 97.75 23.67 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 70 SER~? 10.35 CL CL A 101 H 140 TYR A 62 TYR^? -4.89 CL CL A 101s H 144 LYS A 65 LYS~? 13.92 CL CL A 101 coo 15.45 90.62 47.70 16.55 88.57 46.97 8.69 49.45 31.83 11.01 49.78 31.31 coo 21.92 87.58 44.67 19.30 88.41 44.23 8.83 41.55 35.27 8.22 41.73 32.60 coo 21.26 93.70 47.67 18.47 93.68 43.08 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER B 70 SER~? 11.08 CL CL B 101 H 140 TYR B 62 TYR^? -4.93 CL CL B 101s H 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo 15.45 90.62 47.70 16.55 88.57 46.97 -0.88 12.28 43.05 0.57 10.68 44.17 coo 21.92 87.58 44.67 19.30 88.41 44.23 3.66 19.37 41.31 2.04 19.67 43.57 coo 21.26 93.70 47.67 18.47 93.68 43.08 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER B 70 SER~? 11.08 CL CL B 101 I 140 TYR B 62 TYR^? -4.93 CL CL B 101s I 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo 11.78 90.82 7.18 12.84 88.72 7.93 -0.88 12.28 43.05 0.57 10.68 44.17 coo 16.78 87.76 12.19 16.39 88.69 9.59 3.66 19.37 41.31 2.04 19.67 43.57 coo 13.67 93.83 12.65 17.08 93.94 8.58 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 70 SER~? 10.35 CL CL A 101 J 140 TYR A 62 TYR^? -4.89 CL CL A 101s J 144 LYS A 65 LYS~? 13.92 CL CL A 101 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 8.69 49.45 31.83 11.01 49.78 31.31 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 8.83 41.55 35.27 8.22 41.73 32.60 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER B 70 SER~? 11.08 CL CL B 101 J 140 TYR B 62 TYR^? -4.93 CL CL B 101s J 144 LYS B 65 LYS~? 14.42 CL CL B 101 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -0.88 12.28 43.05 0.57 10.68 44.17 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 3.66 19.37 41.31 2.04 19.67 43.57 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 2.20 15.51 35.93 -2.75 14.71 32.15 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 37 LYS~? 12.10 O1 EDO A 103 A 193 GLU A 31 GLU~? 15.39 O1 EDO A 103 A 217 VAL A 33 VAL~? 11.40 O1 EDO A 103 coo 2.10 10.68 61.44 -2.14 13.16 60.61 12.12 40.22 23.70 13.00 44.76 21.03 coo -5.33 11.71 69.72 -4.62 11.92 67.73 10.31 28.74 22.96 10.37 26.64 22.82 coo 0.07 12.29 66.53 -0.24 11.95 64.38 10.28 35.90 19.65 9.57 36.73 17.71 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 76 LYS~? 8.49 CL CL A 102 A 193 GLU A 81 GLU~? 14.16 C2 EDO A 103 A 217 VAL A 79 VAL~? 5.03 C2 EDO A 103 coo 2.10 10.68 61.44 -2.14 13.16 60.61 1.66 47.49 24.58 -2.99 49.01 27.08 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -1.07 42.33 16.34 -2.16 43.00 14.64 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -0.14 43.23 23.16 0.04 43.15 25.35 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS A 94 LYS^? 17.13 CL CL A 101 A 193 GLU B 47 GLU^? 13.68 CL CL B 101 A 217 VAL B 49 VAL^? 13.99 CL CL A 101 coo 2.10 10.68 61.44 -2.14 13.16 60.61 3.98 41.23 44.04 4.99 47.03 46.41 coo -5.33 11.71 69.72 -4.62 11.92 67.73 5.37 31.65 43.25 6.96 32.44 42.04 coo 0.07 12.29 66.53 -0.24 11.95 64.38 1.39 36.43 44.02 2.27 36.59 42.01 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS B 37 LYS~? 12.27 CL CL B 101 A 193 GLU B 31 GLU~? 16.05 CL CL B 101 A 217 VAL B 33 VAL~? 11.89 CL CL B 101 coo 2.10 10.68 61.44 -2.14 13.16 60.61 2.75 19.57 52.71 1.11 15.06 54.82 coo -5.33 11.71 69.72 -4.62 11.92 67.73 4.21 30.96 54.15 4.85 32.92 54.48 coo 0.07 12.29 66.53 -0.24 11.95 64.38 0.00 24.44 55.72 -1.88 24.13 56.83 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS B 76 LYS~? 14.96 CL CL B 101 A 193 GLU B 81 GLU~? 14.80 CL CL B 101 A 217 VAL B 79 VAL~? 8.15 CL CL B 101 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -8.46 17.49 49.39 -13.73 16.10 50.24 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -9.05 25.50 55.61 -7.98 24.84 57.33 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -8.50 22.54 49.01 -8.39 21.73 46.93 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS B 94 LYS^? 17.24 CL CL B 101 A 193 GLU A 47 GLU^? 13.35 CL CL A 101 A 217 VAL A 49 VAL^? 13.80 C1 EDO A 103 coo 2.10 10.68 61.44 -2.14 13.16 60.61 2.42 20.83 31.52 1.85 15.08 28.99 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.76 29.94 33.50 7.56 29.03 35.26 coo 0.07 12.29 66.53 -0.24 11.95 64.38 1.83 26.34 30.61 1.89 26.09 32.77 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 6 hits 1et0_c00 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 73 ASP~? 10.71 CL CL A 101 260 GLU A 92 GLU^? 7.22 O2 EDO A 103 370 TYR A 62 TYR^? -4.89 CL CL A 101s coo 8.60 -17.93 28.38 7.67 -19.04 26.88 5.34 51.24 29.08 4.06 51.85 30.69 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 0.05 42.98 37.01 0.92 44.18 35.56 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 8.83 41.55 35.27 8.22 41.73 32.60 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 100 ASP.? 15.68 CL CL B 101 260 GLU B 47 GLU^? 13.68 CL CL B 101 370 TYR B 58 TYR^? 6.57 CL CL B 101 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 11.90 26.11 47.01 13.15 27.58 47.89 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 5.37 31.65 43.25 6.96 32.44 42.04 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -0.68 28.61 46.28 0.81 26.77 47.73 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP B 100 ASP.? 16.19 CL CL A 101 260 GLU A 47 GLU^? 13.35 CL CL A 101 370 TYR A 58 TYR^? 4.97 C1 EDO A 103 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 15.54 31.73 32.19 17.10 30.29 31.96 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 6.76 29.94 33.50 7.56 29.03 35.26 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 3.55 34.19 28.36 5.98 35.22 27.53 1euu_c00 source 1euu SIALIDASE : 3 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 47 GLU^? 13.35 CL CL A 101 A 260 ARG B 11 ARG^? -4.26 CL CL B 101s A 270 LYS B 94 LYS^? 17.24 CL CL B 101 coo 50.99 29.43 12.86 52.11 29.45 14.65 6.76 29.94 33.50 7.56 29.03 35.26 coo 39.80 27.50 22.98 42.20 26.56 21.34 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 48.83 21.70 19.50 47.44 24.99 15.25 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 78 GLU~? 10.37 C2 EDO A 103 A 260 ARG A 11 ARG^? 4.24 CL CL A 101s A 270 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 50.99 29.43 12.86 52.11 29.45 14.65 4.50 44.13 19.44 5.14 46.14 19.71 coo 39.80 27.50 22.98 42.20 26.56 21.34 2.42 41.34 32.49 3.79 44.02 33.12 coo 48.83 21.70 19.50 47.44 24.99 15.25 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 81 GLU~? 14.16 C2 EDO A 103 A 260 ARG A 11 ARG^? 4.24 CL CL A 101s A 270 LYS A 76 LYS~? 8.49 CL CL A 102 coo 50.99 29.43 12.86 52.11 29.45 14.65 -1.07 42.33 16.34 -2.16 43.00 14.64 coo 39.80 27.50 22.98 42.20 26.56 21.34 2.42 41.34 32.49 3.79 44.02 33.12 coo 48.83 21.70 19.50 47.44 24.99 15.25 1.66 47.49 24.58 -2.99 49.01 27.08 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 31 GLU~? 16.05 CL CL B 101 A 260 ARG B 11 ARG^? -4.26 CL CL B 101s A 270 LYS B 37 LYS~? 12.27 CL CL B 101 coo 50.99 29.43 12.86 52.11 29.45 14.65 4.21 30.96 54.15 4.85 32.92 54.48 coo 39.80 27.50 22.98 42.20 26.56 21.34 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 48.83 21.70 19.50 47.44 24.99 15.25 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 47 GLU^? 13.68 CL CL B 101 A 260 ARG A 11 ARG^? 4.24 CL CL A 101s A 270 LYS A 94 LYS^? 17.13 CL CL A 101 coo 50.99 29.43 12.86 52.11 29.45 14.65 5.37 31.65 43.25 6.96 32.44 42.04 coo 39.80 27.50 22.98 42.20 26.56 21.34 2.42 41.34 32.49 3.79 44.02 33.12 coo 48.83 21.70 19.50 47.44 24.99 15.25 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU B 81 GLU~? 14.80 CL CL B 101 A 260 ARG B 11 ARG^? -4.26 CL CL B 101s A 270 LYS B 76 LYS~? 14.96 CL CL B 101 coo 50.99 29.43 12.86 52.11 29.45 14.65 -9.05 25.50 55.61 -7.98 24.84 57.33 coo 39.80 27.50 22.98 42.20 26.56 21.34 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 48.83 21.70 19.50 47.44 24.99 15.25 -8.46 17.49 49.39 -13.73 16.10 50.24 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU B 92 GLU^? 7.39 CL CL B 101 A 260 ARG B 95 ARG^? 16.04 CL CL B 101 A 270 LYS B 65 LYS~? 14.42 CL CL B 101 coo 50.99 29.43 12.86 52.11 29.45 14.65 -4.23 21.44 36.57 -4.25 20.15 38.22 coo 39.80 27.50 22.98 42.20 26.56 21.34 7.82 25.35 32.62 10.50 24.66 33.91 coo 48.83 21.70 19.50 47.44 24.99 15.25 2.20 15.51 35.93 -2.75 14.71 32.15 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 7 hits 1euy_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 61 HIS^? 11.02 CL CL A 101 C 62 LYS A 37 LYS~? 12.10 O1 EDO A 103 F 35 ASP B 100 ASP.? 16.19 CL CL A 101 coo 15.40 22.79 16.66 13.93 24.10 15.98 8.98 34.66 37.52 7.84 33.05 38.23 coo 19.95 18.98 4.81 18.82 20.94 10.49 12.12 40.22 23.70 13.00 44.76 21.03 coo 16.32 15.30 17.19 17.71 14.73 18.69 15.54 31.73 32.19 17.10 30.29 31.96 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 37 LYS~? 12.10 O1 EDO A 103 C 105 HIS A 61 HIS^? 11.02 CL CL A 101 D 35 ASP B 100 ASP.? 16.19 CL CL A 101 coo 38.76 28.25 7.87 36.33 26.41 13.58 12.12 40.22 23.70 13.00 44.76 21.03 coo 34.93 19.72 17.37 34.72 18.17 15.98 8.98 34.66 37.52 7.84 33.05 38.23 coo 41.01 23.02 20.83 40.65 24.26 22.55 15.54 31.73 32.19 17.10 30.29 31.96 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 37 LYS~? 12.10 O1 EDO A 103 B 105 HIS A 61 HIS^? 11.02 CL CL A 101 E 35 ASP B 100 ASP.? 16.19 CL CL A 101 coo 20.51 39.76 8.83 21.23 37.38 14.18 12.12 40.22 23.70 13.00 44.76 21.03 coo 27.18 37.56 20.68 29.07 38.28 20.13 8.98 34.66 37.52 7.84 33.05 38.23 coo 19.97 40.39 22.03 18.53 39.30 23.18 15.54 31.73 32.19 17.10 30.29 31.96 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS B 37 LYS~? 12.27 CL CL B 101 B 105 HIS B 61 HIS^? 11.05 CL CL B 101 E 35 ASP A 100 ASP.? 15.68 CL CL B 101 coo 20.51 39.76 8.83 21.23 37.38 14.18 2.75 19.57 52.71 1.11 15.06 54.82 coo 27.18 37.56 20.68 29.07 38.28 20.13 6.99 25.63 39.23 6.79 27.36 38.08 coo 19.97 40.39 22.03 18.53 39.30 23.18 11.90 26.11 47.01 13.15 27.58 47.89 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 97 PHE^? 12.39 CL CL B 101 A 210 ASP A 100 ASP.? 15.68 CL CL B 101 A 244 LYS B 37 LYS~? 12.27 CL CL B 101 coo 9.23 46.77 25.11 11.48 48.39 24.76 4.50 32.64 50.54 2.47 30.85 50.01 coo 10.51 37.86 19.71 9.07 39.38 20.04 11.90 26.11 47.01 13.15 27.58 47.89 coo -1.20 42.34 17.67 3.19 45.13 19.06 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE B 97 PHE^? 11.11 C1 EDO A 103 A 210 ASP B 100 ASP.? 16.19 CL CL A 101 A 244 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 9.23 46.77 25.11 11.48 48.39 24.76 8.21 28.14 26.14 7.00 30.62 25.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 15.54 31.73 32.19 17.10 30.29 31.96 coo -1.20 42.34 17.67 3.19 45.13 19.06 12.12 40.22 23.70 13.00 44.76 21.03 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 97 PHE^? 12.39 CL CL B 101 B 210 ASP A 100 ASP.? 15.68 CL CL B 101 B 244 LYS B 37 LYS~? 12.27 CL CL B 101 coo 8.76 47.85 34.91 11.08 46.36 35.41 4.50 32.64 50.54 2.47 30.85 50.01 coo 9.06 56.85 40.30 7.71 55.27 39.90 11.90 26.11 47.01 13.15 27.58 47.89 coo -2.38 51.82 41.62 2.07 49.19 40.42 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE B 97 PHE^? 11.11 C1 EDO A 103 B 210 ASP B 100 ASP.? 16.19 CL CL A 101 B 244 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 8.76 47.85 34.91 11.08 46.36 35.41 8.21 28.14 26.14 7.00 30.62 25.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 15.54 31.73 32.19 17.10 30.29 31.96 coo -2.38 51.82 41.62 2.07 49.19 40.42 12.12 40.22 23.70 13.00 44.76 21.03 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 62 TYR^? -4.89 CL CL A 101s A 142 LEU A 41 LEU~? 8.90 CL CL A 101 A 165 LYS A 65 LYS~? 13.92 CL CL A 101 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 8.83 41.55 35.27 8.22 41.73 32.60 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 12.47 44.72 27.62 12.18 45.79 25.69 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR B 62 TYR^? -4.93 CL CL B 101s A 142 LEU B 41 LEU~? 9.69 CL CL B 101 A 165 LYS B 65 LYS~? 14.42 CL CL B 101 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 3.66 19.37 41.31 2.04 19.67 43.57 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 3.88 15.02 48.99 2.68 14.19 50.57 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 2.20 15.51 35.93 -2.75 14.71 32.15 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 62 TYR^? -4.89 CL CL A 101s B 142 LEU A 41 LEU~? 8.90 CL CL A 101 B 165 LYS A 65 LYS~? 13.92 CL CL A 101 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 8.83 41.55 35.27 8.22 41.73 32.60 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 12.47 44.72 27.62 12.18 45.79 25.69 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR B 62 TYR^? -4.93 CL CL B 101s B 142 LEU B 41 LEU~? 9.69 CL CL B 101 B 165 LYS B 65 LYS~? 14.42 CL CL B 101 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 3.66 19.37 41.31 2.04 19.67 43.57 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 3.88 15.02 48.99 2.68 14.19 50.57 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 2.20 15.51 35.93 -2.75 14.71 32.15 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 62 TYR^? -4.89 CL CL A 101s C 142 LEU A 41 LEU~? 8.90 CL CL A 101 C 165 LYS A 65 LYS~? 13.92 CL CL A 101 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 8.83 41.55 35.27 8.22 41.73 32.60 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 12.47 44.72 27.62 12.18 45.79 25.69 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR B 62 TYR^? -4.93 CL CL B 101s C 142 LEU B 41 LEU~? 9.69 CL CL B 101 C 165 LYS B 65 LYS~? 14.42 CL CL B 101 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 3.66 19.37 41.31 2.04 19.67 43.57 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 3.88 15.02 48.99 2.68 14.19 50.57 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 2.20 15.51 35.93 -2.75 14.71 32.15 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 62 TYR^? -4.89 CL CL A 101s D 142 LEU A 41 LEU~? 8.90 CL CL A 101 D 165 LYS A 65 LYS~? 13.92 CL CL A 101 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 8.83 41.55 35.27 8.22 41.73 32.60 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 12.47 44.72 27.62 12.18 45.79 25.69 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR B 62 TYR^? -4.93 CL CL B 101s D 142 LEU B 41 LEU~? 9.69 CL CL B 101 D 165 LYS B 65 LYS~? 14.42 CL CL B 101 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 3.66 19.37 41.31 2.04 19.67 43.57 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 3.88 15.02 48.99 2.68 14.19 50.57 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 2.20 15.51 35.93 -2.75 14.71 32.15 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 70 SER~? 10.35 CL CL A 101 A 48 THR A 67 THR~? 9.89 CL CL A 101 A 165 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 8.69 49.45 31.83 11.01 49.78 31.31 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 10.60 46.69 35.48 12.42 45.52 35.63 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 70 SER~? 10.35 CL CL A 101 A 48 THR A 67 THR~? 9.89 CL CL A 101 A 165 LYS A 76 LYS~? 8.49 CL CL A 102 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 8.69 49.45 31.83 11.01 49.78 31.31 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 10.60 46.69 35.48 12.42 45.52 35.63 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 1.66 47.49 24.58 -2.99 49.01 27.08 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER B 70 SER~? 11.08 CL CL B 101 A 48 THR B 67 THR~? 10.38 CL CL B 101 A 165 LYS B 37 LYS~? 12.27 CL CL B 101 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -0.88 12.28 43.05 0.57 10.68 44.17 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 3.55 13.82 40.95 5.56 14.17 41.67 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER B 70 SER~? 11.08 CL CL B 101 A 48 THR B 67 THR~? 10.38 CL CL B 101 A 165 LYS B 76 LYS~? 14.96 CL CL B 101 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -0.88 12.28 43.05 0.57 10.68 44.17 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 3.55 13.82 40.95 5.56 14.17 41.67 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -8.46 17.49 49.39 -13.73 16.10 50.24 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 70 SER~? 10.35 CL CL A 101 B 48 THR A 67 THR~? 9.89 CL CL A 101 B 165 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 8.69 49.45 31.83 11.01 49.78 31.31 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 10.60 46.69 35.48 12.42 45.52 35.63 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 70 SER~? 11.08 CL CL B 101 B 48 THR B 67 THR~? 10.38 CL CL B 101 B 165 LYS B 37 LYS~? 12.27 CL CL B 101 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -0.88 12.28 43.05 0.57 10.68 44.17 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 3.55 13.82 40.95 5.56 14.17 41.67 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER B 70 SER~? 11.08 CL CL B 101 B 48 THR B 67 THR~? 10.38 CL CL B 101 B 165 LYS B 76 LYS~? 14.96 CL CL B 101 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -0.88 12.28 43.05 0.57 10.68 44.17 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 3.55 13.82 40.95 5.56 14.17 41.67 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -8.46 17.49 49.39 -13.73 16.10 50.24 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 70 SER~? 10.35 CL CL A 101 C 48 THR A 67 THR~? 9.89 CL CL A 101 C 165 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 8.69 49.45 31.83 11.01 49.78 31.31 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 10.60 46.69 35.48 12.42 45.52 35.63 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 70 SER~? 10.35 CL CL A 101 C 48 THR A 67 THR~? 9.89 CL CL A 101 C 165 LYS A 76 LYS~? 8.49 CL CL A 102 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 8.69 49.45 31.83 11.01 49.78 31.31 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 10.60 46.69 35.48 12.42 45.52 35.63 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 1.66 47.49 24.58 -2.99 49.01 27.08 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER B 70 SER~? 11.08 CL CL B 101 C 48 THR B 67 THR~? 10.38 CL CL B 101 C 165 LYS B 37 LYS~? 12.27 CL CL B 101 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -0.88 12.28 43.05 0.57 10.68 44.17 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 3.55 13.82 40.95 5.56 14.17 41.67 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER B 70 SER~? 11.08 CL CL B 101 C 48 THR B 67 THR~? 10.38 CL CL B 101 C 165 LYS B 76 LYS~? 14.96 CL CL B 101 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -0.88 12.28 43.05 0.57 10.68 44.17 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 3.55 13.82 40.95 5.56 14.17 41.67 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -8.46 17.49 49.39 -13.73 16.10 50.24 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 70 SER~? 10.35 CL CL A 101 D 48 THR A 67 THR~? 9.89 CL CL A 101 D 165 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 8.69 49.45 31.83 11.01 49.78 31.31 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 10.60 46.69 35.48 12.42 45.52 35.63 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 55 SER^? 10.96 CL CL B 102 D 48 THR B 16 THR^? 7.95 CL CL B 102 D 165 LYS A 94 LYS^? 17.13 CL CL A 101 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -6.97 38.30 45.24 -8.93 39.11 43.98 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -10.59 36.02 45.58 -11.40 37.39 44.08 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER B 70 SER~? 11.08 CL CL B 101 D 48 THR B 67 THR~? 10.38 CL CL B 101 D 165 LYS B 37 LYS~? 12.27 CL CL B 101 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -0.88 12.28 43.05 0.57 10.68 44.17 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 3.55 13.82 40.95 5.56 14.17 41.67 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER B 70 SER~? 11.08 CL CL B 101 D 48 THR B 67 THR~? 10.38 CL CL B 101 D 165 LYS B 76 LYS~? 14.96 CL CL B 101 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -0.88 12.28 43.05 0.57 10.68 44.17 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 3.55 13.82 40.95 5.56 14.17 41.67 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -8.46 17.49 49.39 -13.73 16.10 50.24 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c07 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 78 GLU~? 10.37 C2 EDO A 103 A 319 ASP A 80 ASP~? 10.02 CL CL A 102 A 359 ARG A 83 ARG~? -3.23 CL CL A 102s coo 14.41 12.40 16.42 12.92 13.74 15.71 4.50 44.13 19.44 5.14 46.14 19.71 coo 12.25 13.04 23.85 11.56 15.02 23.93 -3.16 46.57 21.25 -3.22 47.75 23.02 coo 10.89 14.95 28.28 12.39 12.53 29.31 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU B 78 GLU~? 9.53 CL CL B 101 A 319 ASP B 80 ASP~? 13.43 CL CL B 101 A 359 ARG B 83 ARG~? 10.85 CL CL B 102 coo 14.41 12.40 16.42 12.92 13.74 15.71 -4.08 21.32 52.83 -3.90 19.30 53.45 coo 12.25 13.04 23.85 11.56 15.02 23.93 -12.29 21.04 51.71 -12.95 19.46 50.41 coo 10.89 14.95 28.28 12.39 12.53 29.31 -13.74 24.05 46.82 -12.84 23.81 43.90 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 2 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 78 GLU~? 10.37 C2 EDO A 103 B 319 ASP A 80 ASP~? 10.02 CL CL A 102 B 359 ARG A 83 ARG~? -3.23 CL CL A 102s coo 10.77 13.13 40.94 11.03 14.73 39.51 4.50 44.13 19.44 5.14 46.14 19.71 coo 3.77 12.64 38.21 3.35 14.53 37.39 -3.16 46.57 21.25 -3.22 47.75 23.02 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU B 78 GLU~? 9.53 CL CL B 101 B 319 ASP B 80 ASP~? 13.43 CL CL B 101 B 359 ARG B 83 ARG~? 10.85 CL CL B 102 coo 10.77 13.13 40.94 11.03 14.73 39.51 -4.08 21.32 52.83 -3.90 19.30 53.45 coo 3.77 12.64 38.21 3.35 14.53 37.39 -12.29 21.04 51.71 -12.95 19.46 50.41 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -13.74 24.05 46.82 -12.84 23.81 43.90 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 2 hits 1fr8_c01 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 92 GLU^? 7.22 O2 EDO A 103 A 47 ASP A 73 ASP~? 10.71 CL CL A 101 A 161 TYR A 9 TYR^? 9.51 CL CL A 101 coo 37.12 18.35 73.76 37.09 16.69 72.44 0.05 42.98 37.01 0.92 44.18 35.56 coo 29.81 8.06 73.13 30.21 10.11 72.95 5.34 51.24 29.08 4.06 51.85 30.69 coo 37.29 15.56 67.90 37.37 13.79 70.08 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU B 81 GLU~? 14.80 CL CL B 101 A 47 ASP B 24 ASP~? 18.84 CL CL B 102 A 161 TYR B 29 TYR~? 11.81 CL CL B 101 coo 37.12 18.35 73.76 37.09 16.69 72.44 -9.05 25.50 55.61 -7.98 24.84 57.33 coo 29.81 8.06 73.13 30.21 10.11 72.95 -4.56 38.47 55.74 -4.13 40.38 54.82 coo 37.29 15.56 67.90 37.37 13.79 70.08 -4.54 27.31 54.97 -5.26 24.64 54.93 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU B 92 GLU^? 7.39 CL CL B 101 A 47 ASP B 73 ASP~? 12.11 CL CL B 101 A 161 TYR B 9 TYR^? 9.45 CL CL B 101 coo 37.12 18.35 73.76 37.09 16.69 72.44 -4.23 21.44 36.57 -4.25 20.15 38.22 coo 29.81 8.06 73.13 30.21 10.11 72.95 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 37.29 15.56 67.90 37.37 13.79 70.08 1.66 19.18 35.77 -1.08 19.00 35.58 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 3 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 92 GLU^? 7.22 O2 EDO A 103 B 47 ASP A 73 ASP~? 10.71 CL CL A 101 B 161 TYR A 9 TYR^? 9.51 CL CL A 101 coo 53.87 35.49 53.22 55.44 35.72 54.61 0.05 42.98 37.01 0.92 44.18 35.56 coo 63.47 43.65 53.95 61.45 43.07 54.06 5.34 51.24 29.08 4.06 51.85 30.69 coo 56.38 35.81 59.19 58.25 35.77 57.10 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU B 81 GLU~? 14.80 CL CL B 101 B 47 ASP B 24 ASP~? 18.84 CL CL B 102 B 161 TYR B 29 TYR~? 11.81 CL CL B 101 coo 53.87 35.49 53.22 55.44 35.72 54.61 -9.05 25.50 55.61 -7.98 24.84 57.33 coo 63.47 43.65 53.95 61.45 43.07 54.06 -4.56 38.47 55.74 -4.13 40.38 54.82 coo 56.38 35.81 59.19 58.25 35.77 57.10 -4.54 27.31 54.97 -5.26 24.64 54.93 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU B 92 GLU^? 7.39 CL CL B 101 B 47 ASP B 73 ASP~? 12.11 CL CL B 101 B 161 TYR B 9 TYR^? 9.45 CL CL B 101 coo 53.87 35.49 53.22 55.44 35.72 54.61 -4.23 21.44 36.57 -4.25 20.15 38.22 coo 63.47 43.65 53.95 61.45 43.07 54.06 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 56.38 35.81 59.19 58.25 35.77 57.10 1.66 19.18 35.77 -1.08 19.00 35.58 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 3 hits 1geq_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 37 LYS~? 12.10 O1 EDO A 103 210 ARG B 95 ARG^? 16.04 CL CL B 101 225 ARG B 98 ARG^? 15.14 CL CL A 101 coo 17.51 28.50 73.42 17.24 23.02 75.86 12.12 40.22 23.70 13.00 44.76 21.03 coo 24.74 11.56 73.05 25.29 14.32 71.80 7.82 25.35 32.62 10.50 24.66 33.91 coo 27.81 15.44 77.10 25.66 16.50 75.19 12.36 28.08 33.40 14.26 29.94 34.96 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 94 LYS^? 17.13 CL CL A 101 210 ARG B 95 ARG^? 16.04 CL CL B 101 225 ARG B 98 ARG^? 15.14 CL CL A 101 coo 17.51 28.50 73.42 17.24 23.02 75.86 3.98 41.23 44.04 4.99 47.03 46.41 coo 24.74 11.56 73.05 25.29 14.32 71.80 7.82 25.35 32.62 10.50 24.66 33.91 coo 27.81 15.44 77.10 25.66 16.50 75.19 12.36 28.08 33.40 14.26 29.94 34.96 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 37 LYS~? 12.27 CL CL B 101 210 ARG A 95 ARG^? -17.49 CL CL A 101s 225 ARG A 98 ARG^? 14.79 CL CL B 101 coo 17.51 28.50 73.42 17.24 23.02 75.86 2.75 19.57 52.71 1.11 15.06 54.82 coo 24.74 11.56 73.05 25.29 14.32 71.80 8.08 35.24 44.69 10.92 34.84 45.57 coo 27.81 15.44 77.10 25.66 16.50 75.19 10.54 31.08 44.97 12.01 28.63 43.83 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS B 94 LYS^? 17.24 CL CL B 101 210 ARG A 95 ARG^? -17.49 CL CL A 101s 225 ARG A 98 ARG^? 14.79 CL CL B 101 coo 17.51 28.50 73.42 17.24 23.02 75.86 2.42 20.83 31.52 1.85 15.08 28.99 coo 24.74 11.56 73.05 25.29 14.32 71.80 8.08 35.24 44.69 10.92 34.84 45.57 coo 27.81 15.44 77.10 25.66 16.50 75.19 10.54 31.08 44.97 12.01 28.63 43.83 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 4 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 97 PHE^? 12.39 CL CL B 101 A 298 ASP A 100 ASP.? 15.68 CL CL B 101 A 329 LYS B 37 LYS~? 12.27 CL CL B 101 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 4.50 32.64 50.54 2.47 30.85 50.01 coo 2.59 0.29 25.55 4.65 0.18 25.07 11.90 26.11 47.01 13.15 27.58 47.89 coo 12.42 6.10 23.27 9.95 1.57 20.16 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 97 PHE^? 11.11 C1 EDO A 103 A 298 ASP B 100 ASP.? 16.19 CL CL A 101 A 329 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 8.21 28.14 26.14 7.00 30.62 25.79 coo 2.59 0.29 25.55 4.65 0.18 25.07 15.54 31.73 32.19 17.10 30.29 31.96 coo 12.42 6.10 23.27 9.95 1.57 20.16 12.12 40.22 23.70 13.00 44.76 21.03 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 97 PHE^? 12.39 CL CL B 101 B 298 ASP A 100 ASP.? 15.68 CL CL B 101 B 329 LYS B 37 LYS~? 12.27 CL CL B 101 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 4.50 32.64 50.54 2.47 30.85 50.01 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 11.90 26.11 47.01 13.15 27.58 47.89 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 97 PHE^? 11.11 C1 EDO A 103 B 298 ASP B 100 ASP.? 16.19 CL CL A 101 B 329 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 8.21 28.14 26.14 7.00 30.62 25.79 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 15.54 31.73 32.19 17.10 30.29 31.96 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 12.12 40.22 23.70 13.00 44.76 21.03 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 97 PHE^? 12.39 CL CL B 101 C 298 ASP A 100 ASP.? 15.68 CL CL B 101 C 329 LYS B 37 LYS~? 12.27 CL CL B 101 coo 17.41 60.57 64.39 18.40 58.12 65.34 4.50 32.64 50.54 2.47 30.85 50.01 coo 24.10 66.43 63.33 24.18 64.30 63.40 11.90 26.11 47.01 13.15 27.58 47.89 coo 27.64 56.61 58.17 22.18 57.92 60.36 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 97 PHE^? 11.11 C1 EDO A 103 C 298 ASP B 100 ASP.? 16.19 CL CL A 101 C 329 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 17.41 60.57 64.39 18.40 58.12 65.34 8.21 28.14 26.14 7.00 30.62 25.79 coo 24.10 66.43 63.33 24.18 64.30 63.40 15.54 31.73 32.19 17.10 30.29 31.96 coo 27.64 56.61 58.17 22.18 57.92 60.36 12.12 40.22 23.70 13.00 44.76 21.03 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 97 PHE^? 12.39 CL CL B 101 D 298 ASP A 100 ASP.? 15.68 CL CL B 101 D 329 LYS B 37 LYS~? 12.27 CL CL B 101 coo 35.44 53.35 83.81 35.65 54.53 81.28 4.50 32.64 50.54 2.47 30.85 50.01 coo 29.72 46.46 83.60 30.79 47.36 81.99 11.90 26.11 47.01 13.15 27.58 47.89 coo 36.89 44.91 74.55 37.33 48.94 79.01 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 97 PHE^? 11.11 C1 EDO A 103 D 298 ASP B 100 ASP.? 16.19 CL CL A 101 D 329 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 35.44 53.35 83.81 35.65 54.53 81.28 8.21 28.14 26.14 7.00 30.62 25.79 coo 29.72 46.46 83.60 30.79 47.36 81.99 15.54 31.73 32.19 17.10 30.29 31.96 coo 36.89 44.91 74.55 37.33 48.94 79.01 12.12 40.22 23.70 13.00 44.76 21.03 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER B 51 SER^? 11.77 CL CL A 102 A 164 TYR A 9 TYR^? 9.51 CL CL A 101 A 168 LYS A 94 LYS^? 17.13 CL CL A 101 coo 32.37 52.40 49.35 31.32 53.88 47.74 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 29.69 55.04 42.83 31.98 53.56 43.49 5.74 42.78 39.87 3.37 44.03 39.19 coo 26.96 50.99 47.03 31.03 48.83 44.33 3.98 41.23 44.04 4.99 47.03 46.41 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER B 51 SER^? 11.77 CL CL A 102 B 164 TYR A 9 TYR^? 9.51 CL CL A 101 B 168 LYS A 94 LYS^? 17.13 CL CL A 101 coo 13.08 50.93 56.67 13.12 48.99 55.27 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 11.52 46.03 51.32 10.06 47.90 52.76 5.74 42.78 39.87 3.37 44.03 39.19 coo 15.72 50.86 51.22 10.77 52.35 51.39 3.98 41.23 44.04 4.99 47.03 46.41 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER B 51 SER^? 11.77 CL CL A 102 C 164 TYR A 9 TYR^? 9.51 CL CL A 101 C 168 LYS A 94 LYS^? 17.13 CL CL A 101 coo 11.22 34.38 82.32 11.07 36.29 83.78 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 8.83 39.27 87.38 7.60 37.43 85.69 5.74 42.78 39.87 3.37 44.03 39.19 coo 12.98 34.46 88.14 8.11 32.96 87.14 3.98 41.23 44.04 4.99 47.03 46.41 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER B 51 SER^? 11.77 CL CL A 102 D 164 TYR A 9 TYR^? 9.51 CL CL A 101 D 168 LYS A 94 LYS^? 17.13 CL CL A 101 coo 29.15 32.90 92.57 27.86 31.44 94.02 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 25.49 30.28 98.59 27.88 31.73 98.26 5.74 42.78 39.87 3.37 44.03 39.19 coo 23.46 34.31 94.02 27.08 36.46 97.29 3.98 41.23 44.04 4.99 47.03 46.41 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 85 GLN~? 15.80 C2 EDO A 103 A 296 GLU A 81 GLU~? 14.16 C2 EDO A 103 A 383 TYR A 29 TYR~? 10.97 C1 EDO A 103 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -4.67 37.80 16.12 -5.58 38.39 14.30 coo 40.93 4.45 2.36 38.91 3.75 2.26 -1.07 42.33 16.34 -2.16 43.00 14.64 coo 30.54 7.22 6.23 31.38 5.79 3.97 5.07 34.81 17.81 5.67 37.48 17.25 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 1 hits 1h19_c00 naa= 3 ULMN 3 1hrk_c00 FERROCHELATASE user 1 3 # 1 A 263 HIS B 61 HIS^? 11.05 CL CL B 101 A 341 HIS A 61 HIS^? 11.02 CL CL A 101 A 343 GLU A 47 GLU^? 13.35 CL CL A 101 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 6.99 25.63 39.23 6.79 27.36 38.08 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 8.98 34.66 37.52 7.84 33.05 38.23 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 6.76 29.94 33.50 7.56 29.03 35.26 1hrk_c00 source 1hrk FERROCHELATASE : 1 hits 1hrk_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL B 82 VAL~? 11.13 CL CL B 101 A 200 ASP B 24 ASP~? 18.84 CL CL B 102 A 226 LYS A 94 LYS^? 17.13 CL CL A 101 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -9.42 27.27 51.02 -7.59 27.64 49.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.56 38.47 55.74 -4.13 40.38 54.82 coo 34.47 51.09 7.19 28.58 51.18 7.53 3.98 41.23 44.04 4.99 47.03 46.41 1i29_c03 source 1i29 CSDB : 1 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 74 LYS~? 11.85 CL CL A 101 A 74 LYS A 76 LYS~? 8.49 CL CL A 102 A 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 7.23 49.23 25.52 13.07 49.77 27.70 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 1.66 47.49 24.58 -2.99 49.01 27.08 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 76 LYS~? 8.49 CL CL A 102 A 74 LYS A 74 LYS~? 11.85 CL CL A 101 A 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 1.66 47.49 24.58 -2.99 49.01 27.08 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 7.23 49.23 25.52 13.07 49.77 27.70 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS B 74 LYS~? 11.95 CL CL B 101 A 74 LYS B 76 LYS~? 14.96 CL CL B 101 A 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 76 LYS~? 14.96 CL CL B 101 A 74 LYS B 74 LYS~? 11.95 CL CL B 101 A 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -4.23 21.44 36.57 -4.25 20.15 38.22 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 4 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 65 LYS~? 13.92 CL CL A 101 B 74 LYS A 94 LYS^? 17.13 CL CL A 101 B 165 GLU A 47 GLU^? 13.35 CL CL A 101 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 6.91 46.21 39.54 1.48 48.90 41.27 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 3.98 41.23 44.04 4.99 47.03 46.41 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 74 LYS~? 11.85 CL CL A 101 B 74 LYS A 76 LYS~? 8.49 CL CL A 102 B 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 7.23 49.23 25.52 13.07 49.77 27.70 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 1.66 47.49 24.58 -2.99 49.01 27.08 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS B 74 LYS~? 11.95 CL CL B 101 B 74 LYS B 76 LYS~? 14.96 CL CL B 101 B 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -3.92 13.74 48.91 -1.31 9.83 46.45 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -8.46 17.49 49.39 -13.73 16.10 50.24 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS B 76 LYS~? 14.96 CL CL B 101 B 74 LYS B 74 LYS~? 11.95 CL CL B 101 B 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -8.46 17.49 49.39 -13.73 16.10 50.24 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -3.92 13.74 48.91 -1.31 9.83 46.45 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -4.23 21.44 36.57 -4.25 20.15 38.22 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 4 hits 1idt_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 45 SER^? 10.94 CL CL A 101 A 173 ARG A 11 ARG^? 4.24 CL CL A 101s A 211 ASP B 100 ASP.? 16.19 CL CL A 101 coo 22.72 76.24 0.23 24.60 76.86 -1.25 12.09 34.48 32.88 11.31 33.31 34.87 coo 18.77 77.82 11.69 20.55 80.22 10.73 2.42 41.34 32.49 3.79 44.02 33.12 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 15.54 31.73 32.19 17.10 30.29 31.96 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 45 SER^? 10.95 CL CL B 101 A 173 ARG B 11 ARG^? -4.26 CL CL B 101s A 211 ASP A 100 ASP.? 15.68 CL CL B 101 coo 22.72 76.24 0.23 24.60 76.86 -1.25 8.38 25.14 44.78 8.69 26.36 42.73 coo 18.77 77.82 11.69 20.55 80.22 10.73 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 11.90 26.11 47.01 13.15 27.58 47.89 1ig8_c00 source 1ig8 HEXOKINASE PII : 2 hits 1ig8_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 47 GLU^? 13.35 CL CL A 101 A 61 GLU B 92 GLU^? 7.39 CL CL B 101 A 162 HIS B 61 HIS^? 11.05 CL CL B 101 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 6.76 29.94 33.50 7.56 29.03 35.26 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -4.23 21.44 36.57 -4.25 20.15 38.22 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 6.99 25.63 39.23 6.79 27.36 38.08 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU B 47 GLU^? 13.68 CL CL B 101 A 61 GLU A 92 GLU^? 7.22 O2 EDO A 103 A 162 HIS A 61 HIS^? 11.02 CL CL A 101 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.37 31.65 43.25 6.96 32.44 42.04 coo -4.89 20.85 5.22 -3.95 21.69 6.91 0.05 42.98 37.01 0.92 44.18 35.56 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 8.98 34.66 37.52 7.84 33.05 38.23 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 2 hits 1j53_c00 naa= 3 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 1 3 # 1 A 488 ARG A 95 ARG^? -17.49 CL CL A 101s A 590 ARG A 98 ARG^? 14.79 CL CL B 101 A 632 HIS A 61 HIS^? 11.02 CL CL A 101 coo 19.23 7.38 20.83 18.34 7.79 23.74 8.08 35.24 44.69 10.92 34.84 45.57 coo 23.20 10.66 21.48 21.07 10.68 23.70 10.54 31.08 44.97 12.01 28.63 43.83 coo 20.55 9.13 29.66 21.88 8.70 28.08 8.98 34.66 37.52 7.84 33.05 38.23 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 2 3 # 2 A 488 ARG A 98 ARG^? 14.79 CL CL B 101 A 590 ARG A 95 ARG^? -17.49 CL CL A 101s A 632 HIS A 61 HIS^? 11.02 CL CL A 101 coo 19.23 7.38 20.83 18.34 7.79 23.74 10.54 31.08 44.97 12.01 28.63 43.83 coo 23.20 10.66 21.48 21.07 10.68 23.70 8.08 35.24 44.69 10.92 34.84 45.57 coo 20.55 9.13 29.66 21.88 8.70 28.08 8.98 34.66 37.52 7.84 33.05 38.23 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 3 3 # 3 A 488 ARG B 95 ARG^? 16.04 CL CL B 101 A 590 ARG B 98 ARG^? 15.14 CL CL A 101 A 632 HIS A 61 HIS^? 11.02 CL CL A 101 coo 19.23 7.38 20.83 18.34 7.79 23.74 7.82 25.35 32.62 10.50 24.66 33.91 coo 23.20 10.66 21.48 21.07 10.68 23.70 12.36 28.08 33.40 14.26 29.94 34.96 coo 20.55 9.13 29.66 21.88 8.70 28.08 8.98 34.66 37.52 7.84 33.05 38.23 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 4 3 # 4 A 488 ARG B 98 ARG^? 15.14 CL CL A 101 A 590 ARG B 95 ARG^? 16.04 CL CL B 101 A 632 HIS A 61 HIS^? 11.02 CL CL A 101 coo 19.23 7.38 20.83 18.34 7.79 23.74 12.36 28.08 33.40 14.26 29.94 34.96 coo 23.20 10.66 21.48 21.07 10.68 23.70 7.82 25.35 32.62 10.50 24.66 33.91 coo 20.55 9.13 29.66 21.88 8.70 28.08 8.98 34.66 37.52 7.84 33.05 38.23 1k4t_c00 source 1k4t 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-3' : 4 hits 1k4t_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 78 GLU~? 10.37 C2 EDO A 103 A 56 LYS A 74 LYS~? 11.85 CL CL A 101 A 258 ARG A 83 ARG~? -3.23 CL CL A 102s coo 42.33 1.56 26.99 42.38 2.91 28.66 4.50 44.13 19.44 5.14 46.14 19.71 coo 38.45 -0.44 19.89 37.36 0.90 25.90 7.23 49.23 25.52 13.07 49.77 27.70 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 78 GLU~? 9.53 CL CL B 101 A 56 LYS B 74 LYS~? 11.95 CL CL B 101 A 258 ARG B 83 ARG~? 10.85 CL CL B 102 coo 42.33 1.56 26.99 42.38 2.91 28.66 -4.08 21.32 52.83 -3.90 19.30 53.45 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -13.74 24.05 46.82 -12.84 23.81 43.90 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 78 GLU~? 10.37 C2 EDO A 103 B 56 LYS A 74 LYS~? 11.85 CL CL A 101 B 258 ARG A 83 ARG~? -3.23 CL CL A 102s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 4.50 44.13 19.44 5.14 46.14 19.71 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 7.23 49.23 25.52 13.07 49.77 27.70 coo 2.64 1.83 34.81 1.56 1.13 32.02 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 78 GLU~? 9.53 CL CL B 101 B 56 LYS B 74 LYS~? 11.95 CL CL B 101 B 258 ARG B 83 ARG~? 10.85 CL CL B 102 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -4.08 21.32 52.83 -3.90 19.30 53.45 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 2.64 1.83 34.81 1.56 1.13 32.02 -13.74 24.05 46.82 -12.84 23.81 43.90 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 78 GLU~? 10.37 C2 EDO A 103 C 56 LYS A 74 LYS~? 11.85 CL CL A 101 C 258 ARG A 83 ARG~? -3.23 CL CL A 102s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 4.50 44.13 19.44 5.14 46.14 19.71 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 7.23 49.23 25.52 13.07 49.77 27.70 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 78 GLU~? 9.53 CL CL B 101 C 56 LYS B 74 LYS~? 11.95 CL CL B 101 C 258 ARG B 83 ARG~? 10.85 CL CL B 102 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -4.08 21.32 52.83 -3.90 19.30 53.45 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -13.74 24.05 46.82 -12.84 23.81 43.90 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 78 GLU~? 10.37 C2 EDO A 103 D 56 LYS A 74 LYS~? 11.85 CL CL A 101 D 258 ARG A 83 ARG~? -3.23 CL CL A 102s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 4.50 44.13 19.44 5.14 46.14 19.71 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 7.23 49.23 25.52 13.07 49.77 27.70 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 78 GLU~? 9.53 CL CL B 101 D 56 LYS B 74 LYS~? 11.95 CL CL B 101 D 258 ARG B 83 ARG~? 10.85 CL CL B 102 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -4.08 21.32 52.83 -3.90 19.30 53.45 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -13.74 24.05 46.82 -12.84 23.81 43.90 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 65 LYS~? 13.92 CL CL A 101 A 74 LYS A 94 LYS^? 17.13 CL CL A 101 A 165 GLU A 47 GLU^? 13.35 CL CL A 101 coo 24.97 5.82 58.78 26.79 1.97 55.46 6.91 46.21 39.54 1.48 48.90 41.27 coo 19.46 3.44 61.93 23.95 1.12 60.13 3.98 41.23 44.04 4.99 47.03 46.41 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 74 LYS~? 11.85 CL CL A 101 A 74 LYS A 76 LYS~? 8.49 CL CL A 102 A 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo 24.97 5.82 58.78 26.79 1.97 55.46 7.23 49.23 25.52 13.07 49.77 27.70 coo 19.46 3.44 61.93 23.95 1.12 60.13 1.66 47.49 24.58 -2.99 49.01 27.08 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 74 LYS~? 11.95 CL CL B 101 A 74 LYS B 76 LYS~? 14.96 CL CL B 101 A 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 24.97 5.82 58.78 26.79 1.97 55.46 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 19.46 3.44 61.93 23.95 1.12 60.13 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 76 LYS~? 14.96 CL CL B 101 A 74 LYS B 74 LYS~? 11.95 CL CL B 101 A 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 24.97 5.82 58.78 26.79 1.97 55.46 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 19.46 3.44 61.93 23.95 1.12 60.13 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -4.23 21.44 36.57 -4.25 20.15 38.22 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 65 LYS~? 13.92 CL CL A 101 B 74 LYS A 94 LYS^? 17.13 CL CL A 101 B 165 GLU A 47 GLU^? 13.35 CL CL A 101 coo 4.84 5.09 23.75 3.30 1.39 27.48 6.91 46.21 39.54 1.48 48.90 41.27 coo 10.43 2.88 20.75 5.72 0.41 23.95 3.98 41.23 44.04 4.99 47.03 46.41 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 74 LYS~? 11.85 CL CL A 101 B 74 LYS A 76 LYS~? 8.49 CL CL A 102 B 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo 4.84 5.09 23.75 3.30 1.39 27.48 7.23 49.23 25.52 13.07 49.77 27.70 coo 10.43 2.88 20.75 5.72 0.41 23.95 1.66 47.49 24.58 -2.99 49.01 27.08 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 74 LYS~? 11.95 CL CL B 101 B 74 LYS B 76 LYS~? 14.96 CL CL B 101 B 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 4.84 5.09 23.75 3.30 1.39 27.48 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 10.43 2.88 20.75 5.72 0.41 23.95 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 76 LYS~? 14.96 CL CL B 101 B 74 LYS B 74 LYS~? 11.95 CL CL B 101 B 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 4.84 5.09 23.75 3.30 1.39 27.48 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 10.43 2.88 20.75 5.72 0.41 23.95 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -4.23 21.44 36.57 -4.25 20.15 38.22 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 65 LYS~? 13.92 CL CL A 101 C 74 LYS A 94 LYS^? 17.13 CL CL A 101 C 165 GLU A 47 GLU^? 13.35 CL CL A 101 coo 17.59 37.25 25.80 19.64 34.15 21.60 6.91 46.21 39.54 1.48 48.90 41.27 coo 12.29 34.52 28.11 16.84 32.47 25.43 3.98 41.23 44.04 4.99 47.03 46.41 coo 12.06 27.10 15.56 13.23 27.02 13.80 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 74 LYS~? 11.85 CL CL A 101 C 74 LYS A 76 LYS~? 8.49 CL CL A 102 C 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo 17.59 37.25 25.80 19.64 34.15 21.60 7.23 49.23 25.52 13.07 49.77 27.70 coo 12.29 34.52 28.11 16.84 32.47 25.43 1.66 47.49 24.58 -2.99 49.01 27.08 coo 12.06 27.10 15.56 13.23 27.02 13.80 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS B 74 LYS~? 11.95 CL CL B 101 C 74 LYS B 76 LYS~? 14.96 CL CL B 101 C 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 17.59 37.25 25.80 19.64 34.15 21.60 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 12.29 34.52 28.11 16.84 32.47 25.43 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 12.06 27.10 15.56 13.23 27.02 13.80 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS B 76 LYS~? 14.96 CL CL B 101 C 74 LYS B 74 LYS~? 11.95 CL CL B 101 C 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 17.59 37.25 25.80 19.64 34.15 21.60 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 12.29 34.52 28.11 16.84 32.47 25.43 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 12.06 27.10 15.56 13.23 27.02 13.80 -4.23 21.44 36.57 -4.25 20.15 38.22 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 65 LYS~? 13.92 CL CL A 101 D 74 LYS A 94 LYS^? 17.13 CL CL A 101 D 165 GLU A 47 GLU^? 13.35 CL CL A 101 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 6.91 46.21 39.54 1.48 48.90 41.27 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 3.98 41.23 44.04 4.99 47.03 46.41 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 74 LYS~? 11.85 CL CL A 101 D 74 LYS A 76 LYS~? 8.49 CL CL A 102 D 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 7.23 49.23 25.52 13.07 49.77 27.70 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 1.66 47.49 24.58 -2.99 49.01 27.08 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS B 74 LYS~? 11.95 CL CL B 101 D 74 LYS B 76 LYS~? 14.96 CL CL B 101 D 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS B 76 LYS~? 14.96 CL CL B 101 D 74 LYS B 74 LYS~? 11.95 CL CL B 101 D 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -4.23 21.44 36.57 -4.25 20.15 38.22 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c03 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 20 LYS~? 21.73 C1 EDO A 103 A 202 SER A 55 SER^? 15.30 CL CL A 102 A 226 SER A 51 SER^? 15.30 C1 EDO A 103 coo 1.62 6.10 69.30 3.81 1.25 65.91 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 4.43 1.89 61.79 4.31 0.09 63.40 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS A 94 LYS^? 17.13 CL CL A 101 A 202 SER B 51 SER^? 11.77 CL CL A 102 A 226 SER B 55 SER^? 10.96 CL CL B 102 coo 1.62 6.10 69.30 3.81 1.25 65.91 3.98 41.23 44.04 4.99 47.03 46.41 coo 4.43 1.89 61.79 4.31 0.09 63.40 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS B 20 LYS~? 17.84 CL CL B 102 A 202 SER B 55 SER^? 10.96 CL CL B 102 A 226 SER B 51 SER^? 11.77 CL CL A 102 coo 1.62 6.10 69.30 3.81 1.25 65.91 -8.92 41.44 53.64 -4.60 42.92 50.83 coo 4.43 1.89 61.79 4.31 0.09 63.40 -6.97 38.30 45.24 -8.93 39.11 43.98 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -2.95 40.39 42.14 -4.83 38.89 41.84 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS B 94 LYS^? 17.24 CL CL B 101 A 202 SER A 51 SER^? 15.30 C1 EDO A 103 A 226 SER A 55 SER^? 15.30 CL CL A 102 coo 1.62 6.10 69.30 3.81 1.25 65.91 2.42 20.83 31.52 1.85 15.08 28.99 coo 4.43 1.89 61.79 4.31 0.09 63.40 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -5.33 27.85 25.84 -7.01 27.20 27.45 1m21_c00 source 1m21 PEPTIDE AMIDASE : 4 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 20 LYS~? 21.73 C1 EDO A 103 B 202 SER A 55 SER^? 15.30 CL CL A 102 B 226 SER A 51 SER^? 15.30 C1 EDO A 103 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 32.81 4.27 10.70 32.87 6.07 12.31 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 28.77 6.36 12.44 30.83 7.25 11.75 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS A 94 LYS^? 17.13 CL CL A 101 B 202 SER B 51 SER^? 11.77 CL CL A 102 B 226 SER B 55 SER^? 10.96 CL CL B 102 coo 35.67 -0.01 18.11 33.47 4.84 14.73 3.98 41.23 44.04 4.99 47.03 46.41 coo 32.81 4.27 10.70 32.87 6.07 12.31 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 28.77 6.36 12.44 30.83 7.25 11.75 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS B 20 LYS~? 17.84 CL CL B 102 B 202 SER B 55 SER^? 10.96 CL CL B 102 B 226 SER B 51 SER^? 11.77 CL CL A 102 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -8.92 41.44 53.64 -4.60 42.92 50.83 coo 32.81 4.27 10.70 32.87 6.07 12.31 -6.97 38.30 45.24 -8.93 39.11 43.98 coo 28.77 6.36 12.44 30.83 7.25 11.75 -2.95 40.39 42.14 -4.83 38.89 41.84 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS B 94 LYS^? 17.24 CL CL B 101 B 202 SER A 51 SER^? 15.30 C1 EDO A 103 B 226 SER A 55 SER^? 15.30 CL CL A 102 coo 35.67 -0.01 18.11 33.47 4.84 14.73 2.42 20.83 31.52 1.85 15.08 28.99 coo 32.81 4.27 10.70 32.87 6.07 12.31 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 28.77 6.36 12.44 30.83 7.25 11.75 -5.33 27.85 25.84 -7.01 27.20 27.45 1m21_c01 source 1m21 PEPTIDE AMIDASE : 4 hits 1m21_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 95 ARG^? -17.49 CL CL A 101s 229 SER B 45 SER^? 10.95 CL CL B 101 325 GLU B 47 GLU^? 13.68 CL CL B 101 coo 2.54 15.84 18.57 3.24 17.85 16.30 8.08 35.24 44.69 10.92 34.84 45.57 coo 10.17 13.48 15.92 9.61 15.76 15.27 8.38 25.14 44.78 8.69 26.36 42.73 coo 5.42 13.04 19.75 5.74 13.81 17.79 5.37 31.65 43.25 6.96 32.44 42.04 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 95 ARG^? 16.04 CL CL B 101 229 SER A 45 SER^? 10.94 CL CL A 101 325 GLU A 47 GLU^? 13.35 CL CL A 101 coo 2.54 15.84 18.57 3.24 17.85 16.30 7.82 25.35 32.62 10.50 24.66 33.91 coo 10.17 13.48 15.92 9.61 15.76 15.27 12.09 34.48 32.88 11.31 33.31 34.87 coo 5.42 13.04 19.75 5.74 13.81 17.79 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG B 98 ARG^? 15.14 CL CL A 101 229 SER A 45 SER^? 10.94 CL CL A 101 325 GLU A 47 GLU^? 13.35 CL CL A 101 coo 2.54 15.84 18.57 3.24 17.85 16.30 12.36 28.08 33.40 14.26 29.94 34.96 coo 10.17 13.48 15.92 9.61 15.76 15.27 12.09 34.48 32.88 11.31 33.31 34.87 coo 5.42 13.04 19.75 5.74 13.81 17.79 6.76 29.94 33.50 7.56 29.03 35.26 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 3 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 74 LYS~? 11.85 CL CL A 101 166 LYS A 76 LYS~? 8.49 CL CL A 102 324 SER A 5 SER.? 15.87 CL CL A 101 coo 25.93 8.11 25.51 26.40 7.80 19.66 7.23 49.23 25.52 13.07 49.77 27.70 coo 27.27 1.43 25.09 29.18 5.25 22.89 1.66 47.49 24.58 -2.99 49.01 27.08 coo 46.32 14.55 19.93 45.95 12.72 21.27 17.58 39.41 40.94 17.86 41.61 39.98 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 76 LYS~? 8.49 CL CL A 102 166 LYS A 74 LYS~? 11.85 CL CL A 101 324 SER A 55 SER^? 15.30 CL CL A 102 coo 25.93 8.11 25.51 26.40 7.80 19.66 1.66 47.49 24.58 -2.99 49.01 27.08 coo 27.27 1.43 25.09 29.18 5.25 22.89 7.23 49.23 25.52 13.07 49.77 27.70 coo 46.32 14.55 19.93 45.95 12.72 21.27 -5.33 27.85 25.84 -7.01 27.20 27.45 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS B 76 LYS~? 14.96 CL CL B 101 166 LYS B 74 LYS~? 11.95 CL CL B 101 324 SER B 55 SER^? 10.96 CL CL B 102 coo 25.93 8.11 25.51 26.40 7.80 19.66 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 27.27 1.43 25.09 29.18 5.25 22.89 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 46.32 14.55 19.93 45.95 12.72 21.27 -6.97 38.30 45.24 -8.93 39.11 43.98 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 3 hits 1mdr_c01 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 56 GLY^? 12.41 C1 EDO A 103 A 501 ASP A 73 ASP~? 10.71 CL CL A 101 B 367 TYR B 29 TYR~? 11.81 CL CL B 101 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -2.71 28.45 28.44 -3.06 29.16 28.31 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 5.34 51.24 29.08 4.06 51.85 30.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -4.54 27.31 54.97 -5.26 24.64 54.93 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY B 56 GLY^? 14.57 CL CL B 102 A 501 ASP B 73 ASP~? 12.11 CL CL B 101 B 367 TYR A 29 TYR~? 10.97 C1 EDO A 103 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.95 36.38 44.19 -4.58 35.87 44.11 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 5.07 34.81 17.81 5.67 37.48 17.25 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 2 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 56 GLY^? 12.41 C1 EDO A 103 D 501 ASP A 73 ASP~? 10.71 CL CL A 101 E 367 TYR B 29 TYR~? 11.81 CL CL B 101 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -2.71 28.45 28.44 -3.06 29.16 28.31 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 5.34 51.24 29.08 4.06 51.85 30.69 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -4.54 27.31 54.97 -5.26 24.64 54.93 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY B 56 GLY^? 14.57 CL CL B 102 D 501 ASP B 73 ASP~? 12.11 CL CL B 101 E 367 TYR A 29 TYR~? 10.97 C1 EDO A 103 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.95 36.38 44.19 -4.58 35.87 44.11 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 5.07 34.81 17.81 5.67 37.48 17.25 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 2 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 64 ASP~? 12.85 CL CL A 101 A 55 TYR A 62 TYR^? -4.89 CL CL A 101s A 84 LYS A 94 LYS^? 17.13 CL CL A 101 coo 11.09 42.89 24.44 11.32 42.06 22.49 10.93 45.62 41.10 12.24 46.52 39.71 coo 4.60 40.33 20.42 7.25 39.50 20.05 8.83 41.55 35.27 8.22 41.73 32.60 coo 9.71 44.83 15.47 10.13 41.43 19.93 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 64 ASP~? 13.25 CL CL B 101 A 55 TYR B 62 TYR^? -4.93 CL CL B 101s A 84 LYS B 94 LYS^? 17.24 CL CL B 101 coo 11.09 42.89 24.44 11.32 42.06 22.49 6.48 14.60 36.08 6.70 13.36 37.77 coo 4.60 40.33 20.42 7.25 39.50 20.05 3.66 19.37 41.31 2.04 19.67 43.57 coo 9.71 44.83 15.47 10.13 41.43 19.93 2.42 20.83 31.52 1.85 15.08 28.99 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c02 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 A 217 SER A 55 SER^? 15.30 CL CL A 102 A 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS A 94 LYS^? 17.13 CL CL A 101 A 217 SER B 51 SER^? 11.77 CL CL A 102 A 241 SER B 55 SER^? 10.96 CL CL B 102 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 3.98 41.23 44.04 4.99 47.03 46.41 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS B 94 LYS^? 17.24 CL CL B 101 A 217 SER A 51 SER^? 15.30 C1 EDO A 103 A 241 SER A 55 SER^? 15.30 CL CL A 102 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 2.42 20.83 31.52 1.85 15.08 28.99 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 B 217 SER A 55 SER^? 15.30 CL CL A 102 B 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -5.69 24.17 18.67 -2.24 20.17 19.13 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -5.33 27.85 25.84 -7.01 27.20 27.45 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS A 94 LYS^? 17.13 CL CL A 101 B 217 SER B 51 SER^? 11.77 CL CL A 102 B 241 SER B 55 SER^? 10.96 CL CL B 102 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 3.98 41.23 44.04 4.99 47.03 46.41 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -2.95 40.39 42.14 -4.83 38.89 41.84 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 B 142 LYS B 94 LYS^? 17.24 CL CL B 101 B 217 SER A 51 SER^? 15.30 C1 EDO A 103 B 241 SER A 55 SER^? 15.30 CL CL A 102 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 2.42 20.83 31.52 1.85 15.08 28.99 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -4.34 24.54 30.27 -5.29 26.77 29.80 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 C 217 SER A 55 SER^? 15.30 CL CL A 102 C 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -5.69 24.17 18.67 -2.24 20.17 19.13 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -5.33 27.85 25.84 -7.01 27.20 27.45 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS A 94 LYS^? 17.13 CL CL A 101 C 217 SER B 51 SER^? 11.77 CL CL A 102 C 241 SER B 55 SER^? 10.96 CL CL B 102 coo -12.07 2.83 63.52 -8.95 7.56 61.01 3.98 41.23 44.04 4.99 47.03 46.41 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -2.95 40.39 42.14 -4.83 38.89 41.84 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 C 142 LYS B 94 LYS^? 17.24 CL CL B 101 C 217 SER A 51 SER^? 15.30 C1 EDO A 103 C 241 SER A 55 SER^? 15.30 CL CL A 102 coo -12.07 2.83 63.52 -8.95 7.56 61.01 2.42 20.83 31.52 1.85 15.08 28.99 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -4.34 24.54 30.27 -5.29 26.77 29.80 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 D 217 SER A 55 SER^? 15.30 CL CL A 102 D 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 32.93 17.78 71.88 30.89 13.50 67.83 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 34.38 11.17 66.10 32.18 12.14 65.65 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 31.34 7.96 67.74 31.44 9.08 65.62 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS A 94 LYS^? 17.13 CL CL A 101 D 217 SER B 51 SER^? 11.77 CL CL A 102 D 241 SER B 55 SER^? 10.96 CL CL B 102 coo 32.93 17.78 71.88 30.89 13.50 67.83 3.98 41.23 44.04 4.99 47.03 46.41 coo 34.38 11.17 66.10 32.18 12.14 65.65 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 31.34 7.96 67.74 31.44 9.08 65.62 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 D 142 LYS B 94 LYS^? 17.24 CL CL B 101 D 217 SER A 51 SER^? 15.30 C1 EDO A 103 D 241 SER A 55 SER^? 15.30 CL CL A 102 coo 32.93 17.78 71.88 30.89 13.50 67.83 2.42 20.83 31.52 1.85 15.08 28.99 coo 34.38 11.17 66.10 32.18 12.14 65.65 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 31.34 7.96 67.74 31.44 9.08 65.62 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 E 217 SER A 55 SER^? 15.30 CL CL A 102 E 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS A 94 LYS^? 17.13 CL CL A 101 E 217 SER B 51 SER^? 11.77 CL CL A 102 E 241 SER B 55 SER^? 10.96 CL CL B 102 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 3.98 41.23 44.04 4.99 47.03 46.41 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS B 94 LYS^? 17.24 CL CL B 101 E 217 SER A 51 SER^? 15.30 C1 EDO A 103 E 241 SER A 55 SER^? 15.30 CL CL A 102 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 2.42 20.83 31.52 1.85 15.08 28.99 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 F 217 SER A 55 SER^? 15.30 CL CL A 102 F 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 85.78 13.19 64.96 85.47 13.47 58.63 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 87.43 17.13 57.15 85.84 15.39 56.76 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 89.69 13.60 54.86 87.60 14.67 54.46 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS A 94 LYS^? 17.13 CL CL A 101 F 217 SER B 51 SER^? 11.77 CL CL A 102 F 241 SER B 55 SER^? 10.96 CL CL B 102 coo 85.78 13.19 64.96 85.47 13.47 58.63 3.98 41.23 44.04 4.99 47.03 46.41 coo 87.43 17.13 57.15 85.84 15.39 56.76 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 89.69 13.60 54.86 87.60 14.67 54.46 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS B 94 LYS^? 17.24 CL CL B 101 F 217 SER A 51 SER^? 15.30 C1 EDO A 103 F 241 SER A 55 SER^? 15.30 CL CL A 102 coo 85.78 13.19 64.96 85.47 13.47 58.63 2.42 20.83 31.52 1.85 15.08 28.99 coo 87.43 17.13 57.15 85.84 15.39 56.76 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 89.69 13.60 54.86 87.60 14.67 54.46 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 G 217 SER A 55 SER^? 15.30 CL CL A 102 G 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS A 94 LYS^? 17.13 CL CL A 101 G 217 SER B 51 SER^? 11.77 CL CL A 102 G 241 SER B 55 SER^? 10.96 CL CL B 102 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 3.98 41.23 44.04 4.99 47.03 46.41 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 G 142 LYS B 94 LYS^? 17.24 CL CL B 101 G 217 SER A 51 SER^? 15.30 C1 EDO A 103 G 241 SER A 55 SER^? 15.30 CL CL A 102 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 2.42 20.83 31.52 1.85 15.08 28.99 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 H 217 SER A 55 SER^? 15.30 CL CL A 102 H 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS A 94 LYS^? 17.13 CL CL A 101 H 217 SER B 51 SER^? 11.77 CL CL A 102 H 241 SER B 55 SER^? 10.96 CL CL B 102 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 3.98 41.23 44.04 4.99 47.03 46.41 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS B 94 LYS^? 17.24 CL CL B 101 H 217 SER A 51 SER^? 15.30 C1 EDO A 103 H 241 SER A 55 SER^? 15.30 CL CL A 102 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 2.42 20.83 31.52 1.85 15.08 28.99 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 I 217 SER A 55 SER^? 15.30 CL CL A 102 I 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 2.83 88.63 29.54 1.30 86.82 30.03 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 2.37 88.32 34.25 2.82 86.58 32.61 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS A 94 LYS^? 17.13 CL CL A 101 I 217 SER B 51 SER^? 11.77 CL CL A 102 I 241 SER B 55 SER^? 10.96 CL CL B 102 coo -5.05 91.11 27.04 -1.24 87.39 30.21 3.98 41.23 44.04 4.99 47.03 46.41 coo 2.83 88.63 29.54 1.30 86.82 30.03 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 2.37 88.32 34.25 2.82 86.58 32.61 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS B 94 LYS^? 17.24 CL CL B 101 I 217 SER A 51 SER^? 15.30 C1 EDO A 103 I 241 SER A 55 SER^? 15.30 CL CL A 102 coo -5.05 91.11 27.04 -1.24 87.39 30.21 2.42 20.83 31.52 1.85 15.08 28.99 coo 2.83 88.63 29.54 1.30 86.82 30.03 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 2.37 88.32 34.25 2.82 86.58 32.61 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 J 217 SER A 55 SER^? 15.30 CL CL A 102 J 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -5.69 24.17 18.67 -2.24 20.17 19.13 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -5.33 27.85 25.84 -7.01 27.20 27.45 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS A 94 LYS^? 17.13 CL CL A 101 J 217 SER B 51 SER^? 11.77 CL CL A 102 J 241 SER B 55 SER^? 10.96 CL CL B 102 coo -16.11 59.78 61.53 -15.92 58.68 55.43 3.98 41.23 44.04 4.99 47.03 46.41 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -2.95 40.39 42.14 -4.83 38.89 41.84 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 J 142 LYS B 94 LYS^? 17.24 CL CL B 101 J 217 SER A 51 SER^? 15.30 C1 EDO A 103 J 241 SER A 55 SER^? 15.30 CL CL A 102 coo -16.11 59.78 61.53 -15.92 58.68 55.43 2.42 20.83 31.52 1.85 15.08 28.99 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -4.34 24.54 30.27 -5.29 26.77 29.80 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 K 217 SER A 55 SER^? 15.30 CL CL A 102 K 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -5.69 24.17 18.67 -2.24 20.17 19.13 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -5.33 27.85 25.84 -7.01 27.20 27.45 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS A 94 LYS^? 17.13 CL CL A 101 K 217 SER B 51 SER^? 11.77 CL CL A 102 K 241 SER B 55 SER^? 10.96 CL CL B 102 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 3.98 41.23 44.04 4.99 47.03 46.41 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -2.95 40.39 42.14 -4.83 38.89 41.84 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS B 94 LYS^? 17.24 CL CL B 101 K 217 SER A 51 SER^? 15.30 C1 EDO A 103 K 241 SER A 55 SER^? 15.30 CL CL A 102 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 2.42 20.83 31.52 1.85 15.08 28.99 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -4.34 24.54 30.27 -5.29 26.77 29.80 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 L 217 SER A 55 SER^? 15.30 CL CL A 102 L 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS A 94 LYS^? 17.13 CL CL A 101 L 217 SER B 51 SER^? 11.77 CL CL A 102 L 241 SER B 55 SER^? 10.96 CL CL B 102 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 3.98 41.23 44.04 4.99 47.03 46.41 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS B 94 LYS^? 17.24 CL CL B 101 L 217 SER A 51 SER^? 15.30 C1 EDO A 103 L 241 SER A 55 SER^? 15.30 CL CL A 102 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 2.42 20.83 31.52 1.85 15.08 28.99 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 M 217 SER A 55 SER^? 15.30 CL CL A 102 M 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 57.83 99.61 24.25 54.90 95.14 20.60 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 51.07 94.66 21.52 53.18 93.49 22.20 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 51.67 94.23 16.93 51.60 92.47 18.57 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS A 94 LYS^? 17.13 CL CL A 101 M 217 SER B 51 SER^? 11.77 CL CL A 102 M 241 SER B 55 SER^? 10.96 CL CL B 102 coo 57.83 99.61 24.25 54.90 95.14 20.60 3.98 41.23 44.04 4.99 47.03 46.41 coo 51.07 94.66 21.52 53.18 93.49 22.20 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 51.67 94.23 16.93 51.60 92.47 18.57 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS B 20 LYS~? 17.84 CL CL B 102 M 217 SER B 55 SER^? 10.96 CL CL B 102 M 241 SER B 51 SER^? 11.77 CL CL A 102 coo 57.83 99.61 24.25 54.90 95.14 20.60 -8.92 41.44 53.64 -4.60 42.92 50.83 coo 51.07 94.66 21.52 53.18 93.49 22.20 -6.97 38.30 45.24 -8.93 39.11 43.98 coo 51.67 94.23 16.93 51.60 92.47 18.57 -2.95 40.39 42.14 -4.83 38.89 41.84 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 M 142 LYS B 94 LYS^? 17.24 CL CL B 101 M 217 SER A 51 SER^? 15.30 C1 EDO A 103 M 241 SER A 55 SER^? 15.30 CL CL A 102 coo 57.83 99.61 24.25 54.90 95.14 20.60 2.42 20.83 31.52 1.85 15.08 28.99 coo 51.07 94.66 21.52 53.18 93.49 22.20 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 51.67 94.23 16.93 51.60 92.47 18.57 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 4 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 N 217 SER A 55 SER^? 15.30 CL CL A 102 N 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 82.47 71.15 2.07 80.82 69.44 2.28 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS A 94 LYS^? 17.13 CL CL A 101 N 217 SER B 51 SER^? 11.77 CL CL A 102 N 241 SER B 55 SER^? 10.96 CL CL B 102 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 3.98 41.23 44.04 4.99 47.03 46.41 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 82.47 71.15 2.07 80.82 69.44 2.28 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 N 142 LYS B 94 LYS^? 17.24 CL CL B 101 N 217 SER A 51 SER^? 15.30 C1 EDO A 103 N 241 SER A 55 SER^? 15.30 CL CL A 102 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 2.42 20.83 31.52 1.85 15.08 28.99 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 82.47 71.15 2.07 80.82 69.44 2.28 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 O 217 SER A 55 SER^? 15.30 CL CL A 102 O 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 81.67 70.12 58.71 78.82 64.87 57.22 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 81.62 62.23 55.05 79.32 62.93 55.20 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 79.39 59.54 58.42 78.72 60.00 56.11 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS A 94 LYS^? 17.13 CL CL A 101 O 217 SER B 51 SER^? 11.77 CL CL A 102 O 241 SER B 55 SER^? 10.96 CL CL B 102 coo 81.67 70.12 58.71 78.82 64.87 57.22 3.98 41.23 44.04 4.99 47.03 46.41 coo 81.62 62.23 55.05 79.32 62.93 55.20 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 79.39 59.54 58.42 78.72 60.00 56.11 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS B 94 LYS^? 17.24 CL CL B 101 O 217 SER A 51 SER^? 15.30 C1 EDO A 103 O 241 SER A 55 SER^? 15.30 CL CL A 102 coo 81.67 70.12 58.71 78.82 64.87 57.22 2.42 20.83 31.52 1.85 15.08 28.99 coo 81.62 62.23 55.05 79.32 62.93 55.20 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 79.39 59.54 58.42 78.72 60.00 56.11 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 20 LYS~? 21.73 C1 EDO A 103 P 217 SER A 55 SER^? 15.30 CL CL A 102 P 241 SER A 51 SER^? 15.30 C1 EDO A 103 coo 37.29 55.72 69.54 38.73 59.85 65.07 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 35.55 61.40 62.96 37.72 60.41 62.66 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 38.60 64.77 64.10 38.63 63.28 62.26 -4.34 24.54 30.27 -5.29 26.77 29.80 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS A 94 LYS^? 17.13 CL CL A 101 P 217 SER B 51 SER^? 11.77 CL CL A 102 P 241 SER B 55 SER^? 10.96 CL CL B 102 coo 37.29 55.72 69.54 38.73 59.85 65.07 3.98 41.23 44.04 4.99 47.03 46.41 coo 35.55 61.40 62.96 37.72 60.41 62.66 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 38.60 64.77 64.10 38.63 63.28 62.26 -6.97 38.30 45.24 -8.93 39.11 43.98 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 P 142 LYS B 94 LYS^? 17.24 CL CL B 101 P 217 SER A 51 SER^? 15.30 C1 EDO A 103 P 241 SER A 55 SER^? 15.30 CL CL A 102 coo 37.29 55.72 69.54 38.73 59.85 65.07 2.42 20.83 31.52 1.85 15.08 28.99 coo 35.55 61.40 62.96 37.72 60.41 62.66 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 38.60 64.77 64.10 38.63 63.28 62.26 -5.33 27.85 25.84 -7.01 27.20 27.45 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 3 hits 1mt5_c15 naa= 3 ULMN 3 1myr_c00 MYROSINASE user 1 3 # 1 187 GLN A 50 GLN^? 17.89 C1 EDO A 103 328 ASN A 52 ASN^? 17.78 CL CL A 102 409 GLU A 53 GLU.? 23.22 C1 EDO A 103 coo 45.09 114.33 52.30 45.59 116.18 51.29 -1.80 23.00 26.89 -1.30 22.28 24.96 coo 41.10 116.46 52.80 42.09 116.00 54.64 -7.79 23.14 27.54 -8.54 24.94 26.72 coo 42.69 118.64 56.27 44.58 118.34 55.45 -8.19 22.01 22.51 -9.28 20.94 21.03 1myr_c00 source 1myr MYROSINASE : 1 hits 1myr_c00 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS B 20 LYS~? 17.84 CL CL B 102 A 208 GLN B 50 GLN^? 18.38 CL CL A 102 A 209 LYS A 94 LYS^? 17.13 CL CL A 101 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -8.92 41.44 53.64 -4.60 42.92 50.83 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -2.09 40.88 46.60 -2.04 41.91 48.49 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS B 74 LYS~? 11.95 CL CL B 101 A 208 GLN B 66 GLN~? 13.35 CL CL B 101 A 209 LYS B 65 LYS~? 14.42 CL CL B 101 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 2.63 9.81 38.56 3.65 9.84 40.49 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 2.20 15.51 35.93 -2.75 14.71 32.15 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 2 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 20 LYS~? 21.73 C1 EDO A 103 B 208 GLN A 50 GLN^? 17.89 C1 EDO A 103 B 209 LYS B 94 LYS^? 17.24 CL CL B 101 coo 105.03 46.01 19.55 106.59 42.35 15.55 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 113.93 46.99 13.56 113.37 48.52 14.95 -1.80 23.00 26.89 -1.30 22.28 24.96 coo 115.66 49.12 8.60 111.19 49.52 4.73 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS B 20 LYS~? 17.84 CL CL B 102 B 208 GLN B 50 GLN^? 18.38 CL CL A 102 B 209 LYS A 94 LYS^? 17.13 CL CL A 101 coo 105.03 46.01 19.55 106.59 42.35 15.55 -8.92 41.44 53.64 -4.60 42.92 50.83 coo 113.93 46.99 13.56 113.37 48.52 14.95 -2.09 40.88 46.60 -2.04 41.91 48.49 coo 115.66 49.12 8.60 111.19 49.52 4.73 3.98 41.23 44.04 4.99 47.03 46.41 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 2 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS B 74 LYS~? 11.95 CL CL B 101 C 208 GLN B 66 GLN~? 13.35 CL CL B 101 C 209 LYS B 65 LYS~? 14.42 CL CL B 101 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 2.63 9.81 38.56 3.65 9.84 40.49 coo 113.62 1.19 33.65 109.52 3.92 36.47 2.20 15.51 35.93 -2.75 14.71 32.15 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 1 hits 1ohh_c08 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 73 ASP~? 10.71 CL CL A 101 A 146 TYR A 62 TYR^? -4.89 CL CL A 101s A 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -3.50 124.89 25.05 -2.25 124.77 23.26 5.34 51.24 29.08 4.06 51.85 30.69 coo 1.87 119.38 16.45 1.41 122.11 16.84 8.83 41.55 35.27 8.22 41.73 32.60 coo -2.59 124.07 12.67 -0.91 126.17 18.42 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 73 ASP~? 12.11 CL CL B 101 A 146 TYR B 62 TYR^? -4.93 CL CL B 101s A 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 1.87 119.38 16.45 1.41 122.11 16.84 3.66 19.37 41.31 2.04 19.67 43.57 coo -2.59 124.07 12.67 -0.91 126.17 18.42 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 73 ASP~? 10.71 CL CL A 101 B 146 TYR A 62 TYR^? -4.89 CL CL A 101s B 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -7.43 109.06 51.23 -5.84 110.54 50.86 5.34 51.24 29.08 4.06 51.85 30.69 coo 0.22 114.56 44.62 -0.76 115.18 47.18 8.83 41.55 35.27 8.22 41.73 32.60 coo -4.18 120.17 46.85 -4.02 115.31 51.00 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 73 ASP~? 12.11 CL CL B 101 B 146 TYR B 62 TYR^? -4.93 CL CL B 101s B 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 0.22 114.56 44.62 -0.76 115.18 47.18 3.66 19.37 41.31 2.04 19.67 43.57 coo -4.18 120.17 46.85 -4.02 115.31 51.00 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 73 ASP~? 10.71 CL CL A 101 C 146 TYR A 62 TYR^? -4.89 CL CL A 101s C 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -13.49 79.65 43.90 -12.13 80.29 45.45 5.34 51.24 29.08 4.06 51.85 30.69 coo -5.65 86.78 48.49 -7.16 84.72 49.65 8.83 41.55 35.27 8.22 41.73 32.60 coo -11.22 87.18 53.49 -10.94 81.64 50.31 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 73 ASP~? 12.11 CL CL B 101 C 146 TYR B 62 TYR^? -4.93 CL CL B 101s C 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -5.20 12.36 44.75 -6.92 11.08 44.83 coo -5.65 86.78 48.49 -7.16 84.72 49.65 3.66 19.37 41.31 2.04 19.67 43.57 coo -11.22 87.18 53.49 -10.94 81.64 50.31 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 73 ASP~? 10.71 CL CL A 101 D 146 TYR A 62 TYR^? -4.89 CL CL A 101s D 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -13.44 77.36 13.12 -12.53 75.97 14.48 5.34 51.24 29.08 4.06 51.85 30.69 coo -7.85 74.44 22.75 -9.22 72.86 20.89 8.83 41.55 35.27 8.22 41.73 32.60 coo -14.24 70.61 23.48 -12.55 71.73 17.42 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 73 ASP~? 12.11 CL CL B 101 D 146 TYR B 62 TYR^? -4.93 CL CL B 101s D 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -5.20 12.36 44.75 -6.92 11.08 44.83 coo -7.85 74.44 22.75 -9.22 72.86 20.89 3.66 19.37 41.31 2.04 19.67 43.57 coo -14.24 70.61 23.48 -12.55 71.73 17.42 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 73 ASP~? 10.71 CL CL A 101 E 146 TYR A 62 TYR^? -4.89 CL CL A 101s E 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -7.12 105.25 1.43 -6.30 103.34 0.77 5.34 51.24 29.08 4.06 51.85 30.69 coo -3.11 94.55 3.01 -3.83 95.92 0.66 8.83 41.55 35.27 8.22 41.73 32.60 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 73 ASP~? 12.11 CL CL B 101 E 146 TYR B 62 TYR^? -4.93 CL CL B 101s E 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -5.20 12.36 44.75 -6.92 11.08 44.83 coo -3.11 94.55 3.01 -3.83 95.92 0.66 3.66 19.37 41.31 2.04 19.67 43.57 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 73 ASP~? 10.71 CL CL A 101 F 146 TYR A 62 TYR^? -4.89 CL CL A 101s F 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -44.75 128.15 10.28 -45.68 129.67 11.55 5.34 51.24 29.08 4.06 51.85 30.69 coo -50.43 131.90 19.60 -49.04 133.31 17.60 8.83 41.55 35.27 8.22 41.73 32.60 coo -44.10 135.86 19.99 -45.67 134.21 14.07 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 73 ASP~? 12.11 CL CL B 101 F 146 TYR B 62 TYR^? -4.93 CL CL B 101s F 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -5.20 12.36 44.75 -6.92 11.08 44.83 coo -50.43 131.90 19.60 -49.04 133.31 17.60 3.66 19.37 41.31 2.04 19.67 43.57 coo -44.10 135.86 19.99 -45.67 134.21 14.07 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 73 ASP~? 10.71 CL CL A 101 G 146 TYR A 62 TYR^? -4.89 CL CL A 101s G 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -44.97 128.78 41.20 -46.32 128.26 42.83 5.34 51.24 29.08 4.06 51.85 30.69 coo -52.83 122.13 46.42 -51.31 124.30 47.39 8.83 41.55 35.27 8.22 41.73 32.60 coo -47.30 122.24 51.49 -47.46 127.44 47.81 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 73 ASP~? 12.11 CL CL B 101 G 146 TYR B 62 TYR^? -4.93 CL CL B 101s G 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -5.20 12.36 44.75 -6.92 11.08 44.83 coo -52.83 122.13 46.42 -51.31 124.30 47.39 3.66 19.37 41.31 2.04 19.67 43.57 coo -47.30 122.24 51.49 -47.46 127.44 47.81 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 73 ASP~? 10.71 CL CL A 101 H 146 TYR A 62 TYR^? -4.89 CL CL A 101s H 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -51.11 100.30 51.41 -52.67 98.82 51.12 5.34 51.24 29.08 4.06 51.85 30.69 coo -58.70 94.17 45.32 -57.76 93.82 47.92 8.83 41.55 35.27 8.22 41.73 32.60 coo -54.32 88.79 48.13 -54.61 94.04 51.74 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 73 ASP~? 12.11 CL CL B 101 H 146 TYR B 62 TYR^? -4.93 CL CL B 101s H 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -5.20 12.36 44.75 -6.92 11.08 44.83 coo -58.70 94.17 45.32 -57.76 93.82 47.92 3.66 19.37 41.31 2.04 19.67 43.57 coo -54.32 88.79 48.13 -54.61 94.04 51.74 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 73 ASP~? 10.71 CL CL A 101 I 146 TYR A 62 TYR^? -4.89 CL CL A 101s I 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -54.65 81.97 26.87 -55.88 81.89 25.07 5.34 51.24 29.08 4.06 51.85 30.69 coo -59.92 86.62 17.74 -59.42 83.94 18.40 8.83 41.55 35.27 8.22 41.73 32.60 coo -55.38 81.61 14.50 -57.11 80.05 20.41 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 73 ASP~? 12.11 CL CL B 101 I 146 TYR B 62 TYR^? -4.93 CL CL B 101s I 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -5.20 12.36 44.75 -6.92 11.08 44.83 coo -59.92 86.62 17.74 -59.42 83.94 18.40 3.66 19.37 41.31 2.04 19.67 43.57 coo -55.38 81.61 14.50 -57.11 80.05 20.41 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 73 ASP~? 10.71 CL CL A 101 J 146 TYR A 62 TYR^? -4.89 CL CL A 101s J 177 LYS A 65 LYS~? 13.92 CL CL A 101 coo -50.64 99.08 1.52 -51.52 100.83 0.67 5.34 51.24 29.08 4.06 51.85 30.69 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 8.83 41.55 35.27 8.22 41.73 32.60 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 73 ASP~? 12.11 CL CL B 101 J 146 TYR B 62 TYR^? -4.93 CL CL B 101s J 177 LYS B 65 LYS~? 14.42 CL CL B 101 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -5.20 12.36 44.75 -6.92 11.08 44.83 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 3.66 19.37 41.31 2.04 19.67 43.57 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 2.20 15.51 35.93 -2.75 14.71 32.15 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c09 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER B 35 SER~? 8.71 CL CL B 101 A 239 VAL B 33 VAL~? 11.89 CL CL B 101 A 413 ASN B 32 ASN~? 16.17 CL CL B 101 coo 80.14 40.76 52.28 77.73 40.59 51.94 3.17 24.62 50.92 3.13 26.96 50.21 coo 75.67 35.37 52.30 76.00 35.96 50.23 0.00 24.44 55.72 -1.88 24.13 56.83 coo 81.75 35.21 52.13 80.92 37.12 51.69 1.87 28.17 57.73 3.09 29.83 58.01 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 1 hits 1oqz_c00 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP B 80 ASP~? 13.43 CL CL B 101 A 167 LYS B 76 LYS~? 14.96 CL CL B 101 A 201 LYS B 74 LYS~? 11.95 CL CL B 101 coo 26.53 8.31 20.37 28.45 8.41 19.40 -12.29 21.04 51.71 -12.95 19.46 50.41 coo 24.92 6.08 13.38 27.75 4.33 18.83 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 29.08 5.53 11.69 30.46 5.61 17.93 -3.92 13.74 48.91 -1.31 9.83 46.45 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 1 hits 1p1x_c00 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR A 58 TYR^? 4.97 C1 EDO A 103 A 38 GLU A 31 GLU~? 15.39 O1 EDO A 103 A 46 TRP A 34 TRP~? -4.23 O1 EDO A 103s coo 141.05 24.62 -1.85 142.62 22.60 -2.97 3.55 34.19 28.36 5.98 35.22 27.53 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 10.31 28.74 22.96 10.37 26.64 22.82 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 6.13 38.14 24.92 3.44 40.11 22.82 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 2 3 # 2 A 16 TYR B 58 TYR^? 6.57 CL CL B 101 A 38 GLU B 31 GLU~? 16.05 CL CL B 101 A 46 TRP B 34 TRP~? -4.42 CL CL B 101s coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -0.68 28.61 46.28 0.81 26.77 47.73 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 4.21 30.96 54.15 4.85 32.92 54.48 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -0.74 23.47 48.78 -4.45 24.02 47.66 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 3 3 # 3 A 16 TYR B 58 TYR^? 6.57 CL CL B 101 A 38 GLU B 81 GLU~? 14.80 CL CL B 101 A 46 TRP B 34 TRP~? -4.42 CL CL B 101s coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -0.68 28.61 46.28 0.81 26.77 47.73 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -9.05 25.50 55.61 -7.98 24.84 57.33 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -0.74 23.47 48.78 -4.45 24.02 47.66 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 3 hits 1p7m_c00 naa= 3 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 1 8 TYR A 62 TYR^? -4.89 CL CL A 101s 1 14 ARG A 11 ARG^? 4.24 CL CL A 101s 1 104 TRP A 34 TRP~? -4.23 O1 EDO A 103s coo -6.26 36.66 22.35 -5.62 38.66 24.20 8.83 41.55 35.27 8.22 41.73 32.60 coo -1.84 42.97 23.45 -1.37 45.90 22.68 2.42 41.34 32.49 3.79 44.02 33.12 coo -2.17 45.44 30.78 -5.80 46.76 31.55 6.13 38.14 24.92 3.44 40.11 22.82 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 1 8 TYR B 9 TYR^? 9.45 CL CL B 101 1 14 ARG B 11 ARG^? -4.26 CL CL B 101s 1 104 TRP B 34 TRP~? -4.42 CL CL B 101s coo -6.26 36.66 22.35 -5.62 38.66 24.20 1.66 19.18 35.77 -1.08 19.00 35.58 coo -1.84 42.97 23.45 -1.37 45.90 22.68 -2.97 22.30 41.65 -2.03 19.36 41.23 coo -2.17 45.44 30.78 -5.80 46.76 31.55 -0.74 23.47 48.78 -4.45 24.02 47.66 1pd2_c02 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 2 hits 1pd2_c02 naa= 3 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 2 8 TYR A 62 TYR^? -4.89 CL CL A 101s 2 14 ARG A 11 ARG^? 4.24 CL CL A 101s 2 104 TRP A 34 TRP~? -4.23 O1 EDO A 103s coo 14.82 62.39 20.28 14.73 60.21 22.02 8.83 41.55 35.27 8.22 41.73 32.60 coo 10.81 55.96 22.08 10.04 53.12 21.26 2.42 41.34 32.49 3.79 44.02 33.12 coo 13.42 52.88 28.75 17.04 51.48 28.24 6.13 38.14 24.92 3.44 40.11 22.82 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 2 8 TYR B 9 TYR^? 9.45 CL CL B 101 2 14 ARG B 11 ARG^? -4.26 CL CL B 101s 2 104 TRP B 34 TRP~? -4.42 CL CL B 101s coo 14.82 62.39 20.28 14.73 60.21 22.02 1.66 19.18 35.77 -1.08 19.00 35.58 coo 10.81 55.96 22.08 10.04 53.12 21.26 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 13.42 52.88 28.75 17.04 51.48 28.24 -0.74 23.47 48.78 -4.45 24.02 47.66 1pd2_c03 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 2 hits 1pd2_c03 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 24 ASP~? 18.92 C1 EDO A 103 B 270 LYS A 20 LYS~? 21.73 C1 EDO A 103 B 382 MET A 57 MET?? 12.76 C1 EDO A 103 coo -11.82 154.51 43.38 -12.86 152.74 43.79 0.26 24.62 18.06 -0.77 23.04 19.07 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -5.69 24.17 18.67 -2.24 20.17 19.13 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -0.88 30.74 30.80 -2.20 30.11 34.73 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 89 GLN^? -3.43 CL CL A 102s 294 GLU A 92 GLU^? 7.22 O2 EDO A 103 304 ARG A 87 ARG^? 9.16 CL CL A 102 coo 15.89 18.45 46.53 15.82 16.91 48.02 -7.70 38.20 32.75 -8.35 40.23 32.81 coo 22.84 13.44 52.91 20.84 13.18 52.38 0.05 42.98 37.01 0.92 44.18 35.56 coo 8.71 17.11 46.51 7.23 17.64 49.20 -11.91 35.66 26.57 -12.50 35.32 29.59 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN B 89 GLN^? 10.99 CL CL B 102 294 GLU B 92 GLU^? 7.39 CL CL B 101 304 ARG B 87 ARG^? -4.50 CL CL B 102s coo 15.89 18.45 46.53 15.82 16.91 48.02 -10.20 29.10 37.65 -11.91 27.89 37.21 coo 22.84 13.44 52.91 20.84 13.18 52.38 -4.23 21.44 36.57 -4.25 20.15 38.22 coo 8.71 17.11 46.51 7.23 17.64 49.20 -15.08 34.06 42.30 -17.00 32.98 40.14 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 2 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 19 SER~? 20.08 C1 EDO A 103 B 69 ALA A 17 ALA.? 14.50 C1 EDO A 103 B 241 ASN A 54 ASN.? 17.43 CL CL A 102 coo 13.24 41.94 33.13 13.08 39.54 33.17 -8.21 26.79 17.62 -7.03 27.14 15.50 coo 9.15 37.89 36.69 10.55 37.76 37.22 -6.67 31.09 20.87 -5.46 30.41 20.26 coo 10.91 43.03 38.47 11.81 41.82 36.93 -7.62 26.26 21.95 -9.29 26.64 23.21 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 55 SER^? 15.30 CL CL A 102 B 69 ALA A 17 ALA.? 14.50 C1 EDO A 103 B 241 ASN A 54 ASN.? 17.43 CL CL A 102 coo 13.24 41.94 33.13 13.08 39.54 33.17 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 9.15 37.89 36.69 10.55 37.76 37.22 -6.67 31.09 20.87 -5.46 30.41 20.26 coo 10.91 43.03 38.47 11.81 41.82 36.93 -7.62 26.26 21.95 -9.29 26.64 23.21 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER B 19 SER~? 12.98 CL CL B 102 B 69 ALA B 17 ALA.? 10.11 CL CL B 102 B 241 ASN B 54 ASN.? 13.60 CL CL B 102 coo 13.24 41.94 33.13 13.08 39.54 33.17 -12.54 40.54 52.92 -12.81 39.02 54.79 coo 9.15 37.89 36.69 10.55 37.76 37.22 -11.74 36.65 49.15 -10.64 36.72 50.25 coo 10.91 43.03 38.47 11.81 41.82 36.93 -9.49 40.69 48.71 -9.67 42.13 50.28 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER B 55 SER^? 10.96 CL CL B 102 B 69 ALA B 17 ALA.? 10.11 CL CL B 102 B 241 ASN B 54 ASN.? 13.60 CL CL B 102 coo 13.24 41.94 33.13 13.08 39.54 33.17 -6.97 38.30 45.24 -8.93 39.11 43.98 coo 9.15 37.89 36.69 10.55 37.76 37.22 -11.74 36.65 49.15 -10.64 36.72 50.25 coo 10.91 43.03 38.47 11.81 41.82 36.93 -9.49 40.69 48.71 -9.67 42.13 50.28 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 4 hits 1pnl_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 95 ARG^? -17.49 CL CL A 101s A 479 PHE A 97 PHE^? 12.39 CL CL B 101 A 483 GLU B 47 GLU^? 13.68 CL CL B 101 coo 17.33 52.29 2.24 18.71 54.03 0.18 8.08 35.24 44.69 10.92 34.84 45.57 coo 20.06 57.44 1.28 18.39 56.19 3.12 4.50 32.64 50.54 2.47 30.85 50.01 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 5.37 31.65 43.25 6.96 32.44 42.04 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG B 11 ARG^? -4.26 CL CL B 101s A 479 PHE B 72 PHE~? 5.57 CL CL B 101 A 483 GLU B 92 GLU^? 7.39 CL CL B 101 coo 17.33 52.29 2.24 18.71 54.03 0.18 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 20.06 57.44 1.28 18.39 56.19 3.12 -4.99 18.42 43.35 -6.92 20.39 43.58 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -4.23 21.44 36.57 -4.25 20.15 38.22 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 95 ARG^? -17.49 CL CL A 101s B 479 PHE A 97 PHE^? 12.39 CL CL B 101 B 483 GLU B 47 GLU^? 13.68 CL CL B 101 coo -26.72 93.28 20.13 -28.02 93.55 17.39 8.08 35.24 44.69 10.92 34.84 45.57 coo -29.34 90.48 15.69 -27.62 89.95 17.80 4.50 32.64 50.54 2.47 30.85 50.01 coo -26.63 95.49 14.65 -25.77 93.77 13.77 5.37 31.65 43.25 6.96 32.44 42.04 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG B 11 ARG^? -4.26 CL CL B 101s B 479 PHE B 72 PHE~? 5.57 CL CL B 101 B 483 GLU B 92 GLU^? 7.39 CL CL B 101 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -2.97 22.30 41.65 -2.03 19.36 41.23 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -4.99 18.42 43.35 -6.92 20.39 43.58 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG B 95 ARG^? 16.04 CL CL B 101 B 479 PHE B 97 PHE^? 11.11 C1 EDO A 103 B 483 GLU A 47 GLU^? 13.35 CL CL A 101 coo -26.72 93.28 20.13 -28.02 93.55 17.39 7.82 25.35 32.62 10.50 24.66 33.91 coo -29.34 90.48 15.69 -27.62 89.95 17.80 8.21 28.14 26.14 7.00 30.62 25.79 coo -26.63 95.49 14.65 -25.77 93.77 13.77 6.76 29.94 33.50 7.56 29.03 35.26 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 3 hits 1pow_c03 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER B 45 SER^? 10.95 CL CL B 101 A 310 GLU B 47 GLU^? 13.68 CL CL B 101 A 399 HIS B 61 HIS^? 11.05 CL CL B 101 coo 2.67 37.96 55.23 1.78 40.01 56.16 8.38 25.14 44.78 8.69 26.36 42.73 coo 6.61 38.44 63.61 6.69 38.31 61.50 5.37 31.65 43.25 6.96 32.44 42.04 coo 4.95 41.82 59.53 3.85 40.70 58.14 6.99 25.63 39.23 6.79 27.36 38.08 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 1 hits 1qe3_c00 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG B 11 ARG^? -4.26 CL CL B 101s C 163 TYR B 9 TYR^? 9.45 CL CL B 101 C 236 ASP B 64 ASP~? 13.25 CL CL B 101 coo 39.01 29.77 22.02 37.48 31.30 19.84 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 39.51 34.34 13.63 37.63 32.61 14.79 1.66 19.18 35.77 -1.08 19.00 35.58 coo 45.78 31.11 9.51 44.25 30.06 10.53 6.48 14.60 36.08 6.70 13.36 37.77 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG B 11 ARG^? -4.26 CL CL B 101s D 163 TYR B 9 TYR^? 9.45 CL CL B 101 D 236 ASP B 64 ASP~? 13.25 CL CL B 101 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 1.66 19.18 35.77 -1.08 19.00 35.58 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 6.48 14.60 36.08 6.70 13.36 37.77 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR B 9 TYR^? 9.45 CL CL B 101 A 236 ASP B 64 ASP~? 13.25 CL CL B 101 C 110 ARG B 11 ARG^? -4.26 CL CL B 101s coo 55.48 26.51 40.65 55.39 23.99 39.43 1.66 19.18 35.77 -1.08 19.00 35.58 coo 48.87 29.19 44.63 49.10 27.34 43.63 6.48 14.60 36.08 6.70 13.36 37.77 coo 52.39 23.42 32.10 54.51 23.27 34.29 -2.97 22.30 41.65 -2.03 19.36 41.23 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR B 9 TYR^? 9.45 CL CL B 101 B 236 ASP B 64 ASP~? 13.25 CL CL B 101 D 110 ARG B 11 ARG^? -4.26 CL CL B 101s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 1.66 19.18 35.77 -1.08 19.00 35.58 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 6.48 14.60 36.08 6.70 13.36 37.77 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -2.97 22.30 41.65 -2.03 19.36 41.23 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG B 11 ARG^? -4.26 CL CL B 101s G 163 TYR B 9 TYR^? 9.45 CL CL B 101 G 236 ASP B 64 ASP~? 13.25 CL CL B 101 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 1.66 19.18 35.77 -1.08 19.00 35.58 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 6.48 14.60 36.08 6.70 13.36 37.77 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG B 11 ARG^? -4.26 CL CL B 101s H 163 TYR B 9 TYR^? 9.45 CL CL B 101 H 236 ASP B 64 ASP~? 13.25 CL CL B 101 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 1.66 19.18 35.77 -1.08 19.00 35.58 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 6.48 14.60 36.08 6.70 13.36 37.77 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR B 9 TYR^? 9.45 CL CL B 101 E 236 ASP B 64 ASP~? 13.25 CL CL B 101 G 110 ARG B 11 ARG^? -4.26 CL CL B 101s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 1.66 19.18 35.77 -1.08 19.00 35.58 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 6.48 14.60 36.08 6.70 13.36 37.77 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -2.97 22.30 41.65 -2.03 19.36 41.23 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR B 9 TYR^? 9.45 CL CL B 101 F 236 ASP B 64 ASP~? 13.25 CL CL B 101 H 110 ARG B 11 ARG^? -4.26 CL CL B 101s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 1.66 19.18 35.77 -1.08 19.00 35.58 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 6.48 14.60 36.08 6.70 13.36 37.77 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -2.97 22.30 41.65 -2.03 19.36 41.23 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP B 64 ASP~? 13.25 CL CL B 101 A 147 THR B 67 THR~? 10.38 CL CL B 101 A 294 ASP B 73 ASP~? 12.11 CL CL B 101 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 6.48 14.60 36.08 6.70 13.36 37.77 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 3.55 13.82 40.95 5.56 14.17 41.67 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -5.20 12.36 44.75 -6.92 11.08 44.83 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 1 hits 1qgx_c02 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 46 ALA^? 7.37 O1 EDO A 103 A 148 HIS A 61 HIS^? 11.02 CL CL A 101 A 163 ASP B 100 ASP.? 16.19 CL CL A 101 coo 1.42 19.18 21.84 1.11 19.57 23.28 9.02 33.47 30.96 8.90 34.22 29.65 coo 0.71 19.67 27.92 2.43 19.16 26.83 8.98 34.66 37.52 7.84 33.05 38.23 coo 7.15 16.22 27.50 6.15 18.00 27.94 15.54 31.73 32.19 17.10 30.29 31.96 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA B 43 ALA.? 6.51 CL CL B 101 A 148 HIS B 61 HIS^? 11.05 CL CL B 101 A 163 ASP A 100 ASP.? 15.68 CL CL B 101 coo 1.42 19.18 21.84 1.11 19.57 23.28 6.49 19.72 44.71 5.42 20.69 45.24 coo 0.71 19.67 27.92 2.43 19.16 26.83 6.99 25.63 39.23 6.79 27.36 38.08 coo 7.15 16.22 27.50 6.15 18.00 27.94 11.90 26.11 47.01 13.15 27.58 47.89 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA B 46 ALA^? 7.56 CL CL B 101 A 148 HIS B 61 HIS^? 11.05 CL CL B 101 A 163 ASP A 100 ASP.? 15.68 CL CL B 101 coo 1.42 19.18 21.84 1.11 19.57 23.28 5.28 27.16 45.69 4.41 26.51 46.74 coo 0.71 19.67 27.92 2.43 19.16 26.83 6.99 25.63 39.23 6.79 27.36 38.08 coo 7.15 16.22 27.50 6.15 18.00 27.94 11.90 26.11 47.01 13.15 27.58 47.89 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 46 ALA^? 7.37 O1 EDO A 103 B 148 HIS A 61 HIS^? 11.02 CL CL A 101 B 163 ASP B 100 ASP.? 16.19 CL CL A 101 coo -33.97 19.78 54.18 -33.40 20.11 52.82 9.02 33.47 30.96 8.90 34.22 29.65 coo -33.17 20.01 48.16 -34.95 19.37 49.06 8.98 34.66 37.52 7.84 33.05 38.23 coo -39.82 16.62 48.85 -38.59 18.24 48.48 15.54 31.73 32.19 17.10 30.29 31.96 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA B 43 ALA.? 6.51 CL CL B 101 B 148 HIS B 61 HIS^? 11.05 CL CL B 101 B 163 ASP A 100 ASP.? 15.68 CL CL B 101 coo -33.97 19.78 54.18 -33.40 20.11 52.82 6.49 19.72 44.71 5.42 20.69 45.24 coo -33.17 20.01 48.16 -34.95 19.37 49.06 6.99 25.63 39.23 6.79 27.36 38.08 coo -39.82 16.62 48.85 -38.59 18.24 48.48 11.90 26.11 47.01 13.15 27.58 47.89 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA B 46 ALA^? 7.56 CL CL B 101 B 148 HIS B 61 HIS^? 11.05 CL CL B 101 B 163 ASP A 100 ASP.? 15.68 CL CL B 101 coo -33.97 19.78 54.18 -33.40 20.11 52.82 5.28 27.16 45.69 4.41 26.51 46.74 coo -33.17 20.01 48.16 -34.95 19.37 49.06 6.99 25.63 39.23 6.79 27.36 38.08 coo -39.82 16.62 48.85 -38.59 18.24 48.48 11.90 26.11 47.01 13.15 27.58 47.89 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 46 ALA^? 7.37 O1 EDO A 103 C 148 HIS A 61 HIS^? 11.02 CL CL A 101 C 163 ASP B 100 ASP.? 16.19 CL CL A 101 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 9.02 33.47 30.96 8.90 34.22 29.65 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 8.98 34.66 37.52 7.84 33.05 38.23 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 15.54 31.73 32.19 17.10 30.29 31.96 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 46 ALA^? 7.37 O1 EDO A 103 D 148 HIS A 61 HIS^? 11.02 CL CL A 101 D 163 ASP B 100 ASP.? 16.19 CL CL A 101 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 9.02 33.47 30.96 8.90 34.22 29.65 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 8.98 34.66 37.52 7.84 33.05 38.23 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 15.54 31.73 32.19 17.10 30.29 31.96 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 46 ALA^? 7.37 O1 EDO A 103 E 148 HIS A 61 HIS^? 11.02 CL CL A 101 E 163 ASP B 100 ASP.? 16.19 CL CL A 101 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 9.02 33.47 30.96 8.90 34.22 29.65 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 8.98 34.66 37.52 7.84 33.05 38.23 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 15.54 31.73 32.19 17.10 30.29 31.96 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 46 ALA^? 7.37 O1 EDO A 103 F 148 HIS A 61 HIS^? 11.02 CL CL A 101 F 163 ASP B 100 ASP.? 16.19 CL CL A 101 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 9.02 33.47 30.96 8.90 34.22 29.65 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 8.98 34.66 37.52 7.84 33.05 38.23 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 15.54 31.73 32.19 17.10 30.29 31.96 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA B 46 ALA^? 7.56 CL CL B 101 F 148 HIS B 61 HIS^? 11.05 CL CL B 101 F 163 ASP A 100 ASP.? 15.68 CL CL B 101 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 5.28 27.16 45.69 4.41 26.51 46.74 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 6.99 25.63 39.23 6.79 27.36 38.08 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 11.90 26.11 47.01 13.15 27.58 47.89 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 43 ALA.? 6.26 CL CL A 101 G 148 HIS A 61 HIS^? 11.02 CL CL A 101 G 163 ASP B 100 ASP.? 16.19 CL CL A 101 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 12.18 40.11 32.42 11.18 39.45 31.45 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 8.98 34.66 37.52 7.84 33.05 38.23 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 15.54 31.73 32.19 17.10 30.29 31.96 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA A 46 ALA^? 7.37 O1 EDO A 103 G 148 HIS A 61 HIS^? 11.02 CL CL A 101 G 163 ASP B 100 ASP.? 16.19 CL CL A 101 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 9.02 33.47 30.96 8.90 34.22 29.65 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 8.98 34.66 37.52 7.84 33.05 38.23 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 15.54 31.73 32.19 17.10 30.29 31.96 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 46 ALA^? 7.37 O1 EDO A 103 H 148 HIS A 61 HIS^? 11.02 CL CL A 101 H 163 ASP B 100 ASP.? 16.19 CL CL A 101 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 9.02 33.47 30.96 8.90 34.22 29.65 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 8.98 34.66 37.52 7.84 33.05 38.23 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 15.54 31.73 32.19 17.10 30.29 31.96 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA B 46 ALA^? 7.56 CL CL B 101 H 148 HIS B 61 HIS^? 11.05 CL CL B 101 H 163 ASP A 100 ASP.? 15.68 CL CL B 101 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 5.28 27.16 45.69 4.41 26.51 46.74 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 6.99 25.63 39.23 6.79 27.36 38.08 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 11.90 26.11 47.01 13.15 27.58 47.89 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c07 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 23 PHE~? 13.96 C1 EDO A 103 A 201 ASP A 24 ASP~? 18.92 C1 EDO A 103 A 227 LYS B 94 LYS^? 17.24 CL CL B 101 coo 23.39 49.81 32.16 21.33 51.68 32.26 -2.79 27.22 22.27 -1.51 27.13 24.74 coo 25.52 45.12 37.98 23.98 46.65 37.85 0.26 24.62 18.06 -0.77 23.04 19.07 coo 12.68 46.83 36.69 18.26 48.67 34.51 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 72 PHE~? -4.73 O2 EDO A 103s A 201 ASP A 73 ASP~? 10.71 CL CL A 101 A 227 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 23.39 49.81 32.16 21.33 51.68 32.26 2.30 46.06 29.92 -0.17 45.46 28.81 coo 25.52 45.12 37.98 23.98 46.65 37.85 5.34 51.24 29.08 4.06 51.85 30.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 12.12 40.22 23.70 13.00 44.76 21.03 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 72 PHE~? -4.73 O2 EDO A 103s A 201 ASP A 73 ASP~? 10.71 CL CL A 101 A 227 LYS A 65 LYS~? 13.92 CL CL A 101 coo 23.39 49.81 32.16 21.33 51.68 32.26 2.30 46.06 29.92 -0.17 45.46 28.81 coo 25.52 45.12 37.98 23.98 46.65 37.85 5.34 51.24 29.08 4.06 51.85 30.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 6.91 46.21 39.54 1.48 48.90 41.27 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 72 PHE~? 5.57 CL CL B 101 A 201 ASP B 73 ASP~? 12.11 CL CL B 101 A 227 LYS B 37 LYS~? 12.27 CL CL B 101 coo 23.39 49.81 32.16 21.33 51.68 32.26 -4.99 18.42 43.35 -6.92 20.39 43.58 coo 25.52 45.12 37.98 23.98 46.65 37.85 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 12.68 46.83 36.69 18.26 48.67 34.51 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE B 72 PHE~? 5.57 CL CL B 101 A 201 ASP B 73 ASP~? 12.11 CL CL B 101 A 227 LYS B 65 LYS~? 14.42 CL CL B 101 coo 23.39 49.81 32.16 21.33 51.68 32.26 -4.99 18.42 43.35 -6.92 20.39 43.58 coo 25.52 45.12 37.98 23.98 46.65 37.85 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 12.68 46.83 36.69 18.26 48.67 34.51 2.20 15.51 35.93 -2.75 14.71 32.15 1qz9_c02 source 1qz9 KYNURENINASE : 5 hits 1qz9_c02 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 61 HIS^? 11.02 CL CL A 101 A 41 LYS A 94 LYS^? 17.13 CL CL A 101 A 119 HIS B 61 HIS^? 11.05 CL CL B 101 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 8.98 34.66 37.52 7.84 33.05 38.23 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 3.98 41.23 44.04 4.99 47.03 46.41 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 6.99 25.63 39.23 6.79 27.36 38.08 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS B 61 HIS^? 11.05 CL CL B 101 A 41 LYS B 94 LYS^? 17.24 CL CL B 101 A 119 HIS A 61 HIS^? 11.02 CL CL A 101 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 6.99 25.63 39.23 6.79 27.36 38.08 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 2.42 20.83 31.52 1.85 15.08 28.99 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 8.98 34.66 37.52 7.84 33.05 38.23 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 2 hits 1rbn_c01 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG B 98 ARG^? 15.14 CL CL A 101 D 156 TYR B 9 TYR^? 9.45 CL CL B 101 D 188 HIS B 61 HIS^? 11.05 CL CL B 101 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 12.36 28.08 33.40 14.26 29.94 34.96 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 1.66 19.18 35.77 -1.08 19.00 35.58 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 6.99 25.63 39.23 6.79 27.36 38.08 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 3 # 2 D 129 ARG B 98 ARG^? 15.14 CL CL A 101 D 156 TYR B 62 TYR^? -4.93 CL CL B 101s D 188 HIS B 61 HIS^? 11.05 CL CL B 101 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 12.36 28.08 33.40 14.26 29.94 34.96 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 3.66 19.37 41.31 2.04 19.67 43.57 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 6.99 25.63 39.23 6.79 27.36 38.08 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 2 hits 1ro7_c03 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 81 GLU~? 14.16 C2 EDO A 103 B 288 HIS A 61 HIS^? 11.02 CL CL A 101 B 329 LYS A 94 LYS^? 17.13 CL CL A 101 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -1.07 42.33 16.34 -2.16 43.00 14.64 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 8.98 34.66 37.52 7.84 33.05 38.23 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 3.98 41.23 44.04 4.99 47.03 46.41 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 73 ASP~? 10.71 CL CL A 101 595 GLU A 92 GLU^? 7.22 O2 EDO A 103 713 TYR A 62 TYR^? -4.89 CL CL A 101s coo 5.64 2.82 38.49 4.59 4.19 37.25 5.34 51.24 29.08 4.06 51.85 30.69 coo 4.35 13.73 37.63 3.39 12.18 36.55 0.05 42.98 37.01 0.92 44.18 35.56 coo 3.76 10.25 31.38 3.16 9.87 34.10 8.83 41.55 35.27 8.22 41.73 32.60 1sll_c00 source 1sll SIALIDASE L : 1 hits 1sll_c00 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 24 ASP~? 18.92 C1 EDO A 103 E 168 LYS A 20 LYS~? 21.73 C1 EDO A 103 E 201 THR A 26 THR~? 11.13 C1 EDO A 103 coo 5.36 16.20 22.10 3.88 17.00 23.31 0.26 24.62 18.06 -0.77 23.04 19.07 coo 5.06 22.32 18.11 1.02 22.08 22.74 -5.69 24.17 18.67 -2.24 20.17 19.13 coo -1.79 18.29 19.05 -1.19 20.28 19.71 1.24 31.22 19.26 -0.47 32.28 19.98 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 24 ASP~? 18.84 CL CL B 102 E 168 LYS B 20 LYS~? 17.84 CL CL B 102 E 201 THR B 26 THR~? 13.23 CL CL B 102 coo 5.36 16.20 22.10 3.88 17.00 23.31 -4.56 38.47 55.74 -4.13 40.38 54.82 coo 5.06 22.32 18.11 1.02 22.08 22.74 -8.92 41.44 53.64 -4.60 42.92 50.83 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -5.66 32.28 53.16 -7.14 31.96 51.67 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 2 hits 1stc_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 51 SER^? 15.30 C1 EDO A 103 A 90 SER A 55 SER^? 15.30 CL CL A 102 A 145 LYS A 20 LYS~? 21.73 C1 EDO A 103 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 1.47 40.03 18.48 2.45 41.37 16.68 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 7.35 44.71 16.29 4.71 40.98 14.52 -5.69 24.17 18.67 -2.24 20.17 19.13 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER A 55 SER^? 15.30 CL CL A 102 A 90 SER A 51 SER^? 15.30 C1 EDO A 103 A 145 LYS B 94 LYS^? 17.24 CL CL B 101 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 1.47 40.03 18.48 2.45 41.37 16.68 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 7.35 44.71 16.29 4.71 40.98 14.52 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER B 51 SER^? 11.77 CL CL A 102 A 90 SER B 55 SER^? 10.96 CL CL B 102 A 145 LYS B 20 LYS~? 17.84 CL CL B 102 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 1.47 40.03 18.48 2.45 41.37 16.68 -6.97 38.30 45.24 -8.93 39.11 43.98 coo 7.35 44.71 16.29 4.71 40.98 14.52 -8.92 41.44 53.64 -4.60 42.92 50.83 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 4 3 # 4 A 88 SER B 55 SER^? 10.96 CL CL B 102 A 90 SER B 51 SER^? 11.77 CL CL A 102 A 145 LYS A 94 LYS^? 17.13 CL CL A 101 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -6.97 38.30 45.24 -8.93 39.11 43.98 coo 1.47 40.03 18.48 2.45 41.37 16.68 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 7.35 44.71 16.29 4.71 40.98 14.52 3.98 41.23 44.04 4.99 47.03 46.41 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 51 SER^? 15.30 C1 EDO A 103 B 90 SER A 55 SER^? 15.30 CL CL A 102 B 145 LYS A 20 LYS~? 21.73 C1 EDO A 103 coo 61.01 10.03 12.97 58.78 10.97 12.69 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 56.85 12.22 16.37 55.62 11.34 14.45 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 49.80 9.51 14.88 53.14 11.99 12.77 -5.69 24.17 18.67 -2.24 20.17 19.13 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER A 55 SER^? 15.30 CL CL A 102 B 90 SER A 51 SER^? 15.30 C1 EDO A 103 B 145 LYS B 94 LYS^? 17.24 CL CL B 101 coo 61.01 10.03 12.97 58.78 10.97 12.69 -5.33 27.85 25.84 -7.01 27.20 27.45 coo 56.85 12.22 16.37 55.62 11.34 14.45 -4.34 24.54 30.27 -5.29 26.77 29.80 coo 49.80 9.51 14.88 53.14 11.99 12.77 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER B 51 SER^? 11.77 CL CL A 102 B 90 SER B 55 SER^? 10.96 CL CL B 102 B 145 LYS B 20 LYS~? 17.84 CL CL B 102 coo 61.01 10.03 12.97 58.78 10.97 12.69 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 56.85 12.22 16.37 55.62 11.34 14.45 -6.97 38.30 45.24 -8.93 39.11 43.98 coo 49.80 9.51 14.88 53.14 11.99 12.77 -8.92 41.44 53.64 -4.60 42.92 50.83 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 4 3 # 4 B 88 SER B 55 SER^? 10.96 CL CL B 102 B 90 SER B 51 SER^? 11.77 CL CL A 102 B 145 LYS A 94 LYS^? 17.13 CL CL A 101 coo 61.01 10.03 12.97 58.78 10.97 12.69 -6.97 38.30 45.24 -8.93 39.11 43.98 coo 56.85 12.22 16.37 55.62 11.34 14.45 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 49.80 9.51 14.88 53.14 11.99 12.77 3.98 41.23 44.04 4.99 47.03 46.41 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c01 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 45 SER^? 10.94 CL CL A 101 354 GLU A 47 GLU^? 13.35 CL CL A 101 463 HIS A 61 HIS^? 11.02 CL CL A 101 coo 48.87 13.74 2.81 48.49 11.54 3.93 12.09 34.48 32.88 11.31 33.31 34.87 coo 39.95 14.43 3.01 41.55 14.10 1.63 6.76 29.94 33.50 7.56 29.03 35.26 coo 43.90 10.50 2.81 45.63 11.48 3.27 8.98 34.66 37.52 7.84 33.05 38.23 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER B 45 SER^? 10.95 CL CL B 101 354 GLU B 47 GLU^? 13.68 CL CL B 101 463 HIS B 61 HIS^? 11.05 CL CL B 101 coo 48.87 13.74 2.81 48.49 11.54 3.93 8.38 25.14 44.78 8.69 26.36 42.73 coo 39.95 14.43 3.01 41.55 14.10 1.63 5.37 31.65 43.25 6.96 32.44 42.04 coo 43.90 10.50 2.81 45.63 11.48 3.27 6.99 25.63 39.23 6.79 27.36 38.08 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 2 hits 1thg_c00 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 61 HIS^? 11.02 CL CL A 101 A 174 ASP B 100 ASP.? 16.19 CL CL A 101 A 404 TYR A 9 TYR^? 9.51 CL CL A 101 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 8.98 34.66 37.52 7.84 33.05 38.23 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 15.54 31.73 32.19 17.10 30.29 31.96 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS B 61 HIS^? 11.05 CL CL B 101 A 174 ASP A 100 ASP.? 15.68 CL CL B 101 A 404 TYR B 9 TYR^? 9.45 CL CL B 101 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 6.99 25.63 39.23 6.79 27.36 38.08 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 11.90 26.11 47.01 13.15 27.58 47.89 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 1.66 19.18 35.77 -1.08 19.00 35.58 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 61 HIS^? 11.02 CL CL A 101 C 174 ASP B 100 ASP.? 16.19 CL CL A 101 C 404 TYR A 9 TYR^? 9.51 CL CL A 101 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 8.98 34.66 37.52 7.84 33.05 38.23 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 15.54 31.73 32.19 17.10 30.29 31.96 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS B 61 HIS^? 11.05 CL CL B 101 C 174 ASP A 100 ASP.? 15.68 CL CL B 101 C 404 TYR B 9 TYR^? 9.45 CL CL B 101 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 6.99 25.63 39.23 6.79 27.36 38.08 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 11.90 26.11 47.01 13.15 27.58 47.89 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 1.66 19.18 35.77 -1.08 19.00 35.58 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 61 HIS^? 11.02 CL CL A 101 E 174 ASP B 100 ASP.? 16.19 CL CL A 101 E 404 TYR A 9 TYR^? 9.51 CL CL A 101 coo -7.53-107.59 75.19 -8.14-106.04 76.47 8.98 34.66 37.52 7.84 33.05 38.23 coo -3.55-105.39 83.13 -5.21-106.24 82.09 15.54 31.73 32.19 17.10 30.29 31.96 coo -16.31-108.78 75.35 -14.20-107.14 76.16 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS B 61 HIS^? 11.05 CL CL B 101 E 174 ASP A 100 ASP.? 15.68 CL CL B 101 E 404 TYR B 9 TYR^? 9.45 CL CL B 101 coo -7.53-107.59 75.19 -8.14-106.04 76.47 6.99 25.63 39.23 6.79 27.36 38.08 coo -3.55-105.39 83.13 -5.21-106.24 82.09 11.90 26.11 47.01 13.15 27.58 47.89 coo -16.31-108.78 75.35 -14.20-107.14 76.16 1.66 19.18 35.77 -1.08 19.00 35.58 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 61 HIS^? 11.02 CL CL A 101 G 174 ASP B 100 ASP.? 16.19 CL CL A 101 G 404 TYR A 9 TYR^? 9.51 CL CL A 101 coo 60.48-101.16 45.95 60.56-101.20 43.85 8.98 34.66 37.52 7.84 33.05 38.23 coo 58.10-108.15 40.62 59.57-106.86 41.51 15.54 31.73 32.19 17.10 30.29 31.96 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS B 61 HIS^? 11.05 CL CL B 101 G 174 ASP A 100 ASP.? 15.68 CL CL B 101 G 404 TYR B 9 TYR^? 9.45 CL CL B 101 coo 60.48-101.16 45.95 60.56-101.20 43.85 6.99 25.63 39.23 6.79 27.36 38.08 coo 58.10-108.15 40.62 59.57-106.86 41.51 11.90 26.11 47.01 13.15 27.58 47.89 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 1.66 19.18 35.77 -1.08 19.00 35.58 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 61 HIS^? 11.02 CL CL A 101 I 174 ASP B 100 ASP.? 16.19 CL CL A 101 I 404 TYR A 9 TYR^? 9.51 CL CL A 101 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 8.98 34.66 37.52 7.84 33.05 38.23 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 15.54 31.73 32.19 17.10 30.29 31.96 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS B 61 HIS^? 11.05 CL CL B 101 I 174 ASP A 100 ASP.? 15.68 CL CL B 101 I 404 TYR B 9 TYR^? 9.45 CL CL B 101 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 6.99 25.63 39.23 6.79 27.36 38.08 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 11.90 26.11 47.01 13.15 27.58 47.89 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 1.66 19.18 35.77 -1.08 19.00 35.58 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 61 HIS^? 11.02 CL CL A 101 K 174 ASP B 100 ASP.? 16.19 CL CL A 101 K 404 TYR A 9 TYR^? 9.51 CL CL A 101 coo 100.18 26.45 -1.32 99.24 26.12 0.53 8.98 34.66 37.52 7.84 33.05 38.23 coo 102.36 30.86 6.31 102.45 29.08 5.12 15.54 31.73 32.19 17.10 30.29 31.96 coo 99.93 17.48 -0.85 99.14 19.86 0.39 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS B 61 HIS^? 11.05 CL CL B 101 K 174 ASP A 100 ASP.? 15.68 CL CL B 101 K 404 TYR B 9 TYR^? 9.45 CL CL B 101 coo 100.18 26.45 -1.32 99.24 26.12 0.53 6.99 25.63 39.23 6.79 27.36 38.08 coo 102.36 30.86 6.31 102.45 29.08 5.12 11.90 26.11 47.01 13.15 27.58 47.89 coo 99.93 17.48 -0.85 99.14 19.86 0.39 1.66 19.18 35.77 -1.08 19.00 35.58 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c11 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 52 ASN^? 17.78 CL CL A 102 457 GLY B 93 GLY^? 11.80 CL CL B 101 459 GLU B 92 GLU^? 7.39 CL CL B 101 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -7.79 23.14 27.54 -8.54 24.94 26.72 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -0.92 21.83 32.88 -0.40 22.04 33.47 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN B 52 ASN.? 12.21 CL CL A 102 457 GLY A 93 GLY^? 11.67 CL CL A 101 459 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -6.54 43.02 43.04 -7.74 41.31 42.78 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 1.44 41.59 41.31 1.93 41.06 41.01 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 0.05 42.98 37.01 0.92 44.18 35.56 1vom_c00 source 1vom MYOSIN : 2 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 30 PHE~? 6.00 C1 EDO A 103 A 197 ASN A 32 ASN~? 15.60 O1 EDO A 103 A 198 PRO A 36 PRO~? 10.73 O1 EDO A 103 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 3.91 34.16 23.42 2.15 36.32 23.43 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 10.99 31.52 18.55 11.32 29.43 18.67 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 13.52 34.85 22.73 12.85 36.31 24.27 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE A 97 PHE^? 12.39 CL CL B 101 A 197 ASN B 32 ASN~? 16.17 CL CL B 101 A 198 PRO B 36 PRO~? 11.11 CL CL B 101 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 4.50 32.64 50.54 2.47 30.85 50.01 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 1.87 28.17 57.73 3.09 29.83 58.01 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 4.49 24.03 55.09 4.61 22.98 53.15 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE B 30 PHE~? 8.93 CL CL B 101 A 197 ASN B 32 ASN~? 16.17 CL CL B 101 A 198 PRO B 36 PRO~? 11.11 CL CL B 101 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -2.29 29.30 49.67 -4.50 29.02 48.02 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 1.87 28.17 57.73 3.09 29.83 58.01 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 4.49 24.03 55.09 4.61 22.98 53.15 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE B 97 PHE^? 11.11 C1 EDO A 103 A 197 ASN A 32 ASN~? 15.60 O1 EDO A 103 A 198 PRO A 36 PRO~? 10.73 O1 EDO A 103 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 8.21 28.14 26.14 7.00 30.62 25.79 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 10.99 31.52 18.55 11.32 29.43 18.67 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 13.52 34.85 22.73 12.85 36.31 24.27 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 4 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 30 PHE~? 6.00 C1 EDO A 103 B 197 ASN A 32 ASN~? 15.60 O1 EDO A 103 B 198 PRO A 36 PRO~? 10.73 O1 EDO A 103 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 3.91 34.16 23.42 2.15 36.32 23.43 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 10.99 31.52 18.55 11.32 29.43 18.67 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 13.52 34.85 22.73 12.85 36.31 24.27 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE A 97 PHE^? 12.39 CL CL B 101 B 197 ASN B 32 ASN~? 16.17 CL CL B 101 B 198 PRO B 36 PRO~? 11.11 CL CL B 101 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 4.50 32.64 50.54 2.47 30.85 50.01 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 1.87 28.17 57.73 3.09 29.83 58.01 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 4.49 24.03 55.09 4.61 22.98 53.15 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE B 30 PHE~? 8.93 CL CL B 101 B 197 ASN B 32 ASN~? 16.17 CL CL B 101 B 198 PRO B 36 PRO~? 11.11 CL CL B 101 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -2.29 29.30 49.67 -4.50 29.02 48.02 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 1.87 28.17 57.73 3.09 29.83 58.01 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 4.49 24.03 55.09 4.61 22.98 53.15 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE B 97 PHE^? 11.11 C1 EDO A 103 B 197 ASN A 32 ASN~? 15.60 O1 EDO A 103 B 198 PRO A 36 PRO~? 10.73 O1 EDO A 103 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 8.21 28.14 26.14 7.00 30.62 25.79 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 10.99 31.52 18.55 11.32 29.43 18.67 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 13.52 34.85 22.73 12.85 36.31 24.27 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 4 hits 1vq1_c01 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR B 29 TYR~? 11.81 CL CL B 101 A 317 GLU B 81 GLU~? 14.80 CL CL B 101 A 365 ARG B 11 ARG^? -4.26 CL CL B 101s coo 1.77 6.56 57.05 3.05 7.44 59.37 -4.54 27.31 54.97 -5.26 24.64 54.93 coo 3.06 2.85 52.79 4.83 3.89 53.24 -9.05 25.50 55.61 -7.98 24.84 57.33 coo 3.82 17.09 49.56 4.09 14.32 50.84 -2.97 22.30 41.65 -2.03 19.36 41.23 1vzx_c02 source 1vzx 2.04.01.0087 : 1 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR B 29 TYR~? 11.81 CL CL B 101 B1317 GLU B 81 GLU~? 14.80 CL CL B 101 B1365 ARG B 11 ARG^? -4.26 CL CL B 101s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -4.54 27.31 54.97 -5.26 24.64 54.93 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -9.05 25.50 55.61 -7.98 24.84 57.33 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -2.97 22.30 41.65 -2.03 19.36 41.23 1vzx_c03 source 1vzx 2.04.01.0087 : 1 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR B 62 TYR^? -4.93 CL CL B 101s A 40 ASP B 73 ASP~? 12.11 CL CL B 101 A 103 LEU B 41 LEU~? 9.69 CL CL B 101 coo 12.09 16.13 10.57 11.28 18.80 10.73 3.66 19.37 41.31 2.04 19.67 43.57 coo 7.55 25.51 14.34 9.65 25.73 14.24 -5.20 12.36 44.75 -6.92 11.08 44.83 coo 11.83 18.73 16.99 10.99 19.71 15.26 3.88 15.02 48.99 2.68 14.19 50.57 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 1 hits 1vzz_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 17 ALA.? 14.50 C1 EDO A 103 B 126 ARG A 87 ARG^? 9.16 CL CL A 102 B 138 GLU A 53 GLU.? 23.22 C1 EDO A 103 coo 2.11 4.00 19.31 3.14 4.86 19.99 -6.67 31.09 20.87 -5.46 30.41 20.26 coo 2.45 5.53 11.28 3.59 7.56 13.29 -11.91 35.66 26.57 -12.50 35.32 29.59 coo 6.10 2.00 25.24 6.12 1.84 23.13 -8.19 22.01 22.51 -9.28 20.94 21.03 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 17 ALA.? 14.50 C1 EDO A 103 D 126 ARG A 87 ARG^? 9.16 CL CL A 102 D 138 GLU A 53 GLU.? 23.22 C1 EDO A 103 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -6.67 31.09 20.87 -5.46 30.41 20.26 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -11.91 35.66 26.57 -12.50 35.32 29.59 coo 6.23 0.50 57.10 5.93 0.72 59.19 -8.19 22.01 22.51 -9.28 20.94 21.03 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 17 ALA.? 14.50 C1 EDO A 103 E 126 ARG A 87 ARG^? 9.16 CL CL A 102 E 138 GLU A 53 GLU.? 23.22 C1 EDO A 103 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -6.67 31.09 20.87 -5.46 30.41 20.26 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -11.91 35.66 26.57 -12.50 35.32 29.59 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -8.19 22.01 22.51 -9.28 20.94 21.03 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c10 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 93 GLY^? 11.67 CL CL A 101 B 175 ARG A 11 ARG^? 4.24 CL CL A 101s B 242 TYR A 62 TYR^? -4.89 CL CL A 101s coo 99.45 58.28 3.33 99.57 58.61 4.10 1.44 41.59 41.31 1.93 41.06 41.01 coo 106.37 63.53 0.89 108.02 63.40 -1.62 2.42 41.34 32.49 3.79 44.02 33.12 coo 100.93 69.04 4.38 99.52 68.48 2.09 8.83 41.55 35.27 8.22 41.73 32.60 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY B 93 GLY^? 11.80 CL CL B 101 B 175 ARG B 11 ARG^? -4.26 CL CL B 101s B 242 TYR B 62 TYR^? -4.93 CL CL B 101s coo 99.45 58.28 3.33 99.57 58.61 4.10 -0.92 21.83 32.88 -0.40 22.04 33.47 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 100.93 69.04 4.38 99.52 68.48 2.09 3.66 19.37 41.31 2.04 19.67 43.57 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 2 hits 1xva_c03 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER B 51 SER^? 11.77 CL CL A 102 A 178 TYR A 9 TYR^? 9.51 CL CL A 101 A 182 LYS A 94 LYS^? 17.13 CL CL A 101 coo 81.46 10.53 21.66 82.20 10.82 19.39 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 87.67 8.69 17.10 86.62 10.83 18.52 5.74 42.78 39.87 3.37 44.03 39.19 coo 85.30 6.17 22.83 87.26 11.02 23.50 3.98 41.23 44.04 4.99 47.03 46.41 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 1 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER B 51 SER^? 11.77 CL CL A 102 B 178 TYR A 9 TYR^? 9.51 CL CL A 101 B 182 LYS A 94 LYS^? 17.13 CL CL A 101 coo 61.22 3.61 34.51 60.46 1.86 35.98 -2.95 40.39 42.14 -4.83 38.89 41.84 coo 54.99 -1.20 35.40 56.04 1.15 36.44 5.74 42.78 39.87 3.37 44.03 39.19 coo 57.40 2.23 30.19 55.43 5.44 33.87 3.98 41.23 44.04 4.99 47.03 46.41 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 1 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 65 LYS~? 13.92 CL CL A 101 A 74 LYS A 94 LYS^? 17.13 CL CL A 101 A 165 GLU A 47 GLU^? 13.35 CL CL A 101 coo 18.28 7.83 36.39 22.82 8.75 39.52 6.91 46.21 39.54 1.48 48.90 41.27 coo 14.16 13.09 37.03 20.00 12.44 37.49 3.98 41.23 44.04 4.99 47.03 46.41 coo 22.22 16.06 48.76 23.94 15.33 49.78 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 74 LYS~? 11.85 CL CL A 101 A 74 LYS A 76 LYS~? 8.49 CL CL A 102 A 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo 18.28 7.83 36.39 22.82 8.75 39.52 7.23 49.23 25.52 13.07 49.77 27.70 coo 14.16 13.09 37.03 20.00 12.44 37.49 1.66 47.49 24.58 -2.99 49.01 27.08 coo 22.22 16.06 48.76 23.94 15.33 49.78 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 74 LYS~? 11.95 CL CL B 101 A 74 LYS B 76 LYS~? 14.96 CL CL B 101 A 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 18.28 7.83 36.39 22.82 8.75 39.52 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 14.16 13.09 37.03 20.00 12.44 37.49 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 22.22 16.06 48.76 23.94 15.33 49.78 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 76 LYS~? 14.96 CL CL B 101 A 74 LYS B 74 LYS~? 11.95 CL CL B 101 A 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 18.28 7.83 36.39 22.82 8.75 39.52 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 14.16 13.09 37.03 20.00 12.44 37.49 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 22.22 16.06 48.76 23.94 15.33 49.78 -4.23 21.44 36.57 -4.25 20.15 38.22 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 74 LYS~? 11.85 CL CL A 101 B 74 LYS A 76 LYS~? 8.49 CL CL A 102 B 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo 13.51 0.92 76.10 12.98 6.13 74.68 7.23 49.23 25.52 13.07 49.77 27.70 coo 19.89 -0.55 76.51 17.10 4.32 77.43 1.66 47.49 24.58 -2.99 49.01 27.08 coo 21.39 11.56 68.52 20.24 13.13 67.73 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 76 LYS~? 8.49 CL CL A 102 B 74 LYS A 74 LYS~? 11.85 CL CL A 101 B 165 GLU A 92 GLU^? 7.22 O2 EDO A 103 coo 13.51 0.92 76.10 12.98 6.13 74.68 1.66 47.49 24.58 -2.99 49.01 27.08 coo 19.89 -0.55 76.51 17.10 4.32 77.43 7.23 49.23 25.52 13.07 49.77 27.70 coo 21.39 11.56 68.52 20.24 13.13 67.73 0.05 42.98 37.01 0.92 44.18 35.56 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 74 LYS~? 11.95 CL CL B 101 B 74 LYS B 76 LYS~? 14.96 CL CL B 101 B 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 13.51 0.92 76.10 12.98 6.13 74.68 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 21.39 11.56 68.52 20.24 13.13 67.73 -4.23 21.44 36.57 -4.25 20.15 38.22 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 76 LYS~? 14.96 CL CL B 101 B 74 LYS B 74 LYS~? 11.95 CL CL B 101 B 165 GLU B 92 GLU^? 7.39 CL CL B 101 coo 13.51 0.92 76.10 12.98 6.13 74.68 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -3.92 13.74 48.91 -1.31 9.83 46.45 coo 21.39 11.56 68.52 20.24 13.13 67.73 -4.23 21.44 36.57 -4.25 20.15 38.22 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1ylu_c01 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER B 45 SER^? 10.95 CL CL B 101 327 GLU B 47 GLU^? 13.68 CL CL B 101 440 HIS B 61 HIS^? 11.05 CL CL B 101 coo 6.96 64.04 57.84 6.74 63.69 60.26 8.38 25.14 44.78 8.69 26.36 42.73 coo 14.82 64.63 62.37 13.47 65.72 61.17 5.37 31.65 43.25 6.96 32.44 42.04 coo 9.52 66.51 63.07 8.75 65.02 61.81 6.99 25.63 39.23 6.79 27.36 38.08 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 1 hits 2ace_c00 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 61 HIS^? 11.02 CL CL A 101 B 163 ALA A 43 ALA.? 6.26 CL CL A 101 B 182 SER A 45 SER^? 10.94 CL CL A 101 coo 30.42 1.98 4.36 29.07 0.41 4.68 8.98 34.66 37.52 7.84 33.05 38.23 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 12.18 40.11 32.42 11.18 39.45 31.45 coo 24.00 -0.17 2.07 24.51 1.00 0.04 12.09 34.48 32.88 11.31 33.31 34.87 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 61 HIS^? 11.02 CL CL A 101 B 163 ALA A 46 ALA^? 7.37 O1 EDO A 103 B 182 SER A 45 SER^? 10.94 CL CL A 101 coo 30.42 1.98 4.36 29.07 0.41 4.68 8.98 34.66 37.52 7.84 33.05 38.23 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 9.02 33.47 30.96 8.90 34.22 29.65 coo 24.00 -0.17 2.07 24.51 1.00 0.04 12.09 34.48 32.88 11.31 33.31 34.87 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS B 61 HIS^? 11.05 CL CL B 101 B 163 ALA B 43 ALA.? 6.51 CL CL B 101 B 182 SER B 45 SER^? 10.95 CL CL B 101 coo 30.42 1.98 4.36 29.07 0.41 4.68 6.99 25.63 39.23 6.79 27.36 38.08 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 6.49 19.72 44.71 5.42 20.69 45.24 coo 24.00 -0.17 2.07 24.51 1.00 0.04 8.38 25.14 44.78 8.69 26.36 42.73 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS B 61 HIS^? 11.05 CL CL B 101 B 163 ALA B 46 ALA^? 7.56 CL CL B 101 B 182 SER B 45 SER^? 10.95 CL CL B 101 coo 30.42 1.98 4.36 29.07 0.41 4.68 6.99 25.63 39.23 6.79 27.36 38.08 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 5.28 27.16 45.69 4.41 26.51 46.74 coo 24.00 -0.17 2.07 24.51 1.00 0.04 8.38 25.14 44.78 8.69 26.36 42.73 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 4 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 98 ARG^? 14.79 CL CL B 101 A 161 ASP A 64 ASP~? 12.85 CL CL A 101 A 174 TYR A 9 TYR^? 9.51 CL CL A 101 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 10.54 31.08 44.97 12.01 28.63 43.83 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 10.93 45.62 41.10 12.24 46.52 39.71 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 98 ARG^? 14.79 CL CL B 101 A 161 ASP A 64 ASP~? 12.85 CL CL A 101 A 174 TYR A 62 TYR^? -4.89 CL CL A 101s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 10.54 31.08 44.97 12.01 28.63 43.83 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 10.93 45.62 41.10 12.24 46.52 39.71 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 8.83 41.55 35.27 8.22 41.73 32.60 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG B 98 ARG^? 15.14 CL CL A 101 A 161 ASP B 64 ASP~? 13.25 CL CL B 101 A 174 TYR B 9 TYR^? 9.45 CL CL B 101 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 12.36 28.08 33.40 14.26 29.94 34.96 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 6.48 14.60 36.08 6.70 13.36 37.77 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 1.66 19.18 35.77 -1.08 19.00 35.58 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG B 98 ARG^? 15.14 CL CL A 101 A 161 ASP B 64 ASP~? 13.25 CL CL B 101 A 174 TYR B 62 TYR^? -4.93 CL CL B 101s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 12.36 28.08 33.40 14.26 29.94 34.96 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 6.48 14.60 36.08 6.70 13.36 37.77 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 3.66 19.37 41.31 2.04 19.67 43.57 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 98 ARG^? 14.79 CL CL B 101 B 161 ASP A 64 ASP~? 12.85 CL CL A 101 B 174 TYR A 9 TYR^? 9.51 CL CL A 101 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 10.54 31.08 44.97 12.01 28.63 43.83 coo -14.86 10.19 8.14 -14.82 12.31 8.42 10.93 45.62 41.10 12.24 46.52 39.71 coo -21.46 12.70 8.53 -19.04 12.30 7.24 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 98 ARG^? 14.79 CL CL B 101 B 161 ASP A 64 ASP~? 12.85 CL CL A 101 B 174 TYR A 62 TYR^? -4.89 CL CL A 101s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 10.54 31.08 44.97 12.01 28.63 43.83 coo -14.86 10.19 8.14 -14.82 12.31 8.42 10.93 45.62 41.10 12.24 46.52 39.71 coo -21.46 12.70 8.53 -19.04 12.30 7.24 8.83 41.55 35.27 8.22 41.73 32.60 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG B 98 ARG^? 15.14 CL CL A 101 B 161 ASP B 64 ASP~? 13.25 CL CL B 101 B 174 TYR B 9 TYR^? 9.45 CL CL B 101 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 12.36 28.08 33.40 14.26 29.94 34.96 coo -14.86 10.19 8.14 -14.82 12.31 8.42 6.48 14.60 36.08 6.70 13.36 37.77 coo -21.46 12.70 8.53 -19.04 12.30 7.24 1.66 19.18 35.77 -1.08 19.00 35.58 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG B 98 ARG^? 15.14 CL CL A 101 B 161 ASP B 64 ASP~? 13.25 CL CL B 101 B 174 TYR B 62 TYR^? -4.93 CL CL B 101s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 12.36 28.08 33.40 14.26 29.94 34.96 coo -14.86 10.19 8.14 -14.82 12.31 8.42 6.48 14.60 36.08 6.70 13.36 37.77 coo -21.46 12.70 8.53 -19.04 12.30 7.24 3.66 19.37 41.31 2.04 19.67 43.57 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 98 ARG^? 14.79 CL CL B 101 C 161 ASP A 64 ASP~? 12.85 CL CL A 101 C 174 TYR A 9 TYR^? 9.51 CL CL A 101 coo 2.84 19.43 40.34 1.59 20.35 37.65 10.54 31.08 44.97 12.01 28.63 43.83 coo -0.62 11.10 28.05 -0.65 13.15 27.46 10.93 45.62 41.10 12.24 46.52 39.71 coo 5.94 13.28 27.17 3.53 13.05 28.58 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 98 ARG^? 14.79 CL CL B 101 C 161 ASP A 64 ASP~? 12.85 CL CL A 101 C 174 TYR A 62 TYR^? -4.89 CL CL A 101s coo 2.84 19.43 40.34 1.59 20.35 37.65 10.54 31.08 44.97 12.01 28.63 43.83 coo -0.62 11.10 28.05 -0.65 13.15 27.46 10.93 45.62 41.10 12.24 46.52 39.71 coo 5.94 13.28 27.17 3.53 13.05 28.58 8.83 41.55 35.27 8.22 41.73 32.60 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG B 98 ARG^? 15.14 CL CL A 101 C 161 ASP B 64 ASP~? 13.25 CL CL B 101 C 174 TYR B 9 TYR^? 9.45 CL CL B 101 coo 2.84 19.43 40.34 1.59 20.35 37.65 12.36 28.08 33.40 14.26 29.94 34.96 coo -0.62 11.10 28.05 -0.65 13.15 27.46 6.48 14.60 36.08 6.70 13.36 37.77 coo 5.94 13.28 27.17 3.53 13.05 28.58 1.66 19.18 35.77 -1.08 19.00 35.58 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG B 98 ARG^? 15.14 CL CL A 101 C 161 ASP B 64 ASP~? 13.25 CL CL B 101 C 174 TYR B 62 TYR^? -4.93 CL CL B 101s coo 2.84 19.43 40.34 1.59 20.35 37.65 12.36 28.08 33.40 14.26 29.94 34.96 coo -0.62 11.10 28.05 -0.65 13.15 27.46 6.48 14.60 36.08 6.70 13.36 37.77 coo 5.94 13.28 27.17 3.53 13.05 28.58 3.66 19.37 41.31 2.04 19.67 43.57 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 98 ARG^? 14.79 CL CL B 101 D 161 ASP A 64 ASP~? 12.85 CL CL A 101 D 174 TYR A 9 TYR^? 9.51 CL CL A 101 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 10.54 31.08 44.97 12.01 28.63 43.83 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 10.93 45.62 41.10 12.24 46.52 39.71 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 98 ARG^? 14.79 CL CL B 101 D 161 ASP A 64 ASP~? 12.85 CL CL A 101 D 174 TYR A 62 TYR^? -4.89 CL CL A 101s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 10.54 31.08 44.97 12.01 28.63 43.83 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 10.93 45.62 41.10 12.24 46.52 39.71 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 8.83 41.55 35.27 8.22 41.73 32.60 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG B 98 ARG^? 15.14 CL CL A 101 D 161 ASP B 64 ASP~? 13.25 CL CL B 101 D 174 TYR B 9 TYR^? 9.45 CL CL B 101 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 12.36 28.08 33.40 14.26 29.94 34.96 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 6.48 14.60 36.08 6.70 13.36 37.77 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 1.66 19.18 35.77 -1.08 19.00 35.58 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG B 98 ARG^? 15.14 CL CL A 101 D 161 ASP B 64 ASP~? 13.25 CL CL B 101 D 174 TYR B 62 TYR^? -4.93 CL CL B 101s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 12.36 28.08 33.40 14.26 29.94 34.96 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 6.48 14.60 36.08 6.70 13.36 37.77 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 3.66 19.37 41.31 2.04 19.67 43.57 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 80 ASP~? 10.02 CL CL A 102 A 233 GLU A 81 GLU~? 14.16 C2 EDO A 103 A 300 ASN A 86 ASN~? 11.47 C1 EDO A 103 coo 12.51 17.07 49.46 12.44 16.89 47.35 -3.16 46.57 21.25 -3.22 47.75 23.02 coo 6.52 19.14 48.16 7.77 18.42 46.61 -1.07 42.33 16.34 -2.16 43.00 14.64 coo 9.30 22.40 41.76 10.10 20.96 40.36 -5.68 35.74 21.70 -4.36 34.88 20.32 2cpu_c01 source 2cpu ALPHA-AMYLASE : 1 hits 2cpu_c01 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS B 65 LYS~? 14.42 CL CL B 101 B 184 LYS B 94 LYS^? 17.24 CL CL B 101 B 345 ASP B 73 ASP~? 12.11 CL CL B 101 coo 38.76 2.27 4.00 34.00 5.99 4.37 2.20 15.51 35.93 -2.75 14.71 32.15 coo 40.63 7.13 9.06 35.85 7.36 8.95 2.42 20.83 31.52 1.85 15.08 28.99 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -5.20 12.36 44.75 -6.92 11.08 44.83 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS B 65 LYS~? 14.42 CL CL B 101 L 184 LYS B 94 LYS^? 17.24 CL CL B 101 L 345 ASP B 73 ASP~? 12.11 CL CL B 101 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 2.20 15.51 35.93 -2.75 14.71 32.15 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 2.42 20.83 31.52 1.85 15.08 28.99 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -5.20 12.36 44.75 -6.92 11.08 44.83 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS B 65 LYS~? 14.42 CL CL B 101 M 184 LYS B 94 LYS^? 17.24 CL CL B 101 M 345 ASP B 73 ASP~? 12.11 CL CL B 101 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 2.20 15.51 35.93 -2.75 14.71 32.15 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 2.42 20.83 31.52 1.85 15.08 28.99 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -5.20 12.36 44.75 -6.92 11.08 44.83 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS B 65 LYS~? 14.42 CL CL B 101 P 184 LYS B 94 LYS^? 17.24 CL CL B 101 P 345 ASP B 73 ASP~? 12.11 CL CL B 101 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 2.20 15.51 35.93 -2.75 14.71 32.15 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 2.42 20.83 31.52 1.85 15.08 28.99 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -5.20 12.36 44.75 -6.92 11.08 44.83 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR B 29 TYR~? 11.81 CL CL B 101 A 245 ASP B 80 ASP~? 13.43 CL CL B 101 A 273 LYS B 74 LYS~? 11.95 CL CL B 101 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -4.54 27.31 54.97 -5.26 24.64 54.93 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -12.29 21.04 51.71 -12.95 19.46 50.41 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -3.92 13.74 48.91 -1.31 9.83 46.45 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 97 PHE^? 12.39 CL CL B 101 A 263 ASP A 100 ASP.? 15.68 CL CL B 101 A 292 LYS B 37 LYS~? 12.27 CL CL B 101 coo 51.51 50.32 16.39 52.13 49.68 13.75 4.50 32.64 50.54 2.47 30.85 50.01 coo 54.43 44.82 23.74 55.21 45.06 21.80 11.90 26.11 47.01 13.15 27.58 47.89 coo 63.95 45.30 16.71 59.11 49.15 16.05 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 97 PHE^? 11.11 C1 EDO A 103 A 263 ASP B 100 ASP.? 16.19 CL CL A 101 A 292 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 51.51 50.32 16.39 52.13 49.68 13.75 8.21 28.14 26.14 7.00 30.62 25.79 coo 54.43 44.82 23.74 55.21 45.06 21.80 15.54 31.73 32.19 17.10 30.29 31.96 coo 63.95 45.30 16.71 59.11 49.15 16.05 12.12 40.22 23.70 13.00 44.76 21.03 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 97 PHE^? 12.39 CL CL B 101 B 263 ASP A 100 ASP.? 15.68 CL CL B 101 B 292 LYS B 37 LYS~? 12.27 CL CL B 101 coo 49.99 26.05 6.28 51.46 26.87 8.49 4.50 32.64 50.54 2.47 30.85 50.01 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 11.90 26.11 47.01 13.15 27.58 47.89 coo 60.53 31.67 0.97 57.79 27.51 3.63 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 97 PHE^? 11.11 C1 EDO A 103 B 263 ASP B 100 ASP.? 16.19 CL CL A 101 B 292 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 49.99 26.05 6.28 51.46 26.87 8.49 8.21 28.14 26.14 7.00 30.62 25.79 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 15.54 31.73 32.19 17.10 30.29 31.96 coo 60.53 31.67 0.97 57.79 27.51 3.63 12.12 40.22 23.70 13.00 44.76 21.03 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 97 PHE^? 12.39 CL CL B 101 C 263 ASP A 100 ASP.? 15.68 CL CL B 101 C 292 LYS B 37 LYS~? 12.27 CL CL B 101 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 4.50 32.64 50.54 2.47 30.85 50.01 coo 19.84 12.02 9.33 18.68 11.23 7.75 11.90 26.11 47.01 13.15 27.58 47.89 coo 12.82 3.49 4.98 17.80 5.59 1.90 2.75 19.57 52.71 1.11 15.06 54.82 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 97 PHE^? 11.11 C1 EDO A 103 C 263 ASP B 100 ASP.? 16.19 CL CL A 101 C 292 LYS A 37 LYS~? 12.10 O1 EDO A 103 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 8.21 28.14 26.14 7.00 30.62 25.79 coo 19.84 12.02 9.33 18.68 11.23 7.75 15.54 31.73 32.19 17.10 30.29 31.96 coo 12.82 3.49 4.98 17.80 5.59 1.90 12.12 40.22 23.70 13.00 44.76 21.03 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 24 ASP~? 18.92 C1 EDO A 103 A 151 LYS A 20 LYS~? 21.73 C1 EDO A 103 A 186 THR A 26 THR~? 11.13 C1 EDO A 103 coo 41.42 17.90 44.98 43.39 18.36 45.61 0.26 24.62 18.06 -0.77 23.04 19.07 coo 45.75 16.58 39.61 47.43 18.26 45.54 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 45.88 23.02 44.72 46.99 21.16 44.68 1.24 31.22 19.26 -0.47 32.28 19.98 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 24 ASP~? 18.84 CL CL B 102 A 151 LYS B 20 LYS~? 17.84 CL CL B 102 A 186 THR B 26 THR~? 13.23 CL CL B 102 coo 41.42 17.90 44.98 43.39 18.36 45.61 -4.56 38.47 55.74 -4.13 40.38 54.82 coo 45.75 16.58 39.61 47.43 18.26 45.54 -8.92 41.44 53.64 -4.60 42.92 50.83 coo 45.88 23.02 44.72 46.99 21.16 44.68 -5.66 32.28 53.16 -7.14 31.96 51.67 2phk_c02 source 2phk MC-PEPTIDE : 2 hits 2phk_c02 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 61 HIS^? 11.02 CL CL A 101 A 40 LYS A 94 LYS^? 17.13 CL CL A 101 A 116 HIS B 61 HIS^? 11.05 CL CL B 101 coo 12.34 -0.45 10.80 13.53 1.19 11.34 8.98 34.66 37.52 7.84 33.05 38.23 coo 18.50 3.53 20.10 16.17 2.61 14.41 3.98 41.23 44.04 4.99 47.03 46.41 coo 14.70 6.01 5.61 14.27 7.69 6.78 6.99 25.63 39.23 6.79 27.36 38.08 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS B 61 HIS^? 11.05 CL CL B 101 A 40 LYS B 94 LYS^? 17.24 CL CL B 101 A 116 HIS A 61 HIS^? 11.02 CL CL A 101 coo 12.34 -0.45 10.80 13.53 1.19 11.34 6.99 25.63 39.23 6.79 27.36 38.08 coo 18.50 3.53 20.10 16.17 2.61 14.41 2.42 20.83 31.52 1.85 15.08 28.99 coo 14.70 6.01 5.61 14.27 7.69 6.78 8.98 34.66 37.52 7.84 33.05 38.23 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 2 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 61 HIS^? 11.02 CL CL A 101 B 40 LYS A 94 LYS^? 17.13 CL CL A 101 B 116 HIS B 61 HIS^? 11.05 CL CL B 101 coo -6.35 21.42 14.69 -6.06 23.46 15.04 8.98 34.66 37.52 7.84 33.05 38.23 coo -10.61 31.45 9.72 -8.75 26.69 13.45 3.98 41.23 44.04 4.99 47.03 46.41 coo -0.95 25.22 19.68 -0.68 26.73 18.24 6.99 25.63 39.23 6.79 27.36 38.08 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS B 61 HIS^? 11.05 CL CL B 101 B 40 LYS B 94 LYS^? 17.24 CL CL B 101 B 116 HIS A 61 HIS^? 11.02 CL CL A 101 coo -6.35 21.42 14.69 -6.06 23.46 15.04 6.99 25.63 39.23 6.79 27.36 38.08 coo -10.61 31.45 9.72 -8.75 26.69 13.45 2.42 20.83 31.52 1.85 15.08 28.99 coo -0.95 25.22 19.68 -0.68 26.73 18.24 8.98 34.66 37.52 7.84 33.05 38.23 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 2 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 80 ASP~? 10.02 CL CL A 102 166 GLY A 56 GLY^? 12.41 C1 EDO A 103 169 GLU A 53 GLU.? 23.22 C1 EDO A 103 coo 8.28 6.87 1.62 10.08 5.77 1.34 -3.16 46.57 21.25 -3.22 47.75 23.02 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -2.71 28.45 28.44 -3.06 29.16 28.31 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.19 22.01 22.51 -9.28 20.94 21.03 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 1 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 29 TYR~? 10.97 C1 EDO A 103 A 214 ASP A 24 ASP~? 18.92 C1 EDO A 103 A 256 LYS B 94 LYS^? 17.24 CL CL B 101 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 5.07 34.81 17.81 5.67 37.48 17.25 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 0.26 24.62 18.06 -0.77 23.04 19.07 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR B 29 TYR~? 11.81 CL CL B 101 A 214 ASP B 24 ASP~? 18.84 CL CL B 102 A 256 LYS A 94 LYS^? 17.13 CL CL A 101 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -4.54 27.31 54.97 -5.26 24.64 54.93 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -4.56 38.47 55.74 -4.13 40.38 54.82 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 3.98 41.23 44.04 4.99 47.03 46.41 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 29 TYR~? 10.97 C1 EDO A 103 B 214 ASP A 24 ASP~? 18.92 C1 EDO A 103 B 256 LYS B 94 LYS^? 17.24 CL CL B 101 coo -32.67 22.74 10.17 -32.85 23.98 7.70 5.07 34.81 17.81 5.67 37.48 17.25 coo -26.88 17.61 16.89 -26.08 17.11 15.00 0.26 24.62 18.06 -0.77 23.04 19.07 coo -16.04 12.06 11.09 -17.97 10.54 5.71 2.42 20.83 31.52 1.85 15.08 28.99 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR B 29 TYR~? 11.81 CL CL B 101 B 214 ASP B 24 ASP~? 18.84 CL CL B 102 B 256 LYS A 94 LYS^? 17.13 CL CL A 101 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -4.54 27.31 54.97 -5.26 24.64 54.93 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -4.56 38.47 55.74 -4.13 40.38 54.82 coo -16.04 12.06 11.09 -17.97 10.54 5.71 3.98 41.23 44.04 4.99 47.03 46.41 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 95 ARG^? -17.49 CL CL A 101s A 130 SER A 5 SER.? 15.87 CL CL A 101 A 159 LYS A 94 LYS^? 17.13 CL CL A 101 coo 18.35 45.84 20.99 16.20 47.83 21.89 8.08 35.24 44.69 10.92 34.84 45.57 coo 15.14 43.67 10.77 15.61 44.43 13.04 17.58 39.41 40.94 17.86 41.61 39.98 coo 11.57 48.49 22.18 13.51 49.99 17.21 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 95 ARG^? 16.04 CL CL B 101 A 130 SER B 5 SER.? 22.41 CL CL B 101 A 159 LYS B 94 LYS^? 17.24 CL CL B 101 coo 18.35 45.84 20.99 16.20 47.83 21.89 7.82 25.35 32.62 10.50 24.66 33.91 coo 15.14 43.67 10.77 15.61 44.43 13.04 11.60 14.15 28.24 11.26 16.06 26.77 coo 11.57 48.49 22.18 13.51 49.99 17.21 2.42 20.83 31.52 1.85 15.08 28.99 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 95 ARG^? -17.49 CL CL A 101s B 130 SER A 5 SER.? 15.87 CL CL A 101 B 159 LYS A 94 LYS^? 17.13 CL CL A 101 coo 58.72 31.58 20.45 60.80 29.39 20.94 8.08 35.24 44.69 10.92 34.84 45.57 coo 61.66 35.17 10.39 61.29 34.14 12.56 17.58 39.41 40.94 17.86 41.61 39.98 coo 65.38 28.77 21.17 63.49 28.03 16.12 3.98 41.23 44.04 4.99 47.03 46.41 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 95 ARG^? 16.04 CL CL B 101 B 130 SER B 5 SER.? 22.41 CL CL B 101 B 159 LYS B 94 LYS^? 17.24 CL CL B 101 coo 58.72 31.58 20.45 60.80 29.39 20.94 7.82 25.35 32.62 10.50 24.66 33.91 coo 61.66 35.17 10.39 61.29 34.14 12.56 11.60 14.15 28.24 11.26 16.06 26.77 coo 65.38 28.77 21.17 63.49 28.03 16.12 2.42 20.83 31.52 1.85 15.08 28.99 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c01 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 95 ARG^? -17.49 CL CL A 101s 127 ARG A 98 ARG^? 14.79 CL CL B 101 270 GLU A 47 GLU^? 13.35 CL CL A 101 coo -1.14 25.72 1.64 0.76 28.10 1.50 8.08 35.24 44.69 10.92 34.84 45.57 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 10.54 31.08 44.97 12.01 28.63 43.83 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 95 ARG^? -17.49 CL CL A 101s 127 ARG A 98 ARG^? 14.79 CL CL B 101 270 GLU B 31 GLU~? 16.05 CL CL B 101 coo -1.14 25.72 1.64 0.76 28.10 1.50 8.08 35.24 44.69 10.92 34.84 45.57 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 10.54 31.08 44.97 12.01 28.63 43.83 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 4.21 30.96 54.15 4.85 32.92 54.48 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 98 ARG^? 14.79 CL CL B 101 127 ARG A 95 ARG^? -17.49 CL CL A 101s 270 GLU A 47 GLU^? 13.35 CL CL A 101 coo -1.14 25.72 1.64 0.76 28.10 1.50 10.54 31.08 44.97 12.01 28.63 43.83 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 8.08 35.24 44.69 10.92 34.84 45.57 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 6.76 29.94 33.50 7.56 29.03 35.26 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG A 98 ARG^? 14.79 CL CL B 101 127 ARG A 95 ARG^? -17.49 CL CL A 101s 270 GLU B 31 GLU~? 16.05 CL CL B 101 coo -1.14 25.72 1.64 0.76 28.10 1.50 10.54 31.08 44.97 12.01 28.63 43.83 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 8.08 35.24 44.69 10.92 34.84 45.57 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 4.21 30.96 54.15 4.85 32.92 54.48 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG B 95 ARG^? 16.04 CL CL B 101 127 ARG B 98 ARG^? 15.14 CL CL A 101 270 GLU A 31 GLU~? 15.39 O1 EDO A 103 coo -1.14 25.72 1.64 0.76 28.10 1.50 7.82 25.35 32.62 10.50 24.66 33.91 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 12.36 28.08 33.40 14.26 29.94 34.96 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 10.31 28.74 22.96 10.37 26.64 22.82 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG B 95 ARG^? 16.04 CL CL B 101 127 ARG B 98 ARG^? 15.14 CL CL A 101 270 GLU B 47 GLU^? 13.68 CL CL B 101 coo -1.14 25.72 1.64 0.76 28.10 1.50 7.82 25.35 32.62 10.50 24.66 33.91 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 12.36 28.08 33.40 14.26 29.94 34.96 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 5.37 31.65 43.25 6.96 32.44 42.04 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG B 98 ARG^? 15.14 CL CL A 101 127 ARG B 95 ARG^? 16.04 CL CL B 101 270 GLU A 31 GLU~? 15.39 O1 EDO A 103 coo -1.14 25.72 1.64 0.76 28.10 1.50 12.36 28.08 33.40 14.26 29.94 34.96 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 7.82 25.35 32.62 10.50 24.66 33.91 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 10.31 28.74 22.96 10.37 26.64 22.82 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG B 98 ARG^? 15.14 CL CL A 101 127 ARG B 95 ARG^? 16.04 CL CL B 101 270 GLU B 47 GLU^? 13.68 CL CL B 101 coo -1.14 25.72 1.64 0.76 28.10 1.50 12.36 28.08 33.40 14.26 29.94 34.96 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 7.82 25.35 32.62 10.50 24.66 33.91 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 5.37 31.65 43.25 6.96 32.44 42.04 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 8 hits 5cpa_c01 naa= 3 ULMN 3 1k12_p00 LECTIN user 1 3 # 1 A 52 HIS A 61 HIS^? 11.02 CL CL A 101 A 79 ARG A 95 ARG^? -17.49 CL CL A 101s A 86 ARG A 98 ARG^? 14.79 CL CL B 101 coo -5.53 26.98 5.69 -5.98 25.70 4.09 8.98 34.66 37.52 7.84 33.05 38.23 coo -12.15 26.35 6.05 -10.94 27.19 3.35 8.08 35.24 44.69 10.92 34.84 45.57 coo -9.59 20.48 4.28 -9.21 22.28 1.82 10.54 31.08 44.97 12.01 28.63 43.83 ULMN 3 1k12_p00 LECTIN user 2 3 # 2 A 52 HIS A 61 HIS^? 11.02 CL CL A 101 A 79 ARG A 98 ARG^? 14.79 CL CL B 101 A 86 ARG A 95 ARG^? -17.49 CL CL A 101s coo -5.53 26.98 5.69 -5.98 25.70 4.09 8.98 34.66 37.52 7.84 33.05 38.23 coo -12.15 26.35 6.05 -10.94 27.19 3.35 10.54 31.08 44.97 12.01 28.63 43.83 coo -9.59 20.48 4.28 -9.21 22.28 1.82 8.08 35.24 44.69 10.92 34.84 45.57 ULMN 3 1k12_p00 LECTIN user 3 3 # 3 A 52 HIS B 61 HIS^? 11.05 CL CL B 101 A 79 ARG B 95 ARG^? 16.04 CL CL B 101 A 86 ARG B 98 ARG^? 15.14 CL CL A 101 coo -5.53 26.98 5.69 -5.98 25.70 4.09 6.99 25.63 39.23 6.79 27.36 38.08 coo -12.15 26.35 6.05 -10.94 27.19 3.35 7.82 25.35 32.62 10.50 24.66 33.91 coo -9.59 20.48 4.28 -9.21 22.28 1.82 12.36 28.08 33.40 14.26 29.94 34.96 ULMN 3 1k12_p00 LECTIN user 4 3 # 4 A 52 HIS B 61 HIS^? 11.05 CL CL B 101 A 79 ARG B 98 ARG^? 15.14 CL CL A 101 A 86 ARG B 95 ARG^? 16.04 CL CL B 101 coo -5.53 26.98 5.69 -5.98 25.70 4.09 6.99 25.63 39.23 6.79 27.36 38.08 coo -12.15 26.35 6.05 -10.94 27.19 3.35 12.36 28.08 33.40 14.26 29.94 34.96 coo -9.59 20.48 4.28 -9.21 22.28 1.82 7.82 25.35 32.62 10.50 24.66 33.91 1k12_p00 source 1k12 LECTIN : 4 hits 1k12_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 32 ASN~? 15.60 O1 EDO A 103 coo 5.80 63.03 55.85 5.52 65.03 56.45 10.99 31.52 18.55 11.32 29.43 18.67 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 52 ASN^? 17.78 CL CL A 102 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.79 23.14 27.54 -8.54 24.94 26.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 54 ASN.? 17.43 CL CL A 102 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.62 26.26 21.95 -9.29 26.64 23.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 86 ASN~? 11.47 C1 EDO A 103 coo 5.80 63.03 55.85 5.52 65.03 56.45 -5.68 35.74 21.70 -4.36 34.88 20.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 32 ASN~? 16.17 CL CL B 101 coo 5.80 63.03 55.85 5.52 65.03 56.45 1.87 28.17 57.73 3.09 29.83 58.01 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 52 ASN.? 12.21 CL CL A 102 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.54 43.02 43.04 -7.74 41.31 42.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 54 ASN.? 13.60 CL CL B 102 coo 5.80 63.03 55.85 5.52 65.03 56.45 -9.49 40.69 48.71 -9.67 42.13 50.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 86 ASN~? 10.05 CL CL B 102 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.17 31.86 48.48 -9.81 32.48 50.00 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 8 hits 1kbk_p00 naa= 1 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 22 GLN~? 19.10 C1 EDO A 103 A 11 ASN A 86 ASN~? 11.47 C1 EDO A 103 A 13 ARG A 87 ARG^? 9.16 CL CL A 102 coo 33.45 2.10 7.21 34.51 1.09 5.67 -5.46 29.31 14.77 -7.09 30.58 14.23 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -5.68 35.74 21.70 -4.36 34.88 20.32 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -11.91 35.66 26.57 -12.50 35.32 29.59 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN A 85 GLN~? 15.80 C2 EDO A 103 A 11 ASN A 86 ASN~? 11.47 C1 EDO A 103 A 13 ARG A 87 ARG^? 9.16 CL CL A 102 coo 33.45 2.10 7.21 34.51 1.09 5.67 -4.67 37.80 16.12 -5.58 38.39 14.30 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -5.68 35.74 21.70 -4.36 34.88 20.32 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -11.91 35.66 26.57 -12.50 35.32 29.59 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 3 3 # 3 A 9 GLN B 22 GLN~? 10.56 CL CL B 102 A 11 ASN B 86 ASN~? 10.05 CL CL B 102 A 13 ARG B 87 ARG^? -4.50 CL CL B 102s coo 33.45 2.10 7.21 34.51 1.09 5.67 -12.55 35.73 55.02 -14.48 35.67 54.07 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -11.17 31.86 48.48 -9.81 32.48 50.00 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -15.08 34.06 42.30 -17.00 32.98 40.14 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 4 3 # 4 A 9 GLN B 85 GLN~? 12.15 CL CL B 102 A 11 ASN B 86 ASN~? 10.05 CL CL B 102 A 13 ARG B 87 ARG^? -4.50 CL CL B 102s coo 33.45 2.10 7.21 34.51 1.09 5.67 -11.80 30.87 54.71 -13.65 31.33 55.59 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -11.17 31.86 48.48 -9.81 32.48 50.00 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -15.08 34.06 42.30 -17.00 32.98 40.14 1bdv_d00 source 1bdv GENE REGULATION/DNA : 4 hits 1bdv_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 29 TYR~? 10.97 C1 EDO A 103 I 306 VAL A 33 VAL~? 11.40 O1 EDO A 103 I 308 VAL A 38 VAL~? 5.36 O1 EDO A 103 coo 26.18 35.24 6.87 24.33 35.18 8.97 5.07 34.81 17.81 5.67 37.48 17.25 coo 23.55 29.53 9.81 23.15 27.39 10.24 10.28 35.90 19.65 9.57 36.73 17.71 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.70 40.65 27.22 8.81 39.64 27.48 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR B 29 TYR~? 11.81 CL CL B 101 I 306 VAL B 33 VAL~? 11.89 CL CL B 101 I 308 VAL B 38 VAL~? 5.23 CL CL B 101 coo 26.18 35.24 6.87 24.33 35.18 8.97 -4.54 27.31 54.97 -5.26 24.64 54.93 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.00 24.44 55.72 -1.88 24.13 56.83 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.05 19.63 48.91 1.73 21.14 48.03 1cqt_d00 source 1cqt GENE REGULATION/DNA : 2 hits 1cqt_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 83 ARG~? -3.23 CL CL A 102s C 71 LYS A 76 LYS~? 8.49 CL CL A 102 C 72 VAL A 79 VAL~? 5.03 C2 EDO A 103 coo 23.89 33.54 29.21 26.59 34.86 28.68 -6.07 43.34 24.57 -5.82 42.72 27.55 coo 25.82 26.89 29.68 23.33 22.98 25.84 1.66 47.49 24.58 -2.99 49.01 27.08 coo 28.86 29.08 30.37 28.04 31.02 29.93 -0.14 43.23 23.16 0.04 43.15 25.35 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG A 95 ARG^? -17.49 CL CL A 101s C 71 LYS A 94 LYS^? 17.13 CL CL A 101 C 72 VAL B 49 VAL^? 13.99 CL CL A 101 coo 23.89 33.54 29.21 26.59 34.86 28.68 8.08 35.24 44.69 10.92 34.84 45.57 coo 25.82 26.89 29.68 23.33 22.98 25.84 3.98 41.23 44.04 4.99 47.03 46.41 coo 28.86 29.08 30.37 28.04 31.02 29.93 1.39 36.43 44.02 2.27 36.59 42.01 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG B 83 ARG~? 10.85 CL CL B 102 C 71 LYS B 76 LYS~? 14.96 CL CL B 101 C 72 VAL B 79 VAL~? 8.15 CL CL B 101 coo 23.89 33.54 29.21 26.59 34.86 28.68 -13.74 24.05 46.82 -12.84 23.81 43.90 coo 25.82 26.89 29.68 23.33 22.98 25.84 -8.46 17.49 49.39 -13.73 16.10 50.24 coo 28.86 29.08 30.37 28.04 31.02 29.93 -8.50 22.54 49.01 -8.39 21.73 46.93 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG B 95 ARG^? 16.04 CL CL B 101 C 71 LYS B 94 LYS^? 17.24 CL CL B 101 C 72 VAL A 49 VAL^? 13.80 C1 EDO A 103 coo 23.89 33.54 29.21 26.59 34.86 28.68 7.82 25.35 32.62 10.50 24.66 33.91 coo 25.82 26.89 29.68 23.33 22.98 25.84 2.42 20.83 31.52 1.85 15.08 28.99 coo 28.86 29.08 30.37 28.04 31.02 29.93 1.83 26.34 30.61 1.89 26.09 32.77 1hwt_d00 source 1hwt GENE REGULATION/DNA : 4 hits 1hwt_d00 naa= 3 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 19 ARG B 11 ARG^? -4.26 CL CL B 101s A 30 THR B 28 THR~? 17.43 CL CL B 101 A 34 VAL B 33 VAL~? 11.89 CL CL B 101 A 38 LYS B 37 LYS~? 12.27 CL CL B 101 coo 30.09 31.19 5.41 30.53 28.24 4.72 -2.97 22.30 41.65 -2.03 19.36 41.23 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -0.99 32.38 55.69 -1.02 33.32 57.62 coo 18.16 36.88 2.14 19.60 35.97 0.73 0.00 24.44 55.72 -1.88 24.13 56.83 coo 16.75 32.35 6.21 21.42 30.93 2.22 2.75 19.57 52.71 1.11 15.06 54.82 1mnm_d00 source 1mnm TRANSCRIPTION/DNA : 1 hits 1mnm_d00 naa= 4 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 76 LYS~? 8.49 CL CL A 102 A 564 VAL A 79 VAL~? 5.03 C2 EDO A 103 A 568 ARG A 83 ARG~? -3.23 CL CL A 102s coo -6.60 80.79 55.64 -8.55 79.48 61.01 1.66 47.49 24.58 -2.99 49.01 27.08 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -0.14 43.23 23.16 0.04 43.15 25.35 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 563 LYS A 94 LYS^? 17.13 CL CL A 101 A 564 VAL B 49 VAL^? 13.99 CL CL A 101 A 568 ARG A 95 ARG^? -17.49 CL CL A 101s coo -6.60 80.79 55.64 -8.55 79.48 61.01 3.98 41.23 44.04 4.99 47.03 46.41 coo -9.25 78.14 55.31 -11.11 77.94 56.39 1.39 36.43 44.02 2.27 36.59 42.01 coo -12.31 74.86 52.32 -13.99 74.91 54.92 8.08 35.24 44.69 10.92 34.84 45.57 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 563 LYS B 76 LYS~? 14.96 CL CL B 101 A 564 VAL B 79 VAL~? 8.15 CL CL B 101 A 568 ARG B 83 ARG~? 10.85 CL CL B 102 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -8.46 17.49 49.39 -13.73 16.10 50.24 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -8.50 22.54 49.01 -8.39 21.73 46.93 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -13.74 24.05 46.82 -12.84 23.81 43.90 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 563 LYS B 94 LYS^? 17.24 CL CL B 101 A 564 VAL A 49 VAL^? 13.80 C1 EDO A 103 A 568 ARG B 95 ARG^? 16.04 CL CL B 101 coo -6.60 80.79 55.64 -8.55 79.48 61.01 2.42 20.83 31.52 1.85 15.08 28.99 coo -9.25 78.14 55.31 -11.11 77.94 56.39 1.83 26.34 30.61 1.89 26.09 32.77 coo -12.31 74.86 52.32 -13.99 74.91 54.92 7.82 25.35 32.62 10.50 24.66 33.91 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 4 hits 1r4i_d00 naa= 3 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 14 SER^? 7.63 CL CL A 102 E 5 VAL A 12 VAL^? 8.61 O2 EDO A 103 E 7 ARG A 11 ARG^? 4.24 CL CL A 101s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -4.09 33.85 30.23 -6.32 34.53 30.57 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 0.46 36.04 34.24 -0.03 34.37 35.58 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 2.42 41.34 32.49 3.79 44.02 33.12 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 35 SER~? 7.73 O1 EDO A 103 E 5 VAL B 99 VAL^? 12.11 O1 EDO A 103 E 7 ARG B 98 ARG^? 15.14 CL CL A 101 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 10.05 35.64 25.48 8.77 33.72 26.17 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 13.02 30.83 28.56 12.89 31.69 26.52 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 12.36 28.08 33.40 14.26 29.94 34.96 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER A 51 SER^? 15.30 C1 EDO A 103 E 5 VAL A 49 VAL^? 13.80 C1 EDO A 103 E 7 ARG B 95 ARG^? 16.04 CL CL B 101 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -4.34 24.54 30.27 -5.29 26.77 29.80 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 1.83 26.34 30.61 1.89 26.09 32.77 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 7.82 25.35 32.62 10.50 24.66 33.91 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER B 35 SER~? 8.71 CL CL B 101 E 5 VAL A 99 VAL^? 12.36 CL CL B 101 E 7 ARG A 98 ARG^? 14.79 CL CL B 101 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 3.17 24.62 50.92 3.13 26.96 50.21 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 8.71 28.11 49.56 7.46 27.42 51.26 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 10.54 31.08 44.97 12.01 28.63 43.83 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER B 51 SER^? 11.77 CL CL A 102 E 5 VAL B 49 VAL^? 13.99 CL CL A 101 E 7 ARG A 95 ARG^? -17.49 CL CL A 101s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -2.95 40.39 42.14 -4.83 38.89 41.84 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 1.39 36.43 44.02 2.27 36.59 42.01 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 8.08 35.24 44.69 10.92 34.84 45.57 2bsq_d00 source 2bsq TRANSCRIPTION : 5 hits 2bsq_d00 naa= 3 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 87 ARG^? 9.16 CL CL A 102 A 50 LYS A 20 LYS~? 21.73 C1 EDO A 103 A 51 ASN A 54 ASN.? 17.43 CL CL A 102 coo 28.68 23.77 42.74 27.76 26.72 42.93 -11.91 35.66 26.57 -12.50 35.32 29.59 coo 14.40 30.33 40.28 14.25 28.31 45.36 -5.69 24.17 18.67 -2.24 20.17 19.13 coo 19.09 30.55 41.51 19.09 28.89 42.82 -7.62 26.26 21.95 -9.29 26.64 23.21 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 5 ARG B 87 ARG^? -4.50 CL CL B 102s A 50 LYS B 20 LYS~? 17.84 CL CL B 102 A 51 ASN B 54 ASN.? 13.60 CL CL B 102 coo 28.68 23.77 42.74 27.76 26.72 42.93 -15.08 34.06 42.30 -17.00 32.98 40.14 coo 14.40 30.33 40.28 14.25 28.31 45.36 -8.92 41.44 53.64 -4.60 42.92 50.83 coo 19.09 30.55 41.51 19.09 28.89 42.82 -9.49 40.69 48.71 -9.67 42.13 50.28 2hos_d00 source 2hos TRANSCRIPTION/DNA : 2 hits 2hos_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 19 SER~? 20.08 C1 EDO A 103 B 37 ASN A 54 ASN.? 17.43 CL CL A 102 B 45 THR A 28 THR~? 16.04 C1 EDO A 103 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -8.21 26.79 17.62 -7.03 27.14 15.50 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -7.62 26.26 21.95 -9.29 26.64 23.21 coo -30.87 34.84 80.57 -28.94 34.51 81.49 6.04 28.84 19.10 6.33 27.60 17.37 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 55 SER^? 15.30 CL CL A 102 B 37 ASN A 54 ASN.? 17.43 CL CL A 102 B 45 THR A 84 THR~? 13.66 CL CL A 102 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -5.33 27.85 25.84 -7.01 27.20 27.45 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -7.62 26.26 21.95 -9.29 26.64 23.21 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -7.25 41.08 18.26 -5.92 42.25 17.01 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER B 19 SER~? 12.98 CL CL B 102 B 37 ASN B 54 ASN.? 13.60 CL CL B 102 B 45 THR B 28 THR~? 17.43 CL CL B 101 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -12.54 40.54 52.92 -12.81 39.02 54.79 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -9.49 40.69 48.71 -9.67 42.13 50.28 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -0.99 32.38 55.69 -1.02 33.32 57.62 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 55 SER^? 10.96 CL CL B 102 B 37 ASN B 54 ASN.? 13.60 CL CL B 102 B 45 THR B 84 THR~? 12.39 CL CL B 102 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -6.97 38.30 45.24 -8.93 39.11 43.98 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -9.49 40.69 48.71 -9.67 42.13 50.28 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -14.62 27.87 52.41 -13.94 26.65 54.08 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 4 hits 2z3x_d00 naa= 3 ULMN 3 3pta_d00 TRANSFERASE/DNA user 1 3 # 1 A 682 SER A 19 SER~? 20.08 C1 EDO A 103 A 683 LYS A 20 LYS~? 21.73 C1 EDO A 103 A 684 GLN A 22 GLN~? 19.10 C1 EDO A 103 coo -8.24 -20.23 36.50 -7.44 -18.27 37.68 -8.21 26.79 17.62 -7.03 27.14 15.50 coo -5.30 -22.52 37.30 -6.47 -26.26 32.30 -5.69 24.17 18.67 -2.24 20.17 19.13 coo -3.80 -18.22 38.13 -1.93 -17.88 37.17 -5.46 29.31 14.77 -7.09 30.58 14.23 3pta_d00 source 3pta TRANSFERASE/DNA : 1 hits 3pta_d00 naa= 3 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 G 386 ARG B 95 ARG^? 16.04 CL CL B 101 G 387 HIS A 61 HIS^? 11.02 CL CL A 101 G 390 SER A 45 SER^? 10.94 CL CL A 101 coo 93.17 52.97 31.81 95.66 54.71 32.14 7.82 25.35 32.62 10.50 24.66 33.91 coo 95.60 53.07 40.31 97.10 52.52 41.67 8.98 34.66 37.52 7.84 33.05 38.23 coo 93.25 46.91 38.79 94.12 47.43 36.62 12.09 34.48 32.88 11.31 33.31 34.87 3qrf_d00 source 3qrf DNA BINDING PROTEIN/DNA : 1 hits 3qrf_d00 naa= 3 ULMN 3 3uby_d00 HYDROLASE/DNA user 1 3 # 1 A 162 TYR A 62 TYR^? -4.89 CL CL A 101s A 164 MET A 8 MET?? 17.07 CL CL A 101 A 165 TYR A 9 TYR^? 9.51 CL CL A 101 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 8.83 41.55 35.27 8.22 41.73 32.60 coo 15.31 0.97 33.48 17.04 -1.81 36.11 9.55 39.74 43.31 10.61 38.96 46.36 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 5.74 42.78 39.87 3.37 44.03 39.19 ULMN 3 3uby_d00 HYDROLASE/DNA user 2 3 # 2 A 162 TYR B 62 TYR^? -4.93 CL CL B 101s A 164 MET B 8 MET?? 13.85 CL CL B 101 A 165 TYR B 9 TYR^? 9.45 CL CL B 101 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 3.66 19.37 41.31 2.04 19.67 43.57 coo 15.31 0.97 33.48 17.04 -1.81 36.11 7.41 20.12 34.56 10.22 22.42 36.60 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 1.66 19.18 35.77 -1.08 19.00 35.58 3uby_d00 source 3uby HYDROLASE/DNA : 2 hits 3uby_d00 naa= 3 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 1 3 # 1 B 442 LYS A 76 LYS~? 8.49 CL CL A 102 B 443 VAL A 79 VAL~? 5.03 C2 EDO A 103 B 447 ARG A 83 ARG~? -3.23 CL CL A 102s coo -11.49 8.72 29.13 -11.20 3.78 25.16 1.66 47.49 24.58 -2.99 49.01 27.08 coo -11.96 6.22 31.96 -10.74 4.61 32.81 -0.14 43.23 23.16 0.04 43.15 25.35 coo -14.58 4.58 36.41 -12.11 2.82 36.84 -6.07 43.34 24.57 -5.82 42.72 27.55 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 2 3 # 2 B 442 LYS A 94 LYS^? 17.13 CL CL A 101 B 443 VAL B 49 VAL^? 13.99 CL CL A 101 B 447 ARG A 95 ARG^? -17.49 CL CL A 101s coo -11.49 8.72 29.13 -11.20 3.78 25.16 3.98 41.23 44.04 4.99 47.03 46.41 coo -11.96 6.22 31.96 -10.74 4.61 32.81 1.39 36.43 44.02 2.27 36.59 42.01 coo -14.58 4.58 36.41 -12.11 2.82 36.84 8.08 35.24 44.69 10.92 34.84 45.57 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 3 3 # 3 B 442 LYS B 76 LYS~? 14.96 CL CL B 101 B 443 VAL B 79 VAL~? 8.15 CL CL B 101 B 447 ARG B 83 ARG~? 10.85 CL CL B 102 coo -11.49 8.72 29.13 -11.20 3.78 25.16 -8.46 17.49 49.39 -13.73 16.10 50.24 coo -11.96 6.22 31.96 -10.74 4.61 32.81 -8.50 22.54 49.01 -8.39 21.73 46.93 coo -14.58 4.58 36.41 -12.11 2.82 36.84 -13.74 24.05 46.82 -12.84 23.81 43.90 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 4 3 # 4 B 442 LYS B 94 LYS^? 17.24 CL CL B 101 B 443 VAL A 49 VAL^? 13.80 C1 EDO A 103 B 447 ARG B 95 ARG^? 16.04 CL CL B 101 coo -11.49 8.72 29.13 -11.20 3.78 25.16 2.42 20.83 31.52 1.85 15.08 28.99 coo -11.96 6.22 31.96 -10.74 4.61 32.81 1.83 26.34 30.61 1.89 26.09 32.77 coo -14.58 4.58 36.41 -12.11 2.82 36.84 7.82 25.35 32.62 10.50 24.66 33.91 4hn5_d00 source 4hn5 TRANSCRIPTION/DNA : 4 hits 4hn5_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 61 HIS^? 11.02 CL CL A 101 A 208 ASP A 100 ASP.? 15.68 CL CL B 101 A 296 SER B 5 SER.? 22.41 CL CL B 101 coo 12.72 17.48 24.71 12.80 19.37 23.81 8.98 34.66 37.52 7.84 33.05 38.23 coo 18.47 29.19 29.68 19.30 29.17 27.75 11.90 26.11 47.01 13.15 27.58 47.89 coo 6.89 17.22 46.63 5.08 16.21 47.91 11.60 14.15 28.24 11.26 16.06 26.77 2odj_o00 source 2ODJ PORIN D : 1 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 61 HIS^? 11.02 CL CL A 101 B 208 ASP A 100 ASP.? 15.68 CL CL B 101 B 296 SER B 5 SER.? 22.41 CL CL B 101 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 8.98 34.66 37.52 7.84 33.05 38.23 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 11.90 26.11 47.01 13.15 27.58 47.89 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 11.60 14.15 28.24 11.26 16.06 26.77 2odj_o01 source 2ODJ PORIN D : 1 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 14 SER^? 7.63 CL CL A 102 A 166 PHE A 30 PHE~? 6.00 C1 EDO A 103 A 182 PHE B 97 PHE^? 11.11 C1 EDO A 103 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -4.09 33.85 30.23 -6.32 34.53 30.57 coo -36.62 39.62 84.60 -38.76 41.24 85.25 3.91 34.16 23.42 2.15 36.32 23.43 coo -36.55 45.66 79.22 -38.34 43.94 80.53 8.21 28.14 26.14 7.00 30.62 25.79 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 45 SER^? 10.94 CL CL A 101 A 166 PHE B 97 PHE^? 11.11 C1 EDO A 103 A 182 PHE A 30 PHE~? 6.00 C1 EDO A 103 coo -46.28 37.24 81.97 -44.96 39.32 82.40 12.09 34.48 32.88 11.31 33.31 34.87 coo -36.62 39.62 84.60 -38.76 41.24 85.25 8.21 28.14 26.14 7.00 30.62 25.79 coo -36.55 45.66 79.22 -38.34 43.94 80.53 3.91 34.16 23.42 2.15 36.32 23.43 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 51 SER^? 15.30 C1 EDO A 103 A 166 PHE A 23 PHE~? 13.96 C1 EDO A 103 A 182 PHE A 30 PHE~? 6.00 C1 EDO A 103 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -4.34 24.54 30.27 -5.29 26.77 29.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -2.79 27.22 22.27 -1.51 27.13 24.74 coo -36.55 45.66 79.22 -38.34 43.94 80.53 3.91 34.16 23.42 2.15 36.32 23.43 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 55 SER^? 15.30 CL CL A 102 A 166 PHE A 30 PHE~? 6.00 C1 EDO A 103 A 182 PHE B 97 PHE^? 11.11 C1 EDO A 103 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -5.33 27.85 25.84 -7.01 27.20 27.45 coo -36.62 39.62 84.60 -38.76 41.24 85.25 3.91 34.16 23.42 2.15 36.32 23.43 coo -36.55 45.66 79.22 -38.34 43.94 80.53 8.21 28.14 26.14 7.00 30.62 25.79 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER B 14 SER^? 11.68 CL CL B 102 A 166 PHE B 30 PHE~? 8.93 CL CL B 101 A 182 PHE A 97 PHE^? 12.39 CL CL B 101 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -6.31 31.64 41.96 -7.17 33.43 40.56 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -2.29 29.30 49.67 -4.50 29.02 48.02 coo -36.55 45.66 79.22 -38.34 43.94 80.53 4.50 32.64 50.54 2.47 30.85 50.01 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER B 45 SER^? 10.95 CL CL B 101 A 166 PHE A 97 PHE^? 12.39 CL CL B 101 A 182 PHE B 30 PHE~? 8.93 CL CL B 101 coo -46.28 37.24 81.97 -44.96 39.32 82.40 8.38 25.14 44.78 8.69 26.36 42.73 coo -36.62 39.62 84.60 -38.76 41.24 85.25 4.50 32.64 50.54 2.47 30.85 50.01 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -2.29 29.30 49.67 -4.50 29.02 48.02 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER B 51 SER^? 11.77 CL CL A 102 A 166 PHE B 23 PHE~? 14.97 CL CL B 102 A 182 PHE B 30 PHE~? 8.93 CL CL B 101 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -2.95 40.39 42.14 -4.83 38.89 41.84 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -6.14 38.29 50.40 -3.96 38.36 48.76 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -2.29 29.30 49.67 -4.50 29.02 48.02 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER B 55 SER^? 10.96 CL CL B 102 A 166 PHE B 30 PHE~? 8.93 CL CL B 101 A 182 PHE A 97 PHE^? 12.39 CL CL B 101 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -6.97 38.30 45.24 -8.93 39.11 43.98 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -2.29 29.30 49.67 -4.50 29.02 48.02 coo -36.55 45.66 79.22 -38.34 43.94 80.53 4.50 32.64 50.54 2.47 30.85 50.01 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 14 SER^? 7.63 CL CL A 102 B 166 PHE A 30 PHE~? 6.00 C1 EDO A 103 B 182 PHE B 97 PHE^? 11.11 C1 EDO A 103 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -4.09 33.85 30.23 -6.32 34.53 30.57 coo -29.59 43.40 95.66 -28.22 45.54 94.50 3.91 34.16 23.42 2.15 36.32 23.43 coo -32.72 50.15 98.46 -30.32 48.85 97.77 8.21 28.14 26.14 7.00 30.62 25.79 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 45 SER^? 10.94 CL CL A 101 B 166 PHE B 97 PHE^? 11.11 C1 EDO A 103 B 182 PHE A 30 PHE~? 6.00 C1 EDO A 103 coo -19.94 46.29 97.83 -22.38 46.56 97.60 12.09 34.48 32.88 11.31 33.31 34.87 coo -29.59 43.40 95.66 -28.22 45.54 94.50 8.21 28.14 26.14 7.00 30.62 25.79 coo -32.72 50.15 98.46 -30.32 48.85 97.77 3.91 34.16 23.42 2.15 36.32 23.43 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 51 SER^? 15.30 C1 EDO A 103 B 166 PHE A 23 PHE~? 13.96 C1 EDO A 103 B 182 PHE A 30 PHE~? 6.00 C1 EDO A 103 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -4.34 24.54 30.27 -5.29 26.77 29.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -2.79 27.22 22.27 -1.51 27.13 24.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 3.91 34.16 23.42 2.15 36.32 23.43 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 55 SER^? 15.30 CL CL A 102 B 166 PHE A 30 PHE~? 6.00 C1 EDO A 103 B 182 PHE B 97 PHE^? 11.11 C1 EDO A 103 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -5.33 27.85 25.84 -7.01 27.20 27.45 coo -29.59 43.40 95.66 -28.22 45.54 94.50 3.91 34.16 23.42 2.15 36.32 23.43 coo -32.72 50.15 98.46 -30.32 48.85 97.77 8.21 28.14 26.14 7.00 30.62 25.79 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER B 14 SER^? 11.68 CL CL B 102 B 166 PHE B 30 PHE~? 8.93 CL CL B 101 B 182 PHE A 97 PHE^? 12.39 CL CL B 101 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -6.31 31.64 41.96 -7.17 33.43 40.56 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -2.29 29.30 49.67 -4.50 29.02 48.02 coo -32.72 50.15 98.46 -30.32 48.85 97.77 4.50 32.64 50.54 2.47 30.85 50.01 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER B 45 SER^? 10.95 CL CL B 101 B 166 PHE A 97 PHE^? 12.39 CL CL B 101 B 182 PHE B 30 PHE~? 8.93 CL CL B 101 coo -19.94 46.29 97.83 -22.38 46.56 97.60 8.38 25.14 44.78 8.69 26.36 42.73 coo -29.59 43.40 95.66 -28.22 45.54 94.50 4.50 32.64 50.54 2.47 30.85 50.01 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -2.29 29.30 49.67 -4.50 29.02 48.02 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER B 51 SER^? 11.77 CL CL A 102 B 166 PHE B 23 PHE~? 14.97 CL CL B 102 B 182 PHE B 30 PHE~? 8.93 CL CL B 101 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -2.95 40.39 42.14 -4.83 38.89 41.84 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -6.14 38.29 50.40 -3.96 38.36 48.76 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -2.29 29.30 49.67 -4.50 29.02 48.02 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER B 55 SER^? 10.96 CL CL B 102 B 166 PHE B 30 PHE~? 8.93 CL CL B 101 B 182 PHE A 97 PHE^? 12.39 CL CL B 101 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -6.97 38.30 45.24 -8.93 39.11 43.98 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -2.29 29.30 49.67 -4.50 29.02 48.02 coo -32.72 50.15 98.46 -30.32 48.85 97.77 4.50 32.64 50.54 2.47 30.85 50.01 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 14 SER^? 7.63 CL CL A 102 C 166 PHE A 30 PHE~? 6.00 C1 EDO A 103 C 182 PHE B 97 PHE^? 11.11 C1 EDO A 103 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -4.09 33.85 30.23 -6.32 34.53 30.57 coo -11.14 61.91 46.89 -9.88 60.30 48.76 3.91 34.16 23.42 2.15 36.32 23.43 coo -7.71 55.92 42.70 -7.18 57.60 44.85 8.21 28.14 26.14 7.00 30.62 25.79 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 45 SER^? 10.94 CL CL A 101 C 166 PHE B 97 PHE^? 11.11 C1 EDO A 103 C 182 PHE A 30 PHE~? 6.00 C1 EDO A 103 coo -2.19 64.27 51.12 -3.34 62.10 50.60 12.09 34.48 32.88 11.31 33.31 34.87 coo -11.14 61.91 46.89 -9.88 60.30 48.76 8.21 28.14 26.14 7.00 30.62 25.79 coo -7.71 55.92 42.70 -7.18 57.60 44.85 3.91 34.16 23.42 2.15 36.32 23.43 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 51 SER^? 15.30 C1 EDO A 103 C 166 PHE A 23 PHE~? 13.96 C1 EDO A 103 C 182 PHE A 30 PHE~? 6.00 C1 EDO A 103 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -4.34 24.54 30.27 -5.29 26.77 29.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -2.79 27.22 22.27 -1.51 27.13 24.74 coo -7.71 55.92 42.70 -7.18 57.60 44.85 3.91 34.16 23.42 2.15 36.32 23.43 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 55 SER^? 15.30 CL CL A 102 C 166 PHE A 30 PHE~? 6.00 C1 EDO A 103 C 182 PHE B 97 PHE^? 11.11 C1 EDO A 103 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -5.33 27.85 25.84 -7.01 27.20 27.45 coo -11.14 61.91 46.89 -9.88 60.30 48.76 3.91 34.16 23.42 2.15 36.32 23.43 coo -7.71 55.92 42.70 -7.18 57.60 44.85 8.21 28.14 26.14 7.00 30.62 25.79 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER B 14 SER^? 11.68 CL CL B 102 C 166 PHE B 30 PHE~? 8.93 CL CL B 101 C 182 PHE A 97 PHE^? 12.39 CL CL B 101 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -6.31 31.64 41.96 -7.17 33.43 40.56 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -2.29 29.30 49.67 -4.50 29.02 48.02 coo -7.71 55.92 42.70 -7.18 57.60 44.85 4.50 32.64 50.54 2.47 30.85 50.01 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER B 45 SER^? 10.95 CL CL B 101 C 166 PHE A 97 PHE^? 12.39 CL CL B 101 C 182 PHE B 30 PHE~? 8.93 CL CL B 101 coo -2.19 64.27 51.12 -3.34 62.10 50.60 8.38 25.14 44.78 8.69 26.36 42.73 coo -11.14 61.91 46.89 -9.88 60.30 48.76 4.50 32.64 50.54 2.47 30.85 50.01 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -2.29 29.30 49.67 -4.50 29.02 48.02 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER B 51 SER^? 11.77 CL CL A 102 C 166 PHE B 23 PHE~? 14.97 CL CL B 102 C 182 PHE B 30 PHE~? 8.93 CL CL B 101 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -2.95 40.39 42.14 -4.83 38.89 41.84 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -6.14 38.29 50.40 -3.96 38.36 48.76 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -2.29 29.30 49.67 -4.50 29.02 48.02 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER B 55 SER^? 10.96 CL CL B 102 C 166 PHE B 30 PHE~? 8.93 CL CL B 101 C 182 PHE A 97 PHE^? 12.39 CL CL B 101 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -6.97 38.30 45.24 -8.93 39.11 43.98 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -2.29 29.30 49.67 -4.50 29.02 48.02 coo -7.71 55.92 42.70 -7.18 57.60 44.85 4.50 32.64 50.54 2.47 30.85 50.01 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 14 SER^? 7.63 CL CL A 102 D 166 PHE A 30 PHE~? 6.00 C1 EDO A 103 D 182 PHE B 97 PHE^? 11.11 C1 EDO A 103 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -4.09 33.85 30.23 -6.32 34.53 30.57 coo -23.62 58.20 50.84 -23.76 56.14 48.96 3.91 34.16 23.42 2.15 36.32 23.43 coo -23.08 51.44 54.96 -24.43 52.71 52.88 8.21 28.14 26.14 7.00 30.62 25.79 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 45 SER^? 10.94 CL CL A 101 D 166 PHE B 97 PHE^? 11.11 C1 EDO A 103 D 182 PHE A 30 PHE~? 6.00 C1 EDO A 103 coo -32.42 55.27 46.18 -30.51 54.94 47.67 12.09 34.48 32.88 11.31 33.31 34.87 coo -23.62 58.20 50.84 -23.76 56.14 48.96 8.21 28.14 26.14 7.00 30.62 25.79 coo -23.08 51.44 54.96 -24.43 52.71 52.88 3.91 34.16 23.42 2.15 36.32 23.43 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 51 SER^? 15.30 C1 EDO A 103 D 166 PHE A 23 PHE~? 13.96 C1 EDO A 103 D 182 PHE A 30 PHE~? 6.00 C1 EDO A 103 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -4.34 24.54 30.27 -5.29 26.77 29.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -2.79 27.22 22.27 -1.51 27.13 24.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 3.91 34.16 23.42 2.15 36.32 23.43 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 55 SER^? 15.30 CL CL A 102 D 166 PHE A 30 PHE~? 6.00 C1 EDO A 103 D 182 PHE B 97 PHE^? 11.11 C1 EDO A 103 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -5.33 27.85 25.84 -7.01 27.20 27.45 coo -23.62 58.20 50.84 -23.76 56.14 48.96 3.91 34.16 23.42 2.15 36.32 23.43 coo -23.08 51.44 54.96 -24.43 52.71 52.88 8.21 28.14 26.14 7.00 30.62 25.79 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER B 14 SER^? 11.68 CL CL B 102 D 166 PHE B 30 PHE~? 8.93 CL CL B 101 D 182 PHE A 97 PHE^? 12.39 CL CL B 101 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -6.31 31.64 41.96 -7.17 33.43 40.56 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -2.29 29.30 49.67 -4.50 29.02 48.02 coo -23.08 51.44 54.96 -24.43 52.71 52.88 4.50 32.64 50.54 2.47 30.85 50.01 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER B 45 SER^? 10.95 CL CL B 101 D 166 PHE A 97 PHE^? 12.39 CL CL B 101 D 182 PHE B 30 PHE~? 8.93 CL CL B 101 coo -32.42 55.27 46.18 -30.51 54.94 47.67 8.38 25.14 44.78 8.69 26.36 42.73 coo -23.62 58.20 50.84 -23.76 56.14 48.96 4.50 32.64 50.54 2.47 30.85 50.01 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -2.29 29.30 49.67 -4.50 29.02 48.02 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER B 51 SER^? 11.77 CL CL A 102 D 166 PHE B 23 PHE~? 14.97 CL CL B 102 D 182 PHE B 30 PHE~? 8.93 CL CL B 101 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -2.95 40.39 42.14 -4.83 38.89 41.84 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -6.14 38.29 50.40 -3.96 38.36 48.76 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -2.29 29.30 49.67 -4.50 29.02 48.02 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER B 55 SER^? 10.96 CL CL B 102 D 166 PHE B 30 PHE~? 8.93 CL CL B 101 D 182 PHE A 97 PHE^? 12.39 CL CL B 101 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -6.97 38.30 45.24 -8.93 39.11 43.98 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -2.29 29.30 49.67 -4.50 29.02 48.02 coo -23.08 51.44 54.96 -24.43 52.71 52.88 4.50 32.64 50.54 2.47 30.85 50.01 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o03 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 31 GLU~? 15.39 O1 EDO A 103 A 44 ASP A 24 ASP~? 18.92 C1 EDO A 103 A 50 THR A 26 THR~? 11.13 C1 EDO A 103 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 10.31 28.74 22.96 10.37 26.64 22.82 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 0.26 24.62 18.06 -0.77 23.04 19.07 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 1.24 31.22 19.26 -0.47 32.28 19.98 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 92 GLU^? 7.22 O2 EDO A 103 A 44 ASP A 64 ASP~? 12.85 CL CL A 101 A 50 THR A 67 THR~? 9.89 CL CL A 101 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 0.05 42.98 37.01 0.92 44.18 35.56 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 10.93 45.62 41.10 12.24 46.52 39.71 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 10.60 46.69 35.48 12.42 45.52 35.63 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU B 31 GLU~? 16.05 CL CL B 101 A 44 ASP B 24 ASP~? 18.84 CL CL B 102 A 50 THR B 26 THR~? 13.23 CL CL B 102 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 4.21 30.96 54.15 4.85 32.92 54.48 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -4.56 38.47 55.74 -4.13 40.38 54.82 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -5.66 32.28 53.16 -7.14 31.96 51.67 3hde_o00 source 3HDE LYSOZYME : 3 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 31 GLU~? 15.39 O1 EDO A 103 B 44 ASP A 24 ASP~? 18.92 C1 EDO A 103 B 50 THR A 26 THR~? 11.13 C1 EDO A 103 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 10.31 28.74 22.96 10.37 26.64 22.82 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 0.26 24.62 18.06 -0.77 23.04 19.07 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 1.24 31.22 19.26 -0.47 32.28 19.98 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 92 GLU^? 7.22 O2 EDO A 103 B 44 ASP A 64 ASP~? 12.85 CL CL A 101 B 50 THR A 67 THR~? 9.89 CL CL A 101 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 0.05 42.98 37.01 0.92 44.18 35.56 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 10.93 45.62 41.10 12.24 46.52 39.71 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 10.60 46.69 35.48 12.42 45.52 35.63 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU B 31 GLU~? 16.05 CL CL B 101 B 44 ASP B 24 ASP~? 18.84 CL CL B 102 B 50 THR B 26 THR~? 13.23 CL CL B 102 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 4.21 30.96 54.15 4.85 32.92 54.48 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -4.56 38.47 55.74 -4.13 40.38 54.82 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -5.66 32.28 53.16 -7.14 31.96 51.67 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU B 81 GLU~? 14.80 CL CL B 101 B 44 ASP B 24 ASP~? 18.84 CL CL B 102 B 50 THR B 28 THR~? 17.43 CL CL B 101 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -9.05 25.50 55.61 -7.98 24.84 57.33 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -4.56 38.47 55.74 -4.13 40.38 54.82 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -0.99 32.38 55.69 -1.02 33.32 57.62 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU B 92 GLU^? 7.39 CL CL B 101 B 44 ASP B 64 ASP~? 13.25 CL CL B 101 B 50 THR B 67 THR~? 10.38 CL CL B 101 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -4.23 21.44 36.57 -4.25 20.15 38.22 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 6.48 14.60 36.08 6.70 13.36 37.77 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 3.55 13.82 40.95 5.56 14.17 41.67 3hde_o01 source 3HDE LYSOZYME : 5 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 31 GLU~? 15.39 O1 EDO A 103 C 44 ASP A 24 ASP~? 18.92 C1 EDO A 103 C 50 THR A 26 THR~? 11.13 C1 EDO A 103 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 10.31 28.74 22.96 10.37 26.64 22.82 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 0.26 24.62 18.06 -0.77 23.04 19.07 coo 25.48 4.87 1.60 23.90 4.95 0.15 1.24 31.22 19.26 -0.47 32.28 19.98 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 92 GLU^? 7.22 O2 EDO A 103 C 44 ASP A 64 ASP~? 12.85 CL CL A 101 C 50 THR A 67 THR~? 9.89 CL CL A 101 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 0.05 42.98 37.01 0.92 44.18 35.56 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 10.93 45.62 41.10 12.24 46.52 39.71 coo 25.48 4.87 1.60 23.90 4.95 0.15 10.60 46.69 35.48 12.42 45.52 35.63 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU B 31 GLU~? 16.05 CL CL B 101 C 44 ASP B 24 ASP~? 18.84 CL CL B 102 C 50 THR B 26 THR~? 13.23 CL CL B 102 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 4.21 30.96 54.15 4.85 32.92 54.48 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -4.56 38.47 55.74 -4.13 40.38 54.82 coo 25.48 4.87 1.60 23.90 4.95 0.15 -5.66 32.28 53.16 -7.14 31.96 51.67 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU B 81 GLU~? 14.80 CL CL B 101 C 44 ASP B 24 ASP~? 18.84 CL CL B 102 C 50 THR B 28 THR~? 17.43 CL CL B 101 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -9.05 25.50 55.61 -7.98 24.84 57.33 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -4.56 38.47 55.74 -4.13 40.38 54.82 coo 25.48 4.87 1.60 23.90 4.95 0.15 -0.99 32.38 55.69 -1.02 33.32 57.62 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU B 92 GLU^? 7.39 CL CL B 101 C 44 ASP B 64 ASP~? 13.25 CL CL B 101 C 50 THR B 67 THR~? 10.38 CL CL B 101 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -4.23 21.44 36.57 -4.25 20.15 38.22 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 6.48 14.60 36.08 6.70 13.36 37.77 coo 25.48 4.87 1.60 23.90 4.95 0.15 3.55 13.82 40.95 5.56 14.17 41.67 3hde_o02 source 3HDE LYSOZYME : 5 hits 3hde_o02 naa= 3